[{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/9TCjSFw60C","expanded_url":"http://www.pharmafile.com/news/186036/clinical-trials-transparency-journey-so-far#.U3DSUB6n6Ew.twitter","display_url":"pharmafile.com/news/186036/cl…"}],"hashtags":[{"start":20,"end":35,"tag":"ClinicalTrials"},{"start":36,"end":49,"tag":"transparency"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465852885130297344","possibly_sensitive":false,"created_at":"2014-05-12T13:55:57.000Z","referenced_tweets":[{"type":"retweeted","id":"465852275399729152"}],"id":"465852885130297344","text":"RT @nakosbalamotis: #ClinicalTrials #transparency: the journey so far | Pharmafile http://t.co/9TCjSFw60C","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465850186754195457","possibly_sensitive":false,"created_at":"2014-05-12T13:45:14.000Z","referenced_tweets":[{"type":"retweeted","id":"465844411335995392"}],"id":"465850186754195457","text":"RT @Eurovaccine: Epi surveillance of pertussis requires standardisation across EU/EEA, esp standardisation of lab diagnostic methods http:/…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":107,"end":121,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465849478730493952","possibly_sensitive":false,"created_at":"2014-05-12T13:42:25.000Z","referenced_tweets":[{"type":"retweeted","id":"465839670132482048"}],"id":"465849478730493952","text":"RT @EU_Health: Help us improve your experience on our websites! What are your reasons for interacting with @EU_Commission? Survey: https://…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/4lXfJ3u9gi","expanded_url":"http://ow.ly/wJP1D","display_url":"ow.ly/wJP1D"}],"hashtags":[{"start":107,"end":114,"tag":"cancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465848062741864450","possibly_sensitive":false,"created_at":"2014-05-12T13:36:47.000Z","referenced_tweets":[{"type":"retweeted","id":"465819997638787072"}],"id":"465848062741864450","text":"RT @myESMO: ESMOChannel panel discussion: Confronting complexity of targeting the PI3K/AKT/mTOR pathway in #cancer http://t.co/4lXfJ3u9gi","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":33,"end":43,"tag":"Hepatitis"},{"start":93,"end":108,"tag":"thinkhepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465847476902457344","possibly_sensitive":false,"created_at":"2014-05-12T13:34:28.000Z","referenced_tweets":[{"type":"retweeted","id":"465814918181027840"}],"id":"465847476902457344","text":"RT @Hep_Alliance: Official World #Hepatitis Day website just launched! Get involved with our #thinkhepatitis picture campaign now: http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/kY3vKd0BKc","expanded_url":"http://bit.ly/1gcxMb7","display_url":"bit.ly/1gcxMb7"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465817367151665152","possibly_sensitive":false,"created_at":"2014-05-12T11:34:49.000Z","referenced_tweets":{},"id":"465817367151665152","text":"Last Friday we published the PRAC meeting highlights : http://t.co/kY3vKd0BKc","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":109,"end":123,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465802267653066752","possibly_sensitive":false,"created_at":"2014-05-12T10:34:49.000Z","referenced_tweets":[{"type":"retweeted","id":"465788173667557376"}],"id":"465802267653066752","text":"RT @EU_Consumer: Help us improve your experience on our websites! What are your reasons for interacting with @EU_Commission? Survey: https:…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/BbwIaXDjTE","expanded_url":"http://bit.ly/1otvMAs","display_url":"bit.ly/1otvMAs"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"465800782529695744","possibly_sensitive":false,"created_at":"2014-05-12T10:28:55.000Z","referenced_tweets":{},"id":"465800782529695744","text":"Our best practice guidance on scientific advice with health-technology-assessment bodies is open for comments: http://t.co/BbwIaXDjTE","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/8eFhirMg6J","expanded_url":"http://bit.ly/Qi9CVy","display_url":"bit.ly/Qi9CVy"}],"hashtags":[{"start":13,"end":21,"tag":"Deltyba"},{"start":23,"end":33,"tag":"delamanid"},{"start":42,"end":51,"tag":"medicine"},{"start":56,"end":69,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465800444292628480","possibly_sensitive":false,"created_at":"2014-05-12T10:27:34.000Z","referenced_tweets":{},"id":"465800444292628480","text":"The EPAR for #Deltyba (#delamanid), a new #medicine for #tuberculosis, is available on our website: http://t.co/8eFhirMg6J","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/rhabDg3hiA","expanded_url":"http://bit.ly/1hH5feq","display_url":"bit.ly/1hH5feq"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465795661481668608","possibly_sensitive":false,"created_at":"2014-05-12T10:08:34.000Z","referenced_tweets":{},"id":"465795661481668608","text":"RT @ansm_sante: Everything on health products in 2 clicks with the new search on the French medicines agency's site http://t.co/rhabDg3hiA","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/hiOL5UyXze","expanded_url":"http://bit.ly/1ol9Zxu","display_url":"bit.ly/1ol9Zxu"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":77,"end":91,"username":"MichelGoldman","id":"163225697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465775328712200192","possibly_sensitive":false,"created_at":"2014-05-12T08:47:46.000Z","referenced_tweets":[{"type":"retweeted","id":"465775281022988288"}],"id":"465775328712200192","text":"RT @IMI_JU: IMI: uniting 6000 researchers to crack medicine’s toughest nuts. @MichelGoldman in Horizon Mag http://t.co/hiOL5UyXze #JTICalls…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/hPE7fRMYnh","expanded_url":"http://bit.ly/1jjMaU8","display_url":"bit.ly/1jjMaU8"}],"hashtags":[{"start":38,"end":49,"tag":"paediatric"},{"start":83,"end":97,"tag":"ophthalmology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465770324672647168","possibly_sensitive":false,"created_at":"2014-05-12T08:27:53.000Z","referenced_tweets":{},"id":"465770324672647168","text":"Comment now on our draft inventory of #paediatric therapeutic needs in the area of #ophthalmology: http://t.co/hPE7fRMYnh","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"hashtags":[{"start":38,"end":49,"tag":"paediatric"},{"start":83,"end":93,"tag":"neurology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"465770103578296320","possibly_sensitive":false,"created_at":"2014-05-12T08:27:00.000Z","referenced_tweets":{},"id":"465770103578296320","text":"Comment now on our draft inventory of #paediatric therapeutic needs in the area of #neurology: http://t.co/lJ3kCZKKPp","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/Vh5F0yJJeR","expanded_url":"http://bit.ly/1g0Muaq","display_url":"bit.ly/1g0Muaq"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465768044175048704","possibly_sensitive":false,"created_at":"2014-05-12T08:18:49.000Z","referenced_tweets":[{"type":"retweeted","id":"465757436172050432"}],"id":"465768044175048704","text":"RT @EFPIA: \"Patient stem cells used to make 'heart disease-on-a-chip'\" - http://t.co/Vh5F0yJJeR","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/kY3vKd0BKc","expanded_url":"http://bit.ly/1gcxMb7","display_url":"bit.ly/1gcxMb7"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464477070446571520","possibly_sensitive":false,"created_at":"2014-05-08T18:48:57.000Z","referenced_tweets":{},"id":"464477070446571520","text":"We've just published the May 2014 PRAC meeting highlights : http://t.co/kY3vKd0BKc","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":64,"end":78,"tag":"allergenicity"},{"start":87,"end":91,"tag":"GMO"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464437151221174272","possibly_sensitive":false,"created_at":"2014-05-08T16:10:20.000Z","referenced_tweets":[{"type":"retweeted","id":"464434564010889216"}],"id":"464437151221174272","text":"RT @EFSA_EU: #EFSApanel renewal: EFSA is looking for experts in #allergenicity for its #GMO panel. Apply online http://t.co/osrcX2XG6R","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":38,"end":48,"tag":"EuropeDay"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464437102709850112","possibly_sensitive":false,"created_at":"2014-05-08T16:10:08.000Z","referenced_tweets":[{"type":"retweeted","id":"464435063896420352"}],"id":"464437102709850112","text":"RT @eubookshop: On 9 May we celebrate #EuropeDay: wanna know more, easily explained? Check this selection of titles we made for you http://…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/ATxkV2E3yu","expanded_url":"http://europa.eu/!uC47gP","display_url":"europa.eu/!uC47gP"}],"hashtags":[{"start":23,"end":31,"tag":"eHealth"},{"start":71,"end":74,"tag":"EU"},{"start":75,"end":82,"tag":"Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464412135851040769","possibly_sensitive":false,"created_at":"2014-05-08T14:30:56.000Z","referenced_tweets":[{"type":"retweeted","id":"464368400538820609"}],"id":"464412135851040769","text":"RT @EU_Health: Driving #eHealth from promise to reality - focus of our #EU #Health newsletter. Read it at http://t.co/ATxkV2E3yu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/65dIAwLuLs","expanded_url":"http://bit.ly/1mBMMrc","display_url":"bit.ly/1mBMMrc"},{"start":113,"end":135,"url":"http://t.co/H3uZgYVZ6r","expanded_url":"https://twitter.com/IMI_JU/status/464370529118736384/photo/1","display_url":"pic.twitter.com/H3uZgYVZ6r"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464412046826958849","possibly_sensitive":false,"created_at":"2014-05-08T14:30:34.000Z","referenced_tweets":[{"type":"retweeted","id":"464370529118736384"}],"id":"464412046826958849","text":"RT @IMI_JU: The citation impact of IMI research is twice the world average. Find out more http://t.co/65dIAwLuLs http://t.co/H3uZgYVZ6r","attachments":{"media_keys":["3_464370526962475008"]}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/ubDE8Bz2zE","expanded_url":"http://bit.ly/1g40utE","display_url":"bit.ly/1g40utE"}],"hashtags":[{"start":35,"end":46,"tag":"IFAHEurope"},{"start":115,"end":128,"tag":"IEAnConf2014"}],"mentions":[{"start":129,"end":139,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":80,"end":87,"probability":0.7105,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464412013192814592","possibly_sensitive":false,"created_at":"2014-05-08T14:30:26.000Z","referenced_tweets":[{"type":"retweeted","id":"464370838318645248"}],"id":"464412013192814592","text":"RT @IFAHEurope: Registration open! #IFAHEurope Annual Conference, 19 June 2014, Brussels: http://t.co/ubDE8Bz2zE   #IEAnConf2014 @EU_Health…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/8eFhirMg6J","expanded_url":"http://bit.ly/Qi9CVy","display_url":"bit.ly/Qi9CVy"}],"hashtags":[{"start":42,"end":50,"tag":"Deltyba"},{"start":52,"end":62,"tag":"delamanid"},{"start":80,"end":93,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464410222854156288","possibly_sensitive":false,"created_at":"2014-05-08T14:23:20.000Z","referenced_tweets":{},"id":"464410222854156288","text":"We've published the assessment report for #Deltyba (#delamanid), a medicine for #tuberculosis : http://t.co/8eFhirMg6J","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/lJ3kCZKKPp","expanded_url":"http://bit.ly/1kRsIu7","display_url":"bit.ly/1kRsIu7"}],"hashtags":[{"start":37,"end":48,"tag":"paediatric"},{"start":82,"end":92,"tag":"neurology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464408782823751680","possibly_sensitive":false,"created_at":"2014-05-08T14:17:36.000Z","referenced_tweets":{},"id":"464408782823751680","text":"We've published a draft inventory of #paediatric therapeutic needs in the area of #neurology. Comments invited: http://t.co/lJ3kCZKKPp","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/hPE7fRMYnh","expanded_url":"http://bit.ly/1jjMaU8","display_url":"bit.ly/1jjMaU8"}],"hashtags":[{"start":37,"end":48,"tag":"paediatric"},{"start":82,"end":96,"tag":"ophthalmology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464408305914642433","possibly_sensitive":false,"created_at":"2014-05-08T14:15:43.000Z","referenced_tweets":{},"id":"464408305914642433","text":"We've published a draft inventory of #paediatric therapeutic needs in the area of #ophthalmology: http://t.co/hPE7fRMYnh","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/KQ27unQY00","expanded_url":"http://bit.ly/1pP3ODA","display_url":"bit.ly/1pP3ODA"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":97,"tag":"Paeoniae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464396556717002752","possibly_sensitive":false,"created_at":"2014-05-08T13:29:01.000Z","referenced_tweets":{},"id":"464396556717002752","text":"One more week to respond to our call for scientific #data for use in assessment work on #Paeoniae radix: http://t.co/KQ27unQY00","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/BnOohCUrfv","expanded_url":"http://bit.ly/1iACPrq","display_url":"bit.ly/1iACPrq"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":96,"tag":"Origani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464396376236126208","possibly_sensitive":false,"created_at":"2014-05-08T13:28:18.000Z","referenced_tweets":{},"id":"464396376236126208","text":"One more week to respond to our call for scientific #data for use in assessment work on #Origani majoranae herba: http://t.co/BnOohCUrfv","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Ls6e9ulQtq","expanded_url":"http://bit.ly/1nItEr5","display_url":"bit.ly/1nItEr5"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":99,"tag":"Helichrysi"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464396181070946304","possibly_sensitive":false,"created_at":"2014-05-08T13:27:32.000Z","referenced_tweets":{},"id":"464396181070946304","text":"One more week to respond to our call for scientific #data for use in assessment work on #Helichrysi flos: http://t.co/Ls6e9ulQtq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/V49nyHmaO8","expanded_url":"http://bit.ly/R3EYQD","display_url":"bit.ly/R3EYQD"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":97,"tag":"Epilobii"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464395975935922176","possibly_sensitive":false,"created_at":"2014-05-08T13:26:43.000Z","referenced_tweets":{},"id":"464395975935922176","text":"One more week to respond to our call for scientific #data for use in assessment work on #Epilobii herba : http://t.co/V49nyHmaO8","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/t1KnZ8g2R0","expanded_url":"http://bit.ly/1henesn","display_url":"bit.ly/1henesn"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":94,"tag":"Cyani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464395784512086017","possibly_sensitive":false,"created_at":"2014-05-08T13:25:57.000Z","referenced_tweets":{},"id":"464395784512086017","text":"One more week to respond to our call for scientific #data for use in assessment work on #Cyani flos: http://t.co/t1KnZ8g2R0","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/O5dn8K1YIr","expanded_url":"http://bit.ly/1kp6lgC","display_url":"bit.ly/1kp6lgC"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":96,"tag":"Salviae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464395578185875456","possibly_sensitive":false,"created_at":"2014-05-08T13:25:08.000Z","referenced_tweets":{},"id":"464395578185875456","text":"One more week to respond to our call for scientific #data for use in assessment work on #Salviae trilobae folium: http://t.co/O5dn8K1YIr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/DewlmsjxBK","expanded_url":"http://bit.ly/1mZyHmK","display_url":"bit.ly/1mZyHmK"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":98,"tag":"Sideritis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464395322111053824","possibly_sensitive":false,"created_at":"2014-05-08T13:24:07.000Z","referenced_tweets":{},"id":"464395322111053824","text":"One more week to respond to our call for scientific #data for use in assessment work on #Sideritis herba: http://t.co/DewlmsjxBK","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/oAkCpOpZZb","expanded_url":"http://bit.ly/1ez7ihC","display_url":"bit.ly/1ez7ihC"}],"hashtags":[{"start":47,"end":52,"tag":"data"},{"start":78,"end":92,"tag":"Saccharomyces"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464395112693637120","possibly_sensitive":false,"created_at":"2014-05-08T13:23:17.000Z","referenced_tweets":{},"id":"464395112693637120","text":"One week to respond to our call for scientific #data for use in assessment of #Saccharomyces cerevisiae/boulardii: http://t.co/oAkCpOpZZb","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/X91MxYaS7b","expanded_url":"http://bit.ly/M0p72w","display_url":"bit.ly/M0p72w"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":95,"tag":"Ricini"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464394693389066241","possibly_sensitive":false,"created_at":"2014-05-08T13:21:37.000Z","referenced_tweets":{},"id":"464394693389066241","text":"One more week to respond to our call for scientific #data for use in assessment work on #Ricini oleum: http://t.co/X91MxYaS7b","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/BbwIaXDjTE","expanded_url":"http://bit.ly/1otvMAs","display_url":"bit.ly/1otvMAs"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464391049734291457","possibly_sensitive":false,"created_at":"2014-05-08T13:07:08.000Z","referenced_tweets":{},"id":"464391049734291457","text":"Comment on our draft best practice guidance on parallel scientific advice with health-technology-assessment bodies: http://t.co/BbwIaXDjTE","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/HDHFhxKltk","expanded_url":"http://bit.ly/1jdABxN","display_url":"bit.ly/1jdABxN"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464332844610109440","possibly_sensitive":false,"created_at":"2014-05-08T09:15:51.000Z","referenced_tweets":{},"id":"464332844610109440","text":"We're closed tomorrow. An emergency phone line will be available: http://t.co/HDHFhxKltk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/K0kAzIEQKL","expanded_url":"http://bit.ly/MjDPlP","display_url":"bit.ly/MjDPlP"}],"hashtags":[{"start":87,"end":93,"tag":"Cisti"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464329686714417152","possibly_sensitive":false,"created_at":"2014-05-08T09:03:18.000Z","referenced_tweets":{},"id":"464329686714417152","text":"One more week to respond to our call for scientific data for use in assessment work on #Cisti cretici folium/resinum: http://t.co/K0kAzIEQKL","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/pXxylFEJkS","expanded_url":"http://bit.ly/M0oLc5","display_url":"bit.ly/M0oLc5"}],"hashtags":[{"start":52,"end":57,"tag":"data"},{"start":88,"end":97,"tag":"Pistacia"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464329196014436352","possibly_sensitive":false,"created_at":"2014-05-08T09:01:21.000Z","referenced_tweets":{},"id":"464329196014436352","text":"One more week to respond to our call for scientific #data for use in assessment work on #Pistacia lentiscus, resinum: http://t.co/pXxylFEJkS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/nop9P84twk","expanded_url":"http://bit.ly/1jhhZKy","display_url":"bit.ly/1jhhZKy"}],"hashtags":[{"start":47,"end":52,"tag":"data"},{"start":83,"end":94,"tag":"Calendulae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464328414640754688","possibly_sensitive":false,"created_at":"2014-05-08T08:58:15.000Z","referenced_tweets":{},"id":"464328414640754688","text":"One week to respond to our call for scientific #data for use in assessment work on #Calendulae herba: http://t.co/nop9P84twk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/bTJGNv2f5A","expanded_url":"http://www.egagenerics.com/images/factsheet/IMS_deck_for_website.pdf","display_url":"egagenerics.com/images/factshe…"}],"hashtags":[{"start":111,"end":119,"tag":"quality"},{"start":120,"end":126,"tag":"value"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464082851416506369","possibly_sensitive":false,"created_at":"2014-05-07T16:42:28.000Z","referenced_tweets":[{"type":"retweeted","id":"464082793283461120"}],"id":"464082851416506369","text":"RT @egagenerics: Generic Medicines: Where Are the Opportunities and the Role They Play? http://t.co/bTJGNv2f5A #quality #value #sustainabil…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/pwPkypCHzI","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/introduction","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":100,"end":109,"tag":"patients"},{"start":110,"end":118,"tag":"quality"},{"start":119,"end":125,"tag":"value"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464082427934433280","possibly_sensitive":false,"created_at":"2014-05-07T16:40:47.000Z","referenced_tweets":[{"type":"retweeted","id":"464082320883208193"}],"id":"464082427934433280","text":"RT @egagenerics: Generic Medicines: Equivalent Versions of Trusted Medicines http://t.co/pwPkypCHzI #patients #quality #value #sustainabili…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":58,"end":70,"tag":"antibiotics"}],"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464082086367100928","possibly_sensitive":false,"created_at":"2014-05-07T16:39:26.000Z","referenced_tweets":[{"type":"retweeted","id":"464082008809807872"}],"id":"464082086367100928","text":"RT @EU_ScienceChief: We could start by restricting use of #antibiotics in agri and human overuse - WHO warns against 'post-antibiotic' era …","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Tt3t2X7hwP","expanded_url":"http://bit.ly/1mCIpI5","display_url":"bit.ly/1mCIpI5"}],"hashtags":[{"start":13,"end":20,"tag":"iodine"},{"start":56,"end":61,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464075457759940609","possibly_sensitive":false,"created_at":"2014-05-07T16:13:05.000Z","referenced_tweets":[{"type":"retweeted","id":"464075331973160960"}],"id":"464075457759940609","text":"RT @EFSA_EU: #iodine is essential for thyroid function: #EFSA proposes adequate intakes of this important nutrient http://t.co/Tt3t2X7hwP","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":6,"username":"LaBe0","id":"1319836640"},{"start":76,"end":88,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":7,"end":20,"probability":0.4238,"type":"Person","normalized_text":"Infanrix Tetra"},{"start":121,"end":128,"probability":0.9949,"type":"Place","normalized_text":"Portugal"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"464067906062794752","possibly_sensitive":false,"created_at":"2014-05-07T15:45:20.000Z","referenced_tweets":[{"type":"replied_to","id":"464067906062794752"}],"id":"464068470666043392","text":"@LaBe0 Infanrix Tetra is not authorised centrally in the EU. We leave it to @INFARMED_IP to reply about the situation in Portugal.","attachments":{"media_keys":{}},"in_reply_to_user_id":"1319836640"},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/m5Ux610mit","expanded_url":"http://tinyurl.com/lg6o56k","display_url":"tinyurl.com/lg6o56k"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464066645699592192","possibly_sensitive":false,"created_at":"2014-05-07T15:38:04.000Z","referenced_tweets":[{"type":"retweeted","id":"464066345835835393"}],"id":"464066645699592192","text":"RT @MHRAmedicines: Information sent to healthcare professionals in April about the safety of medicines http://t.co/m5Ux610mit","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/gxFBTeln92","expanded_url":"http://bit.ly/1nj7pbg","display_url":"bit.ly/1nj7pbg"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"fr","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464066617450983424","possibly_sensitive":false,"created_at":"2014-05-07T15:37:58.000Z","referenced_tweets":{},"id":"464066617450983424","text":"RT @ansm_sante: Reference information on medicines available on the PUBLIC MEDICINE DATABASE http://t.co/gxFBTeln92","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/h8a6ppv4rK","expanded_url":"http://bit.ly/1oqi414","display_url":"bit.ly/1oqi414"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464062643653709825","possibly_sensitive":false,"created_at":"2014-05-07T15:22:10.000Z","referenced_tweets":{},"id":"464062643653709825","text":"RT @AEMPSGOB: List of veterinary medicines authorised by the Spanish medicines agency for bees http://t.co/h8a6ppv4rK","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":122,"end":133,"tag":"ECRDBerlin"}],"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":17,"end":27,"username":"TREAT_NMD","id":"301911808"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464059616171950080","possibly_sensitive":false,"created_at":"2014-05-07T15:10:08.000Z","referenced_tweets":[{"type":"retweeted","id":"464058896400007168"}],"id":"464059616171950080","text":"RT @BushbyKate: .@TREAT_NMD advisory cttee on therapeutics website has been updated for our upcoming meeting and tutorial #ECRDBerlin http:…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/164JFmZiih","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON413544","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":19,"end":20,"probability":0.8197,"type":"Place","normalized_text":"UK"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464059467093397505","possibly_sensitive":false,"created_at":"2014-05-07T15:09:33.000Z","referenced_tweets":[{"type":"retweeted","id":"464058427971743744"}],"id":"464059467093397505","text":"RT @GCessak: MHRA (UK) press release: Regulator warns people about buying potentially toxic herbal medicines online http://t.co/164JFmZiih …","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464053823322226688","possibly_sensitive":false,"created_at":"2014-05-07T14:47:07.000Z","referenced_tweets":[{"type":"retweeted","id":"464053741600387072"}],"id":"464053823322226688","text":"RT @US_FDA: Arthritis Awareness Month: A Time to Recognize Advancements and Challenges in Developing New Drug Therapies http://t.co/hR2Srn7…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/W9NBFvKQuk","expanded_url":"http://bit.ly/1iXj0eb","display_url":"bit.ly/1iXj0eb"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464053723052789760","possibly_sensitive":false,"created_at":"2014-05-07T14:46:43.000Z","referenced_tweets":{},"id":"464053723052789760","text":"RT @ansm_sante: CESP (Common European Submission Platform): launch of stage II of the pilot phase on 02/06/2014: http://t.co/W9NBFvKQuk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/VeZccYl6zR","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON413544","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":16,"end":26,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464049831996960768","possibly_sensitive":false,"created_at":"2014-05-07T14:31:16.000Z","referenced_tweets":[{"type":"retweeted","id":"464049311370604545"}],"id":"464049831996960768","text":"RT @MHRApress: .@MHRAgovuk warns people about buying potentially toxic herbal medicines online. http://t.co/VeZccYl6zR","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/HDHFhxKltk","expanded_url":"http://bit.ly/1jdABxN","display_url":"bit.ly/1jdABxN"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464038123778093057","possibly_sensitive":false,"created_at":"2014-05-07T13:44:44.000Z","referenced_tweets":{},"id":"464038123778093057","text":"We're closed on Friday. We have an emergency phone number for problems with medicines: http://t.co/HDHFhxKltk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/dtZoaIaKxw","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":36,"end":44,"tag":"vacancy"},{"start":99,"end":111,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464037717748494336","possibly_sensitive":false,"created_at":"2014-05-07T13:43:07.000Z","referenced_tweets":{},"id":"464037717748494336","text":"One more week left to apply for our #vacancy for a Head of Administration: http://t.co/dtZoaIaKxw  #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/gNmwplizxN","expanded_url":"http://bit.ly/Rre19J","display_url":"bit.ly/Rre19J"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464037383344635904","possibly_sensitive":false,"created_at":"2014-05-07T13:41:48.000Z","referenced_tweets":{},"id":"464037383344635904","text":"RT @ansm_sante: Subscribe to the French medicines agency feed for information organised by health-product category: http://t.co/gNmwplizxN","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/9xLLlozgt7","expanded_url":"http://1.usa.gov/1njhFOc","display_url":"1.usa.gov/1njhFOc"}],"hashtags":[{"start":77,"end":82,"tag":"Pets"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464036662197362688","possibly_sensitive":false,"created_at":"2014-05-07T13:38:56.000Z","referenced_tweets":[{"type":"retweeted","id":"464021977955840000"}],"id":"464036662197362688","text":"RT @FDAanimalhealth: NIH Shedding Light on Health, Research Helps People and #Pets http://t.co/9xLLlozgt7","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/DCJJLFhAon","expanded_url":"http://bit.ly/1fTYXwZ","display_url":"bit.ly/1fTYXwZ"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464036119974137856","possibly_sensitive":false,"created_at":"2014-05-07T13:36:47.000Z","referenced_tweets":[{"type":"retweeted","id":"464017083496267776"}],"id":"464036119974137856","text":"RT @EFSAJournal: L-Tryptophan technically pure for all animal species http://t.co/DCJJLFhAon","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/GyMAzGQqyW","expanded_url":"http://bit.ly/SzB7fz","display_url":"bit.ly/SzB7fz"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464036106950815744","possibly_sensitive":false,"created_at":"2014-05-07T13:36:43.000Z","referenced_tweets":[{"type":"retweeted","id":"464017064831614976"}],"id":"464036106950815744","text":"RT @EFSAJournal: L-Threonine for all animal species http://t.co/GyMAzGQqyW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":42,"end":64,"url":"http://t.co/XubXRbS0Ti","expanded_url":"http://bit.ly/1niLiS8","display_url":"bit.ly/1niLiS8"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464035866709479424","possibly_sensitive":false,"created_at":"2014-05-07T13:35:46.000Z","referenced_tweets":[{"type":"retweeted","id":"464016092885942272"}],"id":"464035866709479424","text":"RT @EFPIA: Bone marrow-on-a-chip unveiled http://t.co/XubXRbS0Ti","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/95R2mnutA2","expanded_url":"http://bit.ly/1qe0cLv","display_url":"bit.ly/1qe0cLv"}],"hashtags":[{"start":20,"end":28,"tag":"Package"},{"start":29,"end":37,"tag":"leaflet"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"464035352853094400","possibly_sensitive":false,"created_at":"2014-05-07T13:33:44.000Z","referenced_tweets":{},"id":"464035352853094400","text":"RT @Aifa_ufficiale: #Package #leaflet always up to date in pharmacies: news from the Italian medicines agency http://t.co/95R2mnutA2","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/lFVqeU9xpD","expanded_url":"http://bit.ly/RrbKLH","display_url":"bit.ly/RrbKLH"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"464033842550951936","possibly_sensitive":false,"created_at":"2014-05-07T13:27:44.000Z","referenced_tweets":{},"id":"464033842550951936","text":"RT @Legemiddelinfo: More improvements in our searchable database of medicines: http://t.co/lFVqeU9xpD","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/qd6nZzB9Ok","expanded_url":"http://bit.ly/1mBatQD","display_url":"bit.ly/1mBatQD"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":[{"start":13,"end":16,"probability":0.5306,"type":"Organization","normalized_text":"EPHA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463958210274402304","possibly_sensitive":false,"created_at":"2014-05-07T08:27:11.000Z","referenced_tweets":[{"type":"retweeted","id":"463958040446652416"}],"id":"463958210274402304","text":"RT @EPHA_EU: EPHA is currently recruiting a Secretary General: http://t.co/qd6nZzB9Ok | Deadline for applications is 31 May 2014 | #recruit…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/vQQeBeoaS5","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":40,"end":48,"tag":"vacancy"},{"start":102,"end":114,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463955317718392834","possibly_sensitive":false,"created_at":"2014-05-07T08:15:42.000Z","referenced_tweets":{},"id":"463955317718392834","text":"There is one week left to apply for our #vacancy for a Head of Administration: http://t.co/vQQeBeoaS5 #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/gzjKJDvfHW","expanded_url":"http://bit.ly/1ngeDNf","display_url":"bit.ly/1ngeDNf"}],"hashtags":[{"start":18,"end":26,"tag":"vacancy"}],"mentions":{},"annotations":[{"start":36,"end":79,"probability":0.3995,"type":"Organization","normalized_text":"Information Technology Operations Department"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463717564359933953","possibly_sensitive":false,"created_at":"2014-05-06T16:30:57.000Z","referenced_tweets":{},"id":"463717564359933953","text":"We've published a #vacancy: Head of Information Technology Operations Department: http://t.co/gzjKJDvfHW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/xwP3qJ9gnm","expanded_url":"http://bit.ly/1iYEHVf","display_url":"bit.ly/1iYEHVf"}],"hashtags":[{"start":12,"end":17,"tag":"IMI2"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":52,"end":67,"probability":0.6883,"type":"Organization","normalized_text":"EU Member States"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463685184861511680","possibly_sensitive":false,"created_at":"2014-05-06T14:22:17.000Z","referenced_tweets":[{"type":"retweeted","id":"463682818741370880"}],"id":"463685184861511680","text":"RT @IMI_JU: #IMI2 legislation gets green light from EU Member States at Council meeting http://t.co/xwP3qJ9gnm","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/ock7BFLKDO","expanded_url":"http://bit.ly/1j76vMi","display_url":"bit.ly/1j76vMi"}],"hashtags":[{"start":40,"end":45,"tag":"MRLs"},{"start":50,"end":62,"tag":"metaldehyde"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463653075040096256","possibly_sensitive":false,"created_at":"2014-05-06T12:14:42.000Z","referenced_tweets":[{"type":"retweeted","id":"463633323844435968"}],"id":"463653075040096256","text":"RT @EFSAJournal: Review of the existing #MRLs for #metaldehyde http://t.co/ock7BFLKDO","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/jVE0vD8mF6","expanded_url":"http://bit.ly/1hubMZH","display_url":"bit.ly/1hubMZH"}],"hashtags":[{"start":40,"end":45,"tag":"MRLs"},{"start":50,"end":60,"tag":"dodemorph"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463652824333942784","possibly_sensitive":false,"created_at":"2014-05-06T12:13:42.000Z","referenced_tweets":[{"type":"retweeted","id":"463634280149962753"}],"id":"463652824333942784","text":"RT @EFSAJournal: Review of the existing #MRLs for #dodemorph http://t.co/jVE0vD8mF6","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/gzjKJDvfHW","expanded_url":"http://bit.ly/1ngeDNf","display_url":"bit.ly/1ngeDNf"}],"hashtags":[{"start":100,"end":107,"tag":"ITjobs"}],"mentions":{},"annotations":[{"start":23,"end":74,"probability":0.5829,"type":"Organization","normalized_text":"Head of Information Technology Operations Department"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"463603187002646528","possibly_sensitive":false,"created_at":"2014-05-06T08:56:27.000Z","referenced_tweets":{},"id":"463603187002646528","text":"We're recruiting for a Head of Information Technology Operations Department: http://t.co/gzjKJDvfHW #ITjobs","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":59,"end":71,"tag":"PrimaryCare"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463597253383700480","possibly_sensitive":false,"created_at":"2014-05-06T08:32:53.000Z","referenced_tweets":[{"type":"retweeted","id":"463595491285270528"}],"id":"463597253383700480","text":"RT @EU_Health: #PublicConsultation Expert Panel Opinion on #PrimaryCare definition including financing &amp; referral systems http://t.co/lrlKZ…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"BioRunUp","id":"102527566"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463355732520230912","possibly_sensitive":false,"created_at":"2014-05-05T16:45:10.000Z","referenced_tweets":[{"type":"replied_to","id":"463355732520230912"}],"id":"463358756441849856","text":"@BioRunUp We're afraid not. We should be able to publish it tomorrow.","attachments":{"media_keys":{}},"in_reply_to_user_id":"102527566"},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/uuIuDD7Hki","expanded_url":"http://bit.ly/Rlk7bN","display_url":"bit.ly/Rlk7bN"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":[{"start":67,"end":90,"probability":0.5782,"type":"Organization","normalized_text":"Veterinary Medicine Dept"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463353079979835393","possibly_sensitive":false,"created_at":"2014-05-05T16:22:37.000Z","referenced_tweets":{},"id":"463353079979835393","text":"RT @AEMPSGOB: Quarterly bulletin from the Spanish medicines agency Veterinary Medicine Dept., January - March 2014 http://t.co/uuIuDD7Hki","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":15,"end":37,"url":"http://t.co/CmaGy0m1xC","expanded_url":"http://twitpic.com/e30al0","display_url":"twitpic.com/e30al0"}],"hashtags":[{"start":79,"end":98,"tag":"medicinesshortages"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463339268656889856","possibly_sensitive":false,"created_at":"2014-05-05T15:27:44.000Z","referenced_tweets":[{"type":"retweeted","id":"463339004180451328"}],"id":"463339268656889856","text":"RT @EAHPtweet: http://t.co/CmaGy0m1xC - Last few days to fill in the survey on #medicinesshortages and possibly win free registration to #e…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/4Y2E4zU3at","expanded_url":"http://bit.ly/1upS4HF","display_url":"bit.ly/1upS4HF"}],"hashtags":[{"start":29,"end":38,"tag":"Bacillus"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463331709204049920","possibly_sensitive":false,"created_at":"2014-05-05T14:57:42.000Z","referenced_tweets":[{"type":"retweeted","id":"463330458508738560"}],"id":"463331709204049920","text":"RT @EFSAJournal: Guidance on #Bacillus safety http://t.co/4Y2E4zU3at","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/KLOda8ymyx","expanded_url":"http://bit.ly/Rh2FoV","display_url":"bit.ly/Rh2FoV"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463331622084149248","possibly_sensitive":false,"created_at":"2014-05-05T14:57:21.000Z","referenced_tweets":[{"type":"retweeted","id":"463330442356486145"}],"id":"463331622084149248","text":"RT @EFSAJournal: Yea-Sacc® for calves, cattle, dairy ruminants, lambs and kids for fattening http://t.co/KLOda8ymyx","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/uWK7jbnNTG","expanded_url":"http://bit.ly/1nek0fJ","display_url":"bit.ly/1nek0fJ"}],"hashtags":[{"start":17,"end":27,"tag":"Fumonisin"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463331601049735168","possibly_sensitive":false,"created_at":"2014-05-05T14:57:16.000Z","referenced_tweets":[{"type":"retweeted","id":"463330424203542528"}],"id":"463331601049735168","text":"RT @EFSAJournal: #Fumonisin esterase for pigs http://t.co/uWK7jbnNTG","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/zWuHraxDBQ","expanded_url":"http://bit.ly/1nYCKjj","display_url":"bit.ly/1nYCKjj"}],"hashtags":[{"start":37,"end":42,"tag":"zinc"},{"start":46,"end":51,"tag":"feed"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463331520087097344","possibly_sensitive":false,"created_at":"2014-05-05T14:56:57.000Z","referenced_tweets":[{"type":"retweeted","id":"463330406214164480"}],"id":"463331520087097344","text":"RT @EFSAJournal: Maximum contents of #zinc in #feed http://t.co/zWuHraxDBQ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/knP1Z8au98","expanded_url":"http://ow.ly/wkYD7","display_url":"ow.ly/wkYD7"}],"hashtags":[{"start":67,"end":77,"tag":"pregnancy"},{"start":95,"end":99,"tag":"HCP"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463331424851197952","possibly_sensitive":false,"created_at":"2014-05-05T14:56:34.000Z","referenced_tweets":[{"type":"retweeted","id":"463328676726439936"}],"id":"463331424851197952","text":"RT @FDAWomen: We’re seeking input on best practices to communicate #pregnancy registry info to #HCP &amp; patients: http://t.co/knP1Z8au98","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/rffi4tf5Ou","expanded_url":"http://bit.ly/1niGF8k","display_url":"bit.ly/1niGF8k"},{"start":98,"end":120,"url":"http://t.co/H6IjNC3pK5","expanded_url":"https://twitter.com/EFPIA/status/463315776720478208/photo/1","display_url":"pic.twitter.com/H6IjNC3pK5"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463316431560794112","possibly_sensitive":false,"created_at":"2014-05-05T13:56:59.000Z","referenced_tweets":[{"type":"retweeted","id":"463315776720478208"}],"id":"463316431560794112","text":"RT @EFPIA: Young mice blood may hold key to age-related diseases in humans http://t.co/rffi4tf5Ou http://t.co/H6IjNC3pK5","attachments":{"media_keys":["3_463315776724672513"]}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/EDP3iAA4vb","expanded_url":"http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm","display_url":"fda.gov/Drugs/Resource…"}],"hashtags":[{"start":20,"end":24,"tag":"FDA"},{"start":32,"end":38,"tag":"Bayer"},{"start":58,"end":66,"tag":"Aspirin"},{"start":78,"end":90,"tag":"HeartAttack"},{"start":92,"end":99,"tag":"Stroke"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463316321170894848","possibly_sensitive":false,"created_at":"2014-05-05T13:56:33.000Z","referenced_tweets":[{"type":"retweeted","id":"463315518326575104"}],"id":"463316321170894848","text":"RT @nakosbalamotis: #FDA Denies #Bayer Petition on Use of #Aspirin to Prevent #HeartAttack, #Stroke http://t.co/EDP3iAA4vb http://t.co/ILD6…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/G0lwJMcz0t","expanded_url":"http://bit.ly/1gc0Y19","display_url":"bit.ly/1gc0Y19"}],"hashtags":[{"start":45,"end":59,"tag":"safemedicines"},{"start":60,"end":78,"tag":"pharmacovigilance"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"463313237132730368","possibly_sensitive":false,"created_at":"2014-05-05T13:44:18.000Z","referenced_tweets":{},"id":"463313237132730368","text":"RT @URPLWMiPB: How do I report side effects? #safemedicines #pharmacovigilance http://t.co/G0lwJMcz0t","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":76,"end":87,"tag":"infectious"},{"start":88,"end":96,"tag":"disease"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463312668829294592","possibly_sensitive":false,"created_at":"2014-05-05T13:42:02.000Z","referenced_tweets":[{"type":"retweeted","id":"463303721209053184"}],"id":"463312668829294592","text":"RT @ECDC_EU: #ESCAIDE 2014 call for abstracts now open: submit abstracts on #infectious #disease control &amp; prevention by 25 May! http://t.c…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/BEBXDDGsyU","expanded_url":"http://bit.ly/PvNXcl","display_url":"bit.ly/PvNXcl"}],"hashtags":[{"start":108,"end":115,"tag":"Pharma"},{"start":116,"end":127,"tag":"Compliance"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463312654501953536","possibly_sensitive":false,"created_at":"2014-05-05T13:41:59.000Z","referenced_tweets":[{"type":"retweeted","id":"463303532251467776"}],"id":"463312654501953536","text":"RT @EFPIA: EVENT TODAY - Pharmaceutical Compliance Congress and Best Practices Forum http://t.co/BEBXDDGsyU #Pharma #Compliance","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/hCb192JCaW","expanded_url":"http://bit.ly/Rgs95R","display_url":"bit.ly/Rgs95R"}],"hashtags":[{"start":94,"end":104,"tag":"HealthyEU"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463312522385559552","possibly_sensitive":false,"created_at":"2014-05-05T13:41:27.000Z","referenced_tweets":[{"type":"retweeted","id":"463302701926084608"}],"id":"463312522385559552","text":"RT @EFPIA: PRESS RELEASE:EFPIA Launches Manifesto for an EU Integrated Life Sciences Strategy #HealthyEU http://t.co/hCb192JCaW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/UtuiUFLFeP","expanded_url":"http://bit.ly/1kOzfZB","display_url":"bit.ly/1kOzfZB"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463312028778909696","possibly_sensitive":false,"created_at":"2014-05-05T13:39:30.000Z","referenced_tweets":{},"id":"463312028778909696","text":"RT @LV_MPA: Registry study of paracetamol poisoning http://t.co/UtuiUFLFeP","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/uQB37Ew1by","expanded_url":"http://bit.ly/1muYCUc","display_url":"bit.ly/1muYCUc"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311810066935808","possibly_sensitive":false,"created_at":"2014-05-05T13:38:38.000Z","referenced_tweets":{},"id":"463311810066935808","text":"RT @LV_MPA: Monthly report from the CHMP (April 2014) http://t.co/uQB37Ew1by","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":116,"end":124,"tag":"urinary"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311599844225024","possibly_sensitive":false,"created_at":"2014-05-05T13:37:47.000Z","referenced_tweets":[{"type":"retweeted","id":"463294543098810368"}],"id":"463311599844225024","text":"RT @EFSAJournal: Substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the #urinary tract http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":99,"end":107,"tag":"urinary"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311510027386880","possibly_sensitive":false,"created_at":"2014-05-05T13:37:26.000Z","referenced_tweets":[{"type":"retweeted","id":"463293403120558080"}],"id":"463311510027386880","text":"RT @EFSAJournal: Substantiation of a health claim related to CranMax® and reduction of the risk of #urinary tract infection http://t.co/EMd…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/s3PAmS6epb","expanded_url":"http://bit.ly/1lRm1wb","display_url":"bit.ly/1lRm1wb"}],"hashtags":[{"start":61,"end":66,"tag":"zinc"},{"start":94,"end":101,"tag":"immune"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311483863314434","possibly_sensitive":false,"created_at":"2014-05-05T13:37:20.000Z","referenced_tweets":[{"type":"retweeted","id":"463292531066036224"}],"id":"463311483863314434","text":"RT @EFSAJournal: Substantiation of a health claim related to #zinc and normal function of the #immune system http://t.co/s3PAmS6epb","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":104,"end":111,"tag":"muscle"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311462124240896","possibly_sensitive":false,"created_at":"2014-05-05T13:37:15.000Z","referenced_tweets":[{"type":"retweeted","id":"463292157382905856"}],"id":"463311462124240896","text":"RT @EFSAJournal: Substantiation of a health claim related to citrulline-malate and faster recovery from #muscle fatigue after exercise http…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/vRM3rzWThZ","expanded_url":"http://bit.ly/1icMeUH","display_url":"bit.ly/1icMeUH"}],"hashtags":[{"start":61,"end":69,"tag":"choline"},{"start":90,"end":96,"tag":"brain"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311420462202880","possibly_sensitive":false,"created_at":"2014-05-05T13:37:05.000Z","referenced_tweets":[{"type":"retweeted","id":"463291652208349184"}],"id":"463311420462202880","text":"RT @EFSAJournal: Substantiation of a health claim related to #choline and \"development of #brain\" http://t.co/vRM3rzWThZ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/eMkEwRZXZa","expanded_url":"http://bit.ly/Q5NCxl","display_url":"bit.ly/Q5NCxl"}],"hashtags":[{"start":69,"end":83,"tag":"carbohydrates"},{"start":102,"end":110,"tag":"satiety"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311369451077632","possibly_sensitive":false,"created_at":"2014-05-05T13:36:53.000Z","referenced_tweets":[{"type":"retweeted","id":"463291206584520704"}],"id":"463311369451077632","text":"RT @EFSAJournal: Substantiation of a health claim related to complex #carbohydrates and contribute to #satiety http://t.co/eMkEwRZXZa","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/EUXxTx7hQj","expanded_url":"http://buswk.co/1iPGuSn","display_url":"buswk.co/1iPGuSn"},{"start":76,"end":98,"url":"http://t.co/IZaFLSbhu1","expanded_url":"https://twitter.com/EFPIA/status/463291005068787712/photo/1","display_url":"pic.twitter.com/IZaFLSbhu1"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463311248877428736","possibly_sensitive":false,"created_at":"2014-05-05T13:36:24.000Z","referenced_tweets":[{"type":"retweeted","id":"463291005068787712"}],"id":"463311248877428736","text":"RT @EFPIA: 'Miracle' Data Could Lead to Cancer Cures http://t.co/EUXxTx7hQj http://t.co/IZaFLSbhu1","attachments":{"media_keys":["3_463291005072982016"]}},{"entities":{"urls":{},"hashtags":[{"start":83,"end":93,"tag":"bacterial"},{"start":106,"end":117,"tag":"intestinal"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463310638694301696","possibly_sensitive":false,"created_at":"2014-05-05T13:33:58.000Z","referenced_tweets":[{"type":"retweeted","id":"463290671676547073"}],"id":"463310638694301696","text":"RT @EFSAJournal: Substantiation of a health claim related to a combination of four #bacterial strains and #intestinal discomfort http://t.c…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":83,"end":93,"tag":"bacterial"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463310611137708032","possibly_sensitive":false,"created_at":"2014-05-05T13:33:52.000Z","referenced_tweets":[{"type":"retweeted","id":"463290063351447552"}],"id":"463310611137708032","text":"RT @EFSAJournal: Substantiation of a health claim related to a combination of four #bacterial strains and stool frequency http://t.co/U8EXR…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/U1A9fUWwDo","expanded_url":"http://bit.ly/1muKday","display_url":"bit.ly/1muKday"}],"hashtags":[{"start":28,"end":34,"tag":"cocoa"},{"start":93,"end":106,"tag":"vasodilation"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463310512621912064","possibly_sensitive":false,"created_at":"2014-05-05T13:33:28.000Z","referenced_tweets":[{"type":"retweeted","id":"463288641180413952"}],"id":"463310512621912064","text":"RT @EFSAJournal: Opinion on #cocoa flavanols and maintenance of normal endothelium-dependent #vasodilation http://t.co/U1A9fUWwDo","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/cnRbyI0fYX","expanded_url":"http://bit.ly/1g2bBV0","display_url":"bit.ly/1g2bBV0"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463259932075524096","possibly_sensitive":false,"created_at":"2014-05-05T10:12:29.000Z","referenced_tweets":{},"id":"463259932075524096","text":"RT @INFARMED_IP: Pharmacovigilance bulletin-new format and layout http://t.co/cnRbyI0fYX","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/QZR1JiYUtY","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"hashtags":[{"start":58,"end":69,"tag":"translator"},{"start":86,"end":91,"tag":"EDQM"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463245573366497280","possibly_sensitive":false,"created_at":"2014-05-05T09:15:26.000Z","referenced_tweets":[{"type":"retweeted","id":"463245277156364288"}],"id":"463245573366497280","text":"RT @edqm_news: Last day to apply for Scientific/technical #translator position at the #EDQM - apply today!  http://t.co/QZR1JiYUtY #employm…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":96,"end":100,"probability":0.5689,"type":"Organization","normalized_text":"PhVig"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463245284773232640","possibly_sensitive":false,"created_at":"2014-05-05T09:14:17.000Z","referenced_tweets":[{"type":"retweeted","id":"463235686829932544"}],"id":"463245284773232640","text":"RT @GCessak: Monitoring the safety of medicines: EMA presents first report on implementation of PhVig legislation to the EC http://t.co/87y…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/JiLqsgEhF3","expanded_url":"http://bit.ly/1rMBwFu","display_url":"bit.ly/1rMBwFu"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"463233367841177600","possibly_sensitive":false,"created_at":"2014-05-05T08:26:56.000Z","referenced_tweets":{},"id":"463233367841177600","text":"Our first report on the implementation of the #pharmacovigilance legislation is now available: http://t.co/JiLqsgEhF3","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/kOl8fbaMCu","expanded_url":"http://bit.ly/1kAIxbr","display_url":"bit.ly/1kAIxbr"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"463232932216598528","possibly_sensitive":false,"created_at":"2014-05-05T08:25:12.000Z","referenced_tweets":{},"id":"463232932216598528","text":"Send us your comments on our paper on viral safety of plasma-derived medicines with respect to hepatitis E virus: http://t.co/kOl8fbaMCu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/P07es0yo73","expanded_url":"http://bit.ly/1q63f8H","display_url":"bit.ly/1q63f8H"}],"hashtags":{},"mentions":[{"start":0,"end":9,"username":"Tweet_Ha","id":"254489074"},{"start":10,"end":17,"username":"dsa_pv","id":"4817119702"},{"start":54,"end":68,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462271711376080896","possibly_sensitive":false,"created_at":"2014-05-05T08:09:08.000Z","referenced_tweets":[{"type":"replied_to","id":"462277668889980928"}],"id":"463228889607966720","text":"@Tweet_Ha @DSA_PV The full report is available on the @EU_Commission website: http://t.co/P07es0yo73","attachments":{"media_keys":{}},"in_reply_to_user_id":"254489074"},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/JiLqsgEhF3","expanded_url":"http://bit.ly/1rMBwFu","display_url":"bit.ly/1rMBwFu"}],"hashtags":[{"start":62,"end":80,"tag":"pharmacovigilance"}],"mentions":[{"start":100,"end":114,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"462254689225289728","possibly_sensitive":false,"created_at":"2014-05-02T15:38:00.000Z","referenced_tweets":{},"id":"462254689225289728","text":"We've presented the first report on the implementation of the #pharmacovigilance legislation to the @EU_Commission: http://t.co/JiLqsgEhF3","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/T5Ljt2V5Rr","expanded_url":"http://bit.ly/1n5M9FK","display_url":"bit.ly/1n5M9FK"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"NathanAhron","id":"377773501"},{"start":13,"end":23,"username":"GekkoWire","id":"185310946"}],"annotations":[{"start":55,"end":62,"probability":0.3137,"type":"Person","normalized_text":"Vynfinit"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462202686113599488","possibly_sensitive":false,"created_at":"2014-05-02T15:27:10.000Z","referenced_tweets":[{"type":"replied_to","id":"462204385716891648"}],"id":"462251962176905217","text":"@NathanAhron @Gekkowire The summary of our opinion for Vynfinit (vintafolide) is here: http://t.co/T5Ljt2V5Rr. Full report after approval.","attachments":{"media_keys":{}},"in_reply_to_user_id":"377773501"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/kOl8fbaMCu","expanded_url":"http://bit.ly/1kAIxbr","display_url":"bit.ly/1kAIxbr"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462193624911216640","possibly_sensitive":false,"created_at":"2014-05-02T11:35:21.000Z","referenced_tweets":{},"id":"462193624911216640","text":"We've published a draft concept paper on viral safety of plasma-derived medicines with respect to hepatitis E virus: http://t.co/kOl8fbaMCu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/hvTcy7ewBe","expanded_url":"http://www.bbc.com/news/health-27204988","display_url":"bbc.com/news/health-27…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":15,"end":22,"probability":0.9073,"type":"Organization","normalized_text":"BBC News"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462189702813319168","possibly_sensitive":false,"created_at":"2014-05-02T11:19:46.000Z","referenced_tweets":[{"type":"retweeted","id":"462181855207256065"}],"id":"462189702813319168","text":"RT @EAHPtweet: BBC News - Antibiotic resistance now 'global threat', WHO warns http://t.co/hvTcy7ewBe","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/LcMAZIC1rm","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/04/news_detail_002090.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462189649822515200","possibly_sensitive":false,"created_at":"2014-05-02T11:19:34.000Z","referenced_tweets":[{"type":"retweeted","id":"462179835708997632"}],"id":"462189649822515200","text":"RT @GCessak: EMA published 2013 Annual Report: http://t.co/LcMAZIC1rm","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/A0BkNz2rZb","expanded_url":"http://bit.ly/1i59YWu","display_url":"bit.ly/1i59YWu"},{"start":118,"end":140,"url":"http://t.co/70eqGEz4HO","expanded_url":"http://bit.ly/1fVdUJt","display_url":"bit.ly/1fVdUJt"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":27,"end":38,"tag":"veterinary"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462176140585893888","possibly_sensitive":false,"created_at":"2014-05-02T10:25:53.000Z","referenced_tweets":{},"id":"462176140585893888","text":"Our #pharmacovigilance and #veterinary committees meet next week. PRAC highlights out Thursday http://t.co/A0BkNz2rZb http://t.co/70eqGEz4HO","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":41,"end":63,"url":"http://t.co/Z8veUqYFVS","expanded_url":"http://bit.ly/QZE1Jn","display_url":"bit.ly/QZE1Jn"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"462142694241079296","possibly_sensitive":false,"created_at":"2014-05-02T08:12:59.000Z","referenced_tweets":{},"id":"462142694241079296","text":"Our 2013 annual report is now available: http://t.co/Z8veUqYFVS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/YFlw45uHxV","expanded_url":"http://bit.ly/R37Kki","display_url":"bit.ly/R37Kki"}],"hashtags":[{"start":53,"end":65,"tag":"biosimilars"},{"start":89,"end":97,"tag":"insulin"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"462142098792529920","possibly_sensitive":false,"created_at":"2014-05-02T08:10:37.000Z","referenced_tweets":{},"id":"462142098792529920","text":"Comment now on our draft guideline on development of #biosimilars containing recombinant #insulin: http://t.co/YFlw45uHxV","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/jHn294kPnJ","expanded_url":"http://bit.ly/1iD4h1X","display_url":"bit.ly/1iD4h1X"}],"hashtags":[{"start":67,"end":77,"tag":"tolerance"},{"start":78,"end":86,"tag":"testing"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462141503788576769","possibly_sensitive":false,"created_at":"2014-05-02T08:08:15.000Z","referenced_tweets":{},"id":"462141503788576769","text":"Send us your comments on our draft guideline on non-clinical local #tolerance #testing of medicinal products: http://t.co/jHn294kPnJ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/KQ27unQY00","expanded_url":"http://bit.ly/1pP3ODA","display_url":"bit.ly/1pP3ODA"}],"hashtags":[{"start":64,"end":73,"tag":"Paeoniae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462140178388484096","possibly_sensitive":false,"created_at":"2014-05-02T08:02:59.000Z","referenced_tweets":{},"id":"462140178388484096","text":"Two more weeks to send us scientific data for the assessment of #Paeoniae: http://t.co/KQ27unQY00","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/BnOohCUrfv","expanded_url":"http://bit.ly/1iACPrq","display_url":"bit.ly/1iACPrq"}],"hashtags":[{"start":64,"end":72,"tag":"Origani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462140074579460096","possibly_sensitive":false,"created_at":"2014-05-02T08:02:34.000Z","referenced_tweets":{},"id":"462140074579460096","text":"Two more weeks to send us scientific data for the assessment of #Origani majoranae: http://t.co/BnOohCUrfv","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/Ls6e9ulQtq","expanded_url":"http://bit.ly/1nItEr5","display_url":"bit.ly/1nItEr5"}],"hashtags":[{"start":64,"end":75,"tag":"Helichrysi"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462139910573809664","possibly_sensitive":false,"created_at":"2014-05-02T08:01:55.000Z","referenced_tweets":{},"id":"462139910573809664","text":"Two more weeks to send us scientific data for the assessment of #Helichrysi: http://t.co/Ls6e9ulQtq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/V49nyHmaO8","expanded_url":"http://bit.ly/R3EYQD","display_url":"bit.ly/R3EYQD"}],"hashtags":[{"start":64,"end":73,"tag":"Epilobii"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462139136993136641","possibly_sensitive":false,"created_at":"2014-05-02T07:58:51.000Z","referenced_tweets":{},"id":"462139136993136641","text":"Two more weeks to send us scientific data for the assessment of #Epilobii: http://t.co/V49nyHmaO8","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/t1KnZ8g2R0","expanded_url":"http://bit.ly/1henesn","display_url":"bit.ly/1henesn"}],"hashtags":[{"start":69,"end":75,"tag":"Cyani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462138846399193088","possibly_sensitive":false,"created_at":"2014-05-02T07:57:41.000Z","referenced_tweets":{},"id":"462138846399193088","text":"Two more weeks left to send us scientific data for the assessment of #Cyani: http://t.co/t1KnZ8g2R0","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/O5dn8K1YIr","expanded_url":"http://bit.ly/1kp6lgC","display_url":"bit.ly/1kp6lgC"}],"hashtags":[{"start":69,"end":77,"tag":"Salviae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462138662457970688","possibly_sensitive":false,"created_at":"2014-05-02T07:56:57.000Z","referenced_tweets":{},"id":"462138662457970688","text":"Two more weeks left to send us scientific data for the assessment of #Salviae trilobae: http://t.co/O5dn8K1YIr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/DewlmsjxBK","expanded_url":"http://bit.ly/1mZyHmK","display_url":"bit.ly/1mZyHmK"}],"hashtags":[{"start":64,"end":74,"tag":"Sideritis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462138498582343680","possibly_sensitive":false,"created_at":"2014-05-02T07:56:18.000Z","referenced_tweets":{},"id":"462138498582343680","text":"Two more weeks to send us scientific data for the assessment of #Sideritis herba: http://t.co/DewlmsjxBK","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/oAkCpOpZZb","expanded_url":"http://bit.ly/1ez7ihC","display_url":"bit.ly/1ez7ihC"}],"hashtags":[{"start":64,"end":78,"tag":"Saccharomyces"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"462138293451509760","possibly_sensitive":false,"created_at":"2014-05-02T07:55:29.000Z","referenced_tweets":{},"id":"462138293451509760","text":"Two more weeks to send us scientific data for the assessment of #Saccharomyces cerevisiae / Saccharomyces boulardii: http://t.co/oAkCpOpZZb","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/X91MxYaS7b","expanded_url":"http://bit.ly/M0p72w","display_url":"bit.ly/M0p72w"}],"hashtags":[{"start":64,"end":71,"tag":"Ricini"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462138073070206976","possibly_sensitive":false,"created_at":"2014-05-02T07:54:37.000Z","referenced_tweets":{},"id":"462138073070206976","text":"Two weeks left to send us scientific data for the assessment of #Ricini oleum: http://t.co/X91MxYaS7b","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/K0kAzIEQKL","expanded_url":"http://bit.ly/MjDPlP","display_url":"bit.ly/MjDPlP"}],"hashtags":[{"start":69,"end":75,"tag":"Cisti"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462136595588841472","possibly_sensitive":false,"created_at":"2014-05-02T07:48:45.000Z","referenced_tweets":{},"id":"462136595588841472","text":"Two more weeks left to send us scientific data for the assessment of #Cisti cretici: http://t.co/K0kAzIEQKL","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/pXxylFEJkS","expanded_url":"http://bit.ly/M0oLc5","display_url":"bit.ly/M0oLc5"}],"hashtags":[{"start":69,"end":78,"tag":"Pistacia"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462136335277760512","possibly_sensitive":false,"created_at":"2014-05-02T07:47:43.000Z","referenced_tweets":{},"id":"462136335277760512","text":"Two more weeks left to send us scientific data for the assessment of #Pistacia lentiscus: http://t.co/pXxylFEJkS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/nop9P84twk","expanded_url":"http://bit.ly/1jhhZKy","display_url":"bit.ly/1jhhZKy"}],"hashtags":[{"start":69,"end":80,"tag":"Calendulae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"462135844766482432","possibly_sensitive":false,"created_at":"2014-05-02T07:45:46.000Z","referenced_tweets":{},"id":"462135844766482432","text":"Two more weeks left to send us scientific data for the assessment of #Calendulae herba: http://t.co/nop9P84twk","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":16,"username":"frtheWhiteHouse","id":"353997128"},{"start":17,"end":28,"username":"PeterJTCoe","id":"610961115"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"410434088562987008","possibly_sensitive":false,"created_at":"2014-05-02T07:36:15.000Z","referenced_tweets":[{"type":"replied_to","id":"462116894687121408"}],"id":"462133453308588032","text":"@frtheWhiteHouse @PeterJTCoe We have already corrected the error.","attachments":{"media_keys":{}},"in_reply_to_user_id":"353997128"},{"entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/Jo96A0SR9S","expanded_url":"http://bit.ly/1iFO1Df","display_url":"bit.ly/1iFO1Df"},{"start":107,"end":129,"url":"http://t.co/1ZfEj0gY24","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459001039455518720","possibly_sensitive":false,"created_at":"2014-05-02T07:35:24.000Z","referenced_tweets":[{"type":"replied_to","id":"462092859127382017"}],"id":"462133236492406784","text":"@VanessaVanHalen Full details on the SAWP are here: http://t.co/Jo96A0SR9S. For more send your question to http://t.co/1ZfEj0gY24.","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/KQ27unQY00","expanded_url":"http://bit.ly/1pP3ODA","display_url":"bit.ly/1pP3ODA"}],"hashtags":[{"start":64,"end":73,"tag":"Paeoniae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461552974452768768","possibly_sensitive":false,"created_at":"2014-04-30T17:09:39.000Z","referenced_tweets":{},"id":"461552974452768768","text":"Two weeks left to send us scientific data for the assessment of #Paeoniae: http://t.co/KQ27unQY00","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/BnOohCUrfv","expanded_url":"http://bit.ly/1iACPrq","display_url":"bit.ly/1iACPrq"}],"hashtags":[{"start":64,"end":72,"tag":"Origani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461552695871283200","possibly_sensitive":false,"created_at":"2014-04-30T17:08:32.000Z","referenced_tweets":{},"id":"461552695871283200","text":"Two weeks left to send us scientific data for the assessment of #Origani majoranae: http://t.co/BnOohCUrfv","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/Ls6e9ulQtq","expanded_url":"http://bit.ly/1nItEr5","display_url":"bit.ly/1nItEr5"}],"hashtags":[{"start":64,"end":75,"tag":"Helichrysi"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461552209445265409","possibly_sensitive":false,"created_at":"2014-04-30T17:06:36.000Z","referenced_tweets":{},"id":"461552209445265409","text":"Two weeks left to send us scientific data for the assessment of #Helichrysi: http://t.co/Ls6e9ulQtq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/V49nyHmaO8","expanded_url":"http://bit.ly/R3EYQD","display_url":"bit.ly/R3EYQD"}],"hashtags":[{"start":64,"end":73,"tag":"Epilobii"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461551927818739712","possibly_sensitive":false,"created_at":"2014-04-30T17:05:29.000Z","referenced_tweets":{},"id":"461551927818739712","text":"Two weeks left to send us scientific data for the assessment of #Epilobii: http://t.co/V49nyHmaO8","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/t1KnZ8g2R0","expanded_url":"http://bit.ly/1henesn","display_url":"bit.ly/1henesn"}],"hashtags":[{"start":64,"end":70,"tag":"Cyani"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461551606342107136","possibly_sensitive":false,"created_at":"2014-04-30T17:04:12.000Z","referenced_tweets":{},"id":"461551606342107136","text":"Two weeks left to send us scientific data for the assessment of #Cyani: http://t.co/t1KnZ8g2R0","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/O5dn8K1YIr","expanded_url":"http://bit.ly/1kp6lgC","display_url":"bit.ly/1kp6lgC"}],"hashtags":[{"start":64,"end":72,"tag":"Salviae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461551284123090944","possibly_sensitive":false,"created_at":"2014-04-30T17:02:56.000Z","referenced_tweets":{},"id":"461551284123090944","text":"Two weeks left to send us scientific data for the assessment of #Salviae trilobae: http://t.co/O5dn8K1YIr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/DewlmsjxBK","expanded_url":"http://bit.ly/1mZyHmK","display_url":"bit.ly/1mZyHmK"}],"hashtags":[{"start":64,"end":74,"tag":"Sideritis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461550897026576384","possibly_sensitive":false,"created_at":"2014-04-30T17:01:23.000Z","referenced_tweets":{},"id":"461550897026576384","text":"Two weeks left to send us scientific data for the assessment of #Sideritis herba: http://t.co/DewlmsjxBK","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/oAkCpOpZZb","expanded_url":"http://bit.ly/1ez7ihC","display_url":"bit.ly/1ez7ihC"}],"hashtags":[{"start":64,"end":78,"tag":"Saccharomyces"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461550464556101633","possibly_sensitive":false,"created_at":"2014-04-30T16:59:40.000Z","referenced_tweets":{},"id":"461550464556101633","text":"Two weeks left to send us scientific data for the assessment of #Saccharomyces cerevisiae / Saccharomyces boulardii: http://t.co/oAkCpOpZZb","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/X91MxYaS7b","expanded_url":"http://bit.ly/M0p72w","display_url":"bit.ly/M0p72w"}],"hashtags":[{"start":64,"end":71,"tag":"Ricini"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461550145541517312","possibly_sensitive":false,"created_at":"2014-04-30T16:58:24.000Z","referenced_tweets":{},"id":"461550145541517312","text":"Two weeks left to send us scientific data for the assessment of #Ricini oleum: http://t.co/X91MxYaS7b","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/K0kAzIEQKL","expanded_url":"http://bit.ly/MjDPlP","display_url":"bit.ly/MjDPlP"}],"hashtags":[{"start":64,"end":70,"tag":"Cisti"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461549822965977088","possibly_sensitive":false,"created_at":"2014-04-30T16:57:07.000Z","referenced_tweets":{},"id":"461549822965977088","text":"Two weeks left to send us scientific data for the assessment of #Cisti cretici: http://t.co/K0kAzIEQKL","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/pXxylFEJkS","expanded_url":"http://bit.ly/M0oLc5","display_url":"bit.ly/M0oLc5"}],"hashtags":[{"start":64,"end":73,"tag":"Pistacia"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461549442387435520","possibly_sensitive":false,"created_at":"2014-04-30T16:55:36.000Z","referenced_tweets":{},"id":"461549442387435520","text":"Two weeks left to send us scientific data for the assessment of #Pistacia lentiscus: http://t.co/pXxylFEJkS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/nop9P84twk","expanded_url":"http://bit.ly/1jhhZKy","display_url":"bit.ly/1jhhZKy"}],"hashtags":[{"start":64,"end":75,"tag":"Calendulae"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461548951611904000","possibly_sensitive":false,"created_at":"2014-04-30T16:53:39.000Z","referenced_tweets":{},"id":"461548951611904000","text":"Two weeks left to send us scientific data for the assessment of #Calendulae herba: http://t.co/nop9P84twk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/4ReP39mDgi","expanded_url":"http://go.usa.gov/k73J","display_url":"go.usa.gov/k73J"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":99,"end":101,"probability":0.7672,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461541634229153792","possibly_sensitive":false,"created_at":"2014-04-30T16:24:35.000Z","referenced_tweets":[{"type":"retweeted","id":"461517864282128386"}],"id":"461541634229153792","text":"RT @US_FDA: Here's the current Patient Network Newsletter with all the most recent happenings from FDA http://t.co/4ReP39mDgi","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/Yg4NbTNPkH","expanded_url":"http://bit.ly/1kop6kg","display_url":"bit.ly/1kop6kg"}],"hashtags":[{"start":40,"end":45,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461540924812976128","possibly_sensitive":false,"created_at":"2014-04-30T16:21:46.000Z","referenced_tweets":[{"type":"retweeted","id":"461523528052125696"}],"id":"461540924812976128","text":"RT @ECDC_Flu: Distribution of confirmed #MERS-CoV cases in April 2014 by reporting country. Full update: http://t.co/Yg4NbTNPkH http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":71,"end":81,"tag":"Hepatitis"},{"start":131,"end":135,"tag":"HCV"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":21,"end":33,"username":"HenryEChang","id":"57406450"},{"start":38,"end":50,"username":"lanacioncom","id":"3730435649"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461540570461372416","possibly_sensitive":false,"created_at":"2014-04-30T16:20:21.000Z","referenced_tweets":[{"type":"retweeted","id":"461531846073802752"}],"id":"461540570461372416","text":"RT @Hep_Alliance: MT @HenryEChang via @lanacioncom: Natural History of #Hepatitis C Infection// Historia natural de la hepatitis C #HCV htt…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":36,"end":39,"tag":"EU"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461540463020093440","possibly_sensitive":false,"created_at":"2014-04-30T16:19:56.000Z","referenced_tweets":[{"type":"retweeted","id":"461536390900367360"}],"id":"461540463020093440","text":"RT @eubookshop: Questions about the #EU? Ask one of the European Documentation Centres – the contact points in your country http://t.co/1Fq…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/dtZoaIaKxw","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":42,"end":50,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461540367712911360","possibly_sensitive":false,"created_at":"2014-04-30T16:19:33.000Z","referenced_tweets":{},"id":"461540367712911360","text":"There are two weeks left to apply for our #vacancy for a Head of Administration: http://t.co/dtZoaIaKxw","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/uyujcXQvNR","expanded_url":"http://bit.ly/1ksgQBq","display_url":"bit.ly/1ksgQBq"}],"hashtags":[{"start":74,"end":88,"tag":"biotechnology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461540289849851906","possibly_sensitive":false,"created_at":"2014-04-30T16:19:14.000Z","referenced_tweets":{},"id":"461540289849851906","text":"We've published a draft guideline on process validation for manufacturing #biotechnology-derived active substances: http://t.co/uyujcXQvNR","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/WLEB56h1Yy","expanded_url":"http://bit.ly/1fx4GIt","display_url":"bit.ly/1fx4GIt"}],"hashtags":[{"start":85,"end":98,"tag":"osteoporosis"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461540129325461504","possibly_sensitive":false,"created_at":"2014-04-30T16:18:36.000Z","referenced_tweets":{},"id":"461540129325461504","text":"We've published the EPAR for Zoledronic acid Teva Generics, a medicine used to treat #osteoporosis: http://t.co/WLEB56h1Yy","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/aU0Rc8rYsG","expanded_url":"http://bit.ly/1hd6SAh","display_url":"bit.ly/1hd6SAh"}],"hashtags":[{"start":58,"end":63,"tag":"ICSR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461539958931873792","possibly_sensitive":false,"created_at":"2014-04-30T16:17:55.000Z","referenced_tweets":{},"id":"461539958931873792","text":"We've published a draft EU individual case safety report (#ICSR) implementation guide: http://t.co/aU0Rc8rYsG","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/jHn294kPnJ","expanded_url":"http://bit.ly/1iD4h1X","display_url":"bit.ly/1iD4h1X"}],"hashtags":[{"start":56,"end":66,"tag":"tolerance"},{"start":67,"end":75,"tag":"testing"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"461523753923780608","possibly_sensitive":false,"created_at":"2014-04-30T15:13:32.000Z","referenced_tweets":{},"id":"461523753923780608","text":"We've published a draft guideline on non-clinical local #tolerance #testing of medicinal products: http://t.co/jHn294kPnJ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/YFlw45uHxV","expanded_url":"http://bit.ly/R37Kki","display_url":"bit.ly/R37Kki"}],"hashtags":[{"start":60,"end":71,"tag":"biological"},{"start":105,"end":113,"tag":"insulin"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461523308677439489","possibly_sensitive":false,"created_at":"2014-04-30T15:11:46.000Z","referenced_tweets":{},"id":"461523308677439489","text":"We've published a draft guideline on development of similar #biological medicines containing recombinant #insulin: http://t.co/YFlw45uHxV","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Hx0JlJmkn3","expanded_url":"http://goo.gl/EoGA7a","display_url":"goo.gl/EoGA7a"}],"hashtags":[{"start":30,"end":51,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":505,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461504911336026112","possibly_sensitive":false,"created_at":"2014-04-30T13:58:39.000Z","referenced_tweets":[{"type":"retweeted","id":"461466752422248449"}],"id":"461504911336026112","text":"RT @WHO: New WHO report finds #AntibioticResistance now a major threat to public health in every region of the world http://t.co/Hx0JlJmkn3","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":52,"end":56,"tag":"HIV"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":107,"end":109,"probability":0.7691,"type":"Other","normalized_text":"HIV"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461504831140540417","possibly_sensitive":false,"created_at":"2014-04-30T13:58:20.000Z","referenced_tweets":[{"type":"retweeted","id":"461467957923954688"}],"id":"461504831140540417","text":"RT @WHO_Europe: There's been no increase in earlier #HIV diagnosis since 2010: 50% of newly diagnosed with HIV were tested late http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":9,"end":30,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":829,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461504052527120384","possibly_sensitive":false,"created_at":"2014-04-30T13:55:15.000Z","referenced_tweets":[{"type":"retweeted","id":"461503248306688000"}],"id":"461504052527120384","text":"RT @WHO: #AntibioticResistance causes people to be sick for longer &amp; increases the risk of death. Prevent infections first: http://t.co/ayK…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":44,"end":66,"url":"http://t.co/Z8veUqYFVS","expanded_url":"http://bit.ly/QZE1Jn","display_url":"bit.ly/QZE1Jn"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"461503965386260480","possibly_sensitive":false,"created_at":"2014-04-30T13:54:54.000Z","referenced_tweets":{},"id":"461503965386260480","text":"We've published our annual report for 2013: http://t.co/Z8veUqYFVS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/gvaWmAHk5s","expanded_url":"http://goo.gl/VmDnki","display_url":"goo.gl/VmDnki"}],"hashtags":[{"start":36,"end":43,"tag":"ESMO14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":73,"end":78,"probability":0.9742,"type":"Place","normalized_text":"Madrid"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461440463690801152","possibly_sensitive":false,"created_at":"2014-04-30T09:42:34.000Z","referenced_tweets":[{"type":"retweeted","id":"461421463107829760"}],"id":"461440463690801152","text":"RT @myESMO: Online registration for #ESMO14 congress (26-30 Sep 2014) in Madrid is now open! Register now! http://t.co/gvaWmAHk5s","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/aU0Rc8rYsG","expanded_url":"http://bit.ly/1hd6SAh","display_url":"bit.ly/1hd6SAh"}],"hashtags":[{"start":84,"end":89,"tag":"ICSR"}],"mentions":{},"annotations":[{"start":49,"end":50,"probability":0.5626,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461437361717772288","possibly_sensitive":false,"created_at":"2014-04-30T09:30:14.000Z","referenced_tweets":{},"id":"461437361717772288","text":"We've published a draft implementation guide for EU individual case safety reports (#ICSR): http://t.co/aU0Rc8rYsG","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/WLEB56h1Yy","expanded_url":"http://bit.ly/1fx4GIt","display_url":"bit.ly/1fx4GIt"}],"hashtags":[{"start":98,"end":111,"tag":"osteoporosis"}],"mentions":{},"annotations":[{"start":42,"end":70,"probability":0.3437,"type":"Product","normalized_text":"Zoledronic acid Teva Generics"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461433958421770240","possibly_sensitive":false,"created_at":"2014-04-30T09:16:43.000Z","referenced_tweets":{},"id":"461433958421770240","text":"We've published the assessment report for Zoledronic acid Teva Generics, a medicine used to treat #osteoporosis:  http://t.co/WLEB56h1Yy","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/uyujcXQvNR","expanded_url":"http://bit.ly/1ksgQBq","display_url":"bit.ly/1ksgQBq"}],"hashtags":[{"start":75,"end":89,"tag":"biotechnology"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461433548650844161","possibly_sensitive":false,"created_at":"2014-04-30T09:15:05.000Z","referenced_tweets":{},"id":"461433548650844161","text":"We've published a draft guideline on process validation for manufacture of #biotechnology-derived active substances: http://t.co/uyujcXQvNR","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/dtZoaIaKxw","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461432787208536065","possibly_sensitive":false,"created_at":"2014-04-30T09:12:04.000Z","referenced_tweets":{},"id":"461432787208536065","text":"Two weeks left to apply for our #vacancy for a Head of Administration: http://t.co/dtZoaIaKxw","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/dOAV1qN05r","expanded_url":"http://go.usa.gov/kfYP","display_url":"go.usa.gov/kfYP"}],"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461174714501955584","possibly_sensitive":false,"created_at":"2014-04-29T16:06:34.000Z","referenced_tweets":[{"type":"retweeted","id":"461173874999447552"}],"id":"461174714501955584","text":"RT @US_FDA: #FDAVoice: The way forward on opioid abuse: A call to action for science-based, comprehensive strategies http://t.co/dOAV1qN05r","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":128,"end":142,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461168213406285825","possibly_sensitive":false,"created_at":"2014-04-29T15:40:44.000Z","referenced_tweets":{},"id":"461168213406285825","text":"RT @agesnews: Suspension of authorisation of metoclopramide-containing drops authorised in EU with concentration &gt; 1 mg / ml @EU_Commission","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Ggsddl0cNZ","expanded_url":"http://bit.ly/1iy1Mhk","display_url":"bit.ly/1iy1Mhk"}],"hashtags":[{"start":45,"end":60,"tag":"metoclopramide"},{"start":75,"end":85,"tag":"Paspertin"},{"start":86,"end":97,"tag":"Metoceolat"},{"start":98,"end":110,"tag":"Metogastron"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461167659481317376","possibly_sensitive":false,"created_at":"2014-04-29T15:38:32.000Z","referenced_tweets":{},"id":"461167659481317376","text":"RT @agesnews: Medicine safety: Suspension of #metoclopramide 4-mg/ml drops #Paspertin #Metoceolat #Metogastron http://t.co/Ggsddl0cNZ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/XHreOV4Uwi","expanded_url":"http://www.forbes.com/sites/larryhusten/2014/04/28/stem-cell-therapy-to-fix-the-heart-a-house-of-cards-about-to-fall/","display_url":"forbes.com/sites/larryhus…"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461166622477389824","possibly_sensitive":false,"created_at":"2014-04-29T15:34:25.000Z","referenced_tweets":[{"type":"retweeted","id":"461153833583116288"}],"id":"461166622477389824","text":"RT @nakosbalamotis: Stem Cell Therapy To Fix The Heart: A House Of Cards About To Fall? http://t.co/XHreOV4Uwi","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/XnXaY33gly","expanded_url":"http://bit.ly/1iy0pPL","display_url":"bit.ly/1iy0pPL"}],"hashtags":[{"start":61,"end":73,"tag":"Metogastron"},{"start":89,"end":104,"tag":"metoclopramide"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461166114052272128","possibly_sensitive":false,"created_at":"2014-04-29T15:32:24.000Z","referenced_tweets":{},"id":"461166114052272128","text":"RT @agesnews: Medicine recall: suspension of the approval of #Metogastron gastric drops (#metoclopramide) on 30/4. http://t.co/XnXaY33gly","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/E8hZNWXmev","expanded_url":"http://bit.ly/1pKfZ4A","display_url":"bit.ly/1pKfZ4A"}],"hashtags":[{"start":61,"end":71,"tag":"Paspertin"},{"start":87,"end":102,"tag":"metoclopramide"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461165353775955968","possibly_sensitive":false,"created_at":"2014-04-29T15:29:23.000Z","referenced_tweets":{},"id":"461165353775955968","text":"RT @agesnews: Medicine recall: suspension of the approval of #Paspertin gastric drops (#metoclopramide) on 30/4. http://t.co/E8hZNWXmev","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FrankPointfr","id":"103437676"}],"annotations":[{"start":53,"end":58,"probability":0.9986,"type":"Place","normalized_text":"France"},{"start":121,"end":126,"probability":0.9972,"type":"Place","normalized_text":"France"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461104014978215936","possibly_sensitive":false,"created_at":"2014-04-29T15:25:47.000Z","referenced_tweets":[{"type":"replied_to","id":"461163233291018241"}],"id":"461164448838082560","text":"@FrankPointfr For information on the release date in France, you will need to contact the national health authorities in France.","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FrankPointfr","id":"103437676"},{"start":47,"end":61,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"461104014978215936","possibly_sensitive":false,"created_at":"2014-04-29T15:20:57.000Z","referenced_tweets":[{"type":"replied_to","id":"461104014978215936"}],"id":"461163233291018241","text":"@FrankPointfr It usually takes 67 days for the @EU_Commission to complete its decision-making process. Contact them for more information.","attachments":{"media_keys":{}},"in_reply_to_user_id":"103437676"},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/VsGzMzVXjs","expanded_url":"http://bit.ly/1k4eOVb","display_url":"bit.ly/1k4eOVb"}],"hashtags":[{"start":64,"end":82,"tag":"Pharmacovigilance"},{"start":87,"end":108,"tag":"Pharmacoepidemiology"}],"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461144915293253633","possibly_sensitive":false,"created_at":"2014-04-29T14:08:10.000Z","referenced_tweets":[{"type":"retweeted","id":"461140970323861504"}],"id":"461144915293253633","text":"RT @Eu2P: Discover why you should apply to our online Master in #Pharmacovigilance and #Pharmacoepidemiology http://t.co/VsGzMzVXjs","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":37,"end":49,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":111,"end":116,"probability":0.9802,"type":"Place","normalized_text":"Berlin"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461144847609757696","possibly_sensitive":false,"created_at":"2014-04-29T14:07:54.000Z","referenced_tweets":[{"type":"retweeted","id":"461138161981489152"}],"id":"461144847609757696","text":"RT @eurordis: European Conference on #RareDisease has sessions on regulatory issues! Join 700+ participants in Berlin! http://t.co/7oK4YBx4…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/OKlvc9qbMZ","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/faq-on-generic-medicines#question07","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":33,"end":42,"tag":"patients"},{"start":117,"end":121,"tag":"FAQ"},{"start":122,"end":130,"tag":"generic"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461126347197136896","possibly_sensitive":false,"created_at":"2014-04-29T12:54:23.000Z","referenced_tweets":[{"type":"retweeted","id":"461124550781308929"}],"id":"461126347197136896","text":"RT @egagenerics: How quickly can #patients access generic medicines after protection expires? http://t.co/OKlvc9qbMZ #FAQ #generic #medicin…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/OKlvc9qbMZ","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/faq-on-generic-medicines#question07","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":115,"end":124,"tag":"patients"},{"start":125,"end":131,"tag":"value"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461126066753785856","possibly_sensitive":false,"created_at":"2014-04-29T12:53:16.000Z","referenced_tweets":[{"type":"retweeted","id":"461121095891165185"}],"id":"461126066753785856","text":"RT @egagenerics: Do you know what are the key treatment areas treated by generic medicines? http://t.co/OKlvc9qbMZ #patients #value #sustai…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/kdT3nsgxzg","expanded_url":"http://ht.ly/wg2yS","display_url":"ht.ly/wg2yS"}],"hashtags":[{"start":109,"end":118,"tag":"FDAvoice"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":63,"end":65,"probability":0.6329,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461125933647544320","possibly_sensitive":false,"created_at":"2014-04-29T12:52:44.000Z","referenced_tweets":[{"type":"retweeted","id":"461119022860607488"}],"id":"461125933647544320","text":"RT @FDA_MCMi: Commissioner's Fellowship Program: A Win-Win for FDA and Public Health: http://t.co/kdT3nsgxzg #FDAvoice blog","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/jfBateUJBn","expanded_url":"http://naukawpolsce.pap.pl/aktualnosci/news,400167,polscy-naukowcy-odslonili-kolejna-tajemnice-alzheimera.html","display_url":"naukawpolsce.pap.pl/aktualnosci/ne…"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"GCessak","id":"556859372"}],"annotations":[{"start":61,"end":69,"probability":0.6102,"type":"Other","normalized_text":"Alzheimer"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"461100530509438976","possibly_sensitive":false,"created_at":"2014-04-29T12:49:05.000Z","referenced_tweets":[{"type":"replied_to","id":"461100530509438976"}],"id":"461125015120125953","text":"@GCessak: Polish scientists have unveiled another mystery of Alzheimer's: http://t.co/jfBateUJBn","attachments":{"media_keys":{}},"in_reply_to_user_id":"556859372"},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/lCo5OzaQpY","expanded_url":"http://bit.ly/1h9fFTH","display_url":"bit.ly/1h9fFTH"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461097982306570240","possibly_sensitive":false,"created_at":"2014-04-29T11:01:40.000Z","referenced_tweets":{},"id":"461097982306570240","text":"Our office is closed on Thursday 1 May. Emergency phone number for problems with centrally authorised medicines: http://t.co/lCo5OzaQpY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/Xrd5MxYgrM","expanded_url":"http://bit.ly/1rIMCNG","display_url":"bit.ly/1rIMCNG"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461095034444869632","possibly_sensitive":false,"created_at":"2014-04-29T10:49:57.000Z","referenced_tweets":{},"id":"461095034444869632","text":"RT @Legemiddelinfo: 2013 adverse reaction report published. This year the focus is on new blood-thinning medicines: http://t.co/Xrd5MxYgrM","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/BBgksbcPU0","expanded_url":"http://bit.ly/1rIIf5f","display_url":"bit.ly/1rIIf5f"}],"hashtags":[{"start":20,"end":25,"tag":"ECDC"},{"start":103,"end":111,"tag":"tourism"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":51,"end":56,"probability":0.9985,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461090963482746880","possibly_sensitive":false,"created_at":"2014-04-29T10:33:47.000Z","referenced_tweets":{},"id":"461090963482746880","text":"RT @Aifa_ufficiale: #ECDC: resistant infections in Europe as a biological consequence of globalisation #tourism http://t.co/BBgksbcPU0","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":40,"end":62,"url":"http://t.co/lCo5OzaQpY","expanded_url":"http://bit.ly/1h9fFTH","display_url":"bit.ly/1h9fFTH"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461073584577064962","possibly_sensitive":false,"created_at":"2014-04-29T09:24:43.000Z","referenced_tweets":{},"id":"461073584577064962","text":"We're closed this Thursday, 1 May 2014: http://t.co/lCo5OzaQpY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/u0oFpiP6qs","expanded_url":"http://bit.ly/QTLARJ","display_url":"bit.ly/QTLARJ"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461067668188332032","possibly_sensitive":false,"created_at":"2014-04-29T09:01:12.000Z","referenced_tweets":{},"id":"461067668188332032","text":"RT @INFARMED_IP: Domperidone - restriction of use http://t.co/u0oFpiP6qs","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/Eap6i5cJAI","expanded_url":"http://bit.ly/1hNH0Kw","display_url":"bit.ly/1hNH0Kw"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461067395046862848","possibly_sensitive":false,"created_at":"2014-04-29T09:00:07.000Z","referenced_tweets":{},"id":"461067395046862848","text":"RT @INFARMED_IP: Adrenaline - start of safety review http://t.co/Eap6i5cJAI","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/7Ttq6smv29","expanded_url":"https://www.cspinet.org/foodsafety/abr.html","display_url":"cspinet.org/foodsafety/abr…"}],"hashtags":[{"start":34,"end":38,"tag":"AMR"},{"start":40,"end":51,"tag":"Antibiotic"},{"start":71,"end":76,"tag":"Food"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":100,"end":105,"username":"CSPI","id":"268282057"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"461065226658779136","possibly_sensitive":false,"created_at":"2014-04-29T08:51:30.000Z","referenced_tweets":[{"type":"retweeted","id":"461064711635992576"}],"id":"461065226658779136","text":"RT @EPHA_EU: Holistic approach to #AMR: #Antibiotic Resistance and the #Food Supply Infographic via @CSPI https://t.co/7Ttq6smv29","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WSKvctsA68","expanded_url":"http://bit.ly/1m0GdKm","display_url":"bit.ly/1m0GdKm"}],"hashtags":[{"start":9,"end":24,"tag":"EudraVigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"461058202294312960","possibly_sensitive":false,"created_at":"2014-04-29T08:23:36.000Z","referenced_tweets":{},"id":"461058202294312960","text":"The 2013 #EudraVigilance annual report is out: over 1 million adverse-drug-reaction reports received and processed: http://t.co/WSKvctsA68","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/0aCEMDZfBL","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/faq-on-generic-medicines","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":29,"end":37,"tag":"quality"},{"start":39,"end":46,"tag":"safety"},{"start":51,"end":60,"tag":"efficacy"},{"start":116,"end":127,"tag":"DidYouKnow"},{"start":128,"end":135,"tag":"pharma"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460845195664580608","possibly_sensitive":false,"created_at":"2014-04-28T18:17:11.000Z","referenced_tweets":[{"type":"retweeted","id":"460823037424988160"}],"id":"460845195664580608","text":"RT @egagenerics: How are the #quality, #safety and #efficacy of medicines ensured in the EU? http://t.co/0aCEMDZfBL #DidYouKnow #pharma #pa…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/0aCEMDZfBL","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/faq-on-generic-medicines","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":113,"end":121,"tag":"quality"},{"start":122,"end":129,"tag":"access"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460845155818668032","possibly_sensitive":false,"created_at":"2014-04-28T18:17:01.000Z","referenced_tweets":[{"type":"retweeted","id":"460822622864175104"}],"id":"460845155818668032","text":"RT @egagenerics: Why are generic medicines regarded as equivalent to originator medicines?http://t.co/0aCEMDZfBL #quality #access #sustaina…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":21,"end":23,"probability":0.8592,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460809502565339136","possibly_sensitive":false,"created_at":"2014-04-28T15:55:21.000Z","referenced_tweets":[{"type":"retweeted","id":"460808465569832960"}],"id":"460809502565339136","text":"RT @US_FDA: Join the FDA Commissioner's Fellowship Program. Accepting applications until May 26. More in the FDA Voice blog http://t.co/0m1…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/joAV97qMKC","expanded_url":"http://bit.ly/1itPXst","display_url":"bit.ly/1itPXst"}],"hashtags":[{"start":18,"end":23,"tag":"MHRA"},{"start":43,"end":55,"tag":"Domperidone"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460792285622718464","possibly_sensitive":false,"created_at":"2014-04-28T14:46:56.000Z","referenced_tweets":[{"type":"retweeted","id":"460791952099639296"}],"id":"460792285622718464","text":"RT @euparkinsons: #MHRA issue new advice 4 #Domperidone: http://t.co/joAV97qMKC","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WSKvctsA68","expanded_url":"http://bit.ly/1m0GdKm","display_url":"bit.ly/1m0GdKm"}],"hashtags":[{"start":0,"end":15,"tag":"EudraVigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"460791162031599616","possibly_sensitive":false,"created_at":"2014-04-28T14:42:28.000Z","referenced_tweets":{},"id":"460791162031599616","text":"#EudraVigilance received and processed over 1 million adverse-drug-reaction reports last year. See the 2013 report: http://t.co/WSKvctsA68","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":64,"end":71,"tag":"animal"},{"start":92,"end":103,"tag":"Biological"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460788147832758272","possibly_sensitive":false,"created_at":"2014-04-28T14:30:30.000Z","referenced_tweets":[{"type":"retweeted","id":"460788031382114304"}],"id":"460788147832758272","text":"RT @EFSA_EU: #EFSApanel renewal: EFSA is looking for experts in #animal-by-products for its #Biological hazards panel. Apply http://t.co/os…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/bTSdhXE80O","expanded_url":"http://bit.ly/1h6MG2V","display_url":"bit.ly/1h6MG2V"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460787085151313921","possibly_sensitive":false,"created_at":"2014-04-28T14:26:16.000Z","referenced_tweets":{},"id":"460787085151313921","text":"RT @INFARMED_IP: Falsified medicine - Herceptin, trastuzumab - update  http://t.co/bTSdhXE80O","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/uA0i5lSoLW","expanded_url":"http://bit.ly/1m1l7jh","display_url":"bit.ly/1m1l7jh"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460786611262066689","possibly_sensitive":false,"created_at":"2014-04-28T14:24:23.000Z","referenced_tweets":[{"type":"retweeted","id":"460782741525909506"}],"id":"460786611262066689","text":"RT @EFPIA: Scientists identify way to target drug-resistant cancer cells http://t.co/uA0i5lSoLW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/wbCj5DK0BU","expanded_url":"http://bit.ly/S1kXLF","display_url":"bit.ly/S1kXLF"}],"hashtags":[{"start":42,"end":55,"tag":"AnimalHealth"}],"mentions":{},"annotations":[{"start":75,"end":80,"probability":0.7195,"type":"Place","normalized_text":"Europe"},{"start":84,"end":97,"probability":0.8745,"type":"Person","normalized_text":"Declan O'Brien"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460780395483922432","possibly_sensitive":false,"created_at":"2014-04-28T13:59:41.000Z","referenced_tweets":[{"type":"retweeted","id":"460772372321402880"}],"id":"460780395483922432","text":"RT @IFAHEurope: VIDEO: Update on European #AnimalHealth industry from IFAH-Europe's Declan O'Brien - http://t.co/wbCj5DK0BU","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":28,"end":36,"tag":"ESCAIDE"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460766930962763777","possibly_sensitive":false,"created_at":"2014-04-28T13:06:11.000Z","referenced_tweets":[{"type":"retweeted","id":"460765015172481026"}],"id":"460766930962763777","text":"RT @ECDC_EU: Save the date: #ESCAIDE 2014 call for abstracts will open in a week!","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460766863497383937","possibly_sensitive":false,"created_at":"2014-04-28T13:05:55.000Z","referenced_tweets":[{"type":"retweeted","id":"460760651561205760"}],"id":"460766863497383937","text":"RT @EU_ECHA: Are you an expert in risk assessment of nanomaterials? Express your interest for our scientific workshop by 15 May http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/VEhzb4K1Se","expanded_url":"http://bit.ly/1itCQre","display_url":"bit.ly/1itCQre"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"460757977231024128","possibly_sensitive":false,"created_at":"2014-04-28T12:30:36.000Z","referenced_tweets":{},"id":"460757977231024128","text":"RT @ansm_sante: 2 clicks to find everything on health products with new search engine on the French agency's website: http://t.co/VEhzb4K1Se","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/jKwa2ePU2S","expanded_url":"http://bit.ly/1ivLKtg","display_url":"bit.ly/1ivLKtg"}],"hashtags":[{"start":16,"end":27,"tag":"IFAHEurope"},{"start":118,"end":131,"tag":"AnimalHealth"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460757219324481536","possibly_sensitive":false,"created_at":"2014-04-28T12:27:36.000Z","referenced_tweets":[{"type":"retweeted","id":"460757079758999552"}],"id":"460757219324481536","text":"RT @IFAHEurope: #IFAHEurope Perspectives newsletter (April 2014) out now: http://t.co/jKwa2ePU2S Feel free to retweet #AnimalHealth  @EU_He…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/robSOf7B1C","expanded_url":"http://bit.ly/1lbYDsV","display_url":"bit.ly/1lbYDsV"}],"hashtags":[{"start":0,"end":5,"tag":"CMDh"},{"start":112,"end":121,"tag":"zolpidem"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460739723578068992","possibly_sensitive":false,"created_at":"2014-04-28T11:18:04.000Z","referenced_tweets":{},"id":"460739723578068992","text":"#CMDh endorsed new advice to minimise risk of next-morning impaired driving ability &amp; mental alertness with #zolpidem http://t.co/robSOf7B1C","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/MT8CWqcSsd","expanded_url":"http://bit.ly/1mLE5K6","display_url":"bit.ly/1mLE5K6"}],"hashtags":[{"start":63,"end":75,"tag":"domperidone"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"460739520234004480","possibly_sensitive":false,"created_at":"2014-04-28T11:17:16.000Z","referenced_tweets":{},"id":"460739520234004480","text":"Last Friday we confirmed recommendations on restricting use of #domperidone-containing medicines: http://t.co/MT8CWqcSsd","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/sJvOx8QuYX","expanded_url":"http://bit.ly/1jLJvhJ","display_url":"bit.ly/1jLJvhJ"}],"hashtags":[{"start":41,"end":52,"tag":"Linoladiol"},{"start":73,"end":83,"tag":"estradiol"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460739321491124224","possibly_sensitive":false,"created_at":"2014-04-28T11:16:29.000Z","referenced_tweets":{},"id":"460739321491124224","text":"We updated recommendations on the use of #Linoladiol N and Linoladiol HN #estradiol-containing creams: http://t.co/sJvOx8QuYX","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/AiPWm4p37i","expanded_url":"http://bit.ly/1hHDDVk","display_url":"bit.ly/1hHDDVk"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460738638230601728","possibly_sensitive":false,"created_at":"2014-04-28T11:13:46.000Z","referenced_tweets":{},"id":"460738638230601728","text":"Consultation open on our draft guideline on pathological Complete Response as an endpoint in breast-cancer studies: http://t.co/AiPWm4p37i","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/sShsD4wVzp","expanded_url":"http://bit.ly/1mHm2Ch","display_url":"bit.ly/1mHm2Ch"}],"hashtags":[{"start":42,"end":53,"tag":"Caustinerf"},{"start":68,"end":77,"tag":"Yranicid"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"460738422345170946","possibly_sensitive":false,"created_at":"2014-04-28T11:12:54.000Z","referenced_tweets":{},"id":"460738422345170946","text":"We recommended revoking authorisations of #Caustinerf arsenical and #Yranicid in dental procedures: http://t.co/sShsD4wVzp","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/MiZoX9ayaV","expanded_url":"http://bit.ly/1ila6AU","display_url":"bit.ly/1ila6AU"}],"hashtags":[{"start":32,"end":40,"tag":"Nexavar"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"460737783255285760","possibly_sensitive":false,"created_at":"2014-04-28T11:10:22.000Z","referenced_tweets":{},"id":"460737783255285760","text":"We recommended extending use of #Nexavar to include treatment of differentiated thyroid cancer: http://t.co/MiZoX9ayaV","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/rhuy7lWV3z","expanded_url":"http://bit.ly/1tKBou1","display_url":"bit.ly/1tKBou1"}],"hashtags":[{"start":27,"end":36,"tag":"Mekinist"},{"start":58,"end":67,"tag":"melanoma"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"460737623129329664","possibly_sensitive":false,"created_at":"2014-04-28T11:09:44.000Z","referenced_tweets":{},"id":"460737623129329664","text":"We recommended approval of #Mekinist for the treatment of #melanoma: http://t.co/rhuy7lWV3z","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/6VEUxhjS9a","expanded_url":"http://bit.ly/1faS2yU","display_url":"bit.ly/1faS2yU"}],"hashtags":[{"start":29,"end":34,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"460737047855366145","possibly_sensitive":false,"created_at":"2014-04-28T11:07:26.000Z","referenced_tweets":{},"id":"460737047855366145","text":"Last Friday we published the #CHMP meeting highlights: http://t.co/6VEUxhjS9a","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/3byJCpSSry","expanded_url":"http://bit.ly/1kkNwwB","display_url":"bit.ly/1kkNwwB"}],"hashtags":[{"start":46,"end":58,"tag":"vaccination"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460728922226049024","possibly_sensitive":false,"created_at":"2014-04-28T10:35:09.000Z","referenced_tweets":[{"type":"retweeted","id":"460727984463556608"}],"id":"460728922226049024","text":"RT @EuropeanLung: Study reveals the impact of #vaccination on whooping cough http://t.co/3byJCpSSry","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/igwFgZwngv","expanded_url":"http://goo.gl/a1sTsa","display_url":"goo.gl/a1sTsa"}],"hashtags":[{"start":75,"end":85,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460722214686691328","possibly_sensitive":false,"created_at":"2014-04-28T10:08:30.000Z","referenced_tweets":[{"type":"retweeted","id":"460721994829672448"}],"id":"460722214686691328","text":"RT @Hep_Alliance: New to our website - interactive map shows prevalence of #hepatitis across the world http://t.co/igwFgZwngv http://t.co/P…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/AiPWm4p37i","expanded_url":"http://bit.ly/1hHDDVk","display_url":"bit.ly/1hHDDVk"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"460719977667244032","possibly_sensitive":false,"created_at":"2014-04-28T09:59:37.000Z","referenced_tweets":{},"id":"460719977667244032","text":"We've published a guideline on pathological Complete Response as endpoint in breast-cancer studies for consultation: http://t.co/AiPWm4p37i","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/EwRCIWNzAd","expanded_url":"http://nyti.ms/1nUWyS0","display_url":"nyti.ms/1nUWyS0"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"460704858170224640","possibly_sensitive":false,"created_at":"2014-04-28T08:59:32.000Z","referenced_tweets":[{"type":"retweeted","id":"460704210263502848"}],"id":"460704858170224640","text":"RT @EFPIA: New Tool to Fight Deadly Tsetse Fly http://t.co/EwRCIWNzAd","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/0HvCubg8ds","expanded_url":"http://bit.ly/1h5YHFL","display_url":"bit.ly/1h5YHFL"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":[{"start":45,"end":110,"probability":0.146,"type":"Product","normalized_text":"Enalapril Balpril 5 mg tablets and Enalapril Balpril 20 mg tablets"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"460700484106723328","possibly_sensitive":false,"created_at":"2014-04-28T08:42:09.000Z","referenced_tweets":{},"id":"460700484106723328","text":"RT @INFARMED_IP: Voluntary recall of lots of Enalapril Balpril 5 mg tablets and Enalapril Balpril 20 mg tablets http://t.co/0HvCubg8ds","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/prf7RT4K8O","expanded_url":"http://bit.ly/1mLfZPy","display_url":"bit.ly/1mLfZPy"}],"hashtags":[{"start":52,"end":70,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"459720762363240449","possibly_sensitive":false,"created_at":"2014-04-25T15:49:05.000Z","referenced_tweets":{},"id":"459720762363240449","text":"We've published revision 3 of our guideline on good #pharmacovigilance practices: annex I - definitions:  http://t.co/prf7RT4K8O","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/JvQAxsRaOe","expanded_url":"http://bit.ly/1ntxOTt","display_url":"bit.ly/1ntxOTt"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"459720644444577793","possibly_sensitive":false,"created_at":"2014-04-25T15:48:37.000Z","referenced_tweets":{},"id":"459720644444577793","text":"We've just published our guideline on good #pharmacovigilance practices: module XVI – risk minimisation measures: http://t.co/JvQAxsRaOe","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/0y6JTYTpsp","expanded_url":"http://bit.ly/1iksEkW","display_url":"bit.ly/1iksEkW"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"459720540006408192","possibly_sensitive":false,"created_at":"2014-04-25T15:48:12.000Z","referenced_tweets":{},"id":"459720540006408192","text":"We've published our guideline on good #pharmacovigilance practices: module V – risk management systems: http://t.co/0y6JTYTpsp","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/CILftmZn0F","expanded_url":"http://bit.ly/1rr4zOL","display_url":"bit.ly/1rr4zOL"}],"hashtags":{},"mentions":{},"annotations":[{"start":17,"end":36,"probability":0.7716,"type":"Other","normalized_text":"World Veterinary Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459720414852554752","possibly_sensitive":false,"created_at":"2014-04-25T15:47:42.000Z","referenced_tweets":{},"id":"459720414852554752","text":"We're supporting World Veterinary Day tomorrow 26 April: http://t.co/CILftmZn0F","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/robSOf7B1C","expanded_url":"http://bit.ly/1lbYDsV","display_url":"bit.ly/1lbYDsV"}],"hashtags":[{"start":0,"end":5,"tag":"CMDh"},{"start":112,"end":121,"tag":"zolpidem"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459709067012096000","possibly_sensitive":false,"created_at":"2014-04-25T15:02:37.000Z","referenced_tweets":{},"id":"459709067012096000","text":"#CMDh endorses new advice to minimise risk of next-morning impaired driving ability &amp; mental alertness with #zolpidem http://t.co/robSOf7B1C","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/sJvOx8QuYX","expanded_url":"http://bit.ly/1jLJvhJ","display_url":"bit.ly/1jLJvhJ"}],"hashtags":[{"start":74,"end":84,"tag":"estradiol"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459708574986670080","possibly_sensitive":false,"created_at":"2014-04-25T15:00:39.000Z","referenced_tweets":{},"id":"459708574986670080","text":"We've put measures in place to manage potential risk of side effects with #estradiol-containing creams http://t.co/sJvOx8QuYX","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/MT8CWqcSsd","expanded_url":"http://bit.ly/1mLE5K6","display_url":"bit.ly/1mLE5K6"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459707977415806976","possibly_sensitive":false,"created_at":"2014-04-25T14:58:17.000Z","referenced_tweets":{},"id":"459707977415806976","text":"We confirm recommendations on restricting use of domperidone-containing medicines. http://t.co/MT8CWqcSsd","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/YrGtALkI5p","expanded_url":"http://bit.ly/1mHm2Ch","display_url":"bit.ly/1mHm2Ch"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459707516671512578","possibly_sensitive":false,"created_at":"2014-04-25T14:56:27.000Z","referenced_tweets":{},"id":"459707516671512578","text":"Our Committee recommends revoking authorisations of two dental products containing arsenic. http://t.co/YrGtALkI5p","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/MiZoX9ayaV","expanded_url":"http://bit.ly/1ila6AU","display_url":"bit.ly/1ila6AU"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"459706547317514240","possibly_sensitive":false,"created_at":"2014-04-25T14:52:36.000Z","referenced_tweets":{},"id":"459706547317514240","text":"We've recommended extending use of Nexavar to include treatment of differentiated thyroid cancer http://t.co/MiZoX9ayaV","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/rhuy7lWV3z","expanded_url":"http://bit.ly/1tKBou1","display_url":"bit.ly/1tKBou1"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"459706122157703168","possibly_sensitive":false,"created_at":"2014-04-25T14:50:55.000Z","referenced_tweets":{},"id":"459706122157703168","text":"We've recommended first MEK inhibitor in the EU. http://t.co/rhuy7lWV3z","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/6VEUxhjS9a","expanded_url":"http://bit.ly/1faS2yU","display_url":"bit.ly/1faS2yU"}],"hashtags":[{"start":11,"end":16,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"459705559080783872","possibly_sensitive":false,"created_at":"2014-04-25T14:48:40.000Z","referenced_tweets":{},"id":"459705559080783872","text":"April 2014 #CHMP outcome has just been published. http://t.co/6VEUxhjS9a","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ZawcY9h5eL","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459001039455518720","possibly_sensitive":false,"created_at":"2014-04-25T12:56:40.000Z","referenced_tweets":[{"type":"replied_to","id":"459372690475085824"}],"id":"459677372242198528","text":"@VanessaVanHalen Please check the meeting minutes for the details discussed in March and April, to be published here: http://t.co/ZawcY9h5eL","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/prf7RT4K8O","expanded_url":"http://bit.ly/1mLfZPy","display_url":"bit.ly/1mLfZPy"}],"hashtags":[{"start":36,"end":54,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459650352326144001","possibly_sensitive":false,"created_at":"2014-04-25T11:09:18.000Z","referenced_tweets":{},"id":"459650352326144001","text":"We've updated our guideline on good #pharmacovigilance practices: annex I - definitions:  http://t.co/prf7RT4K8O","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/JvQAxsRaOe","expanded_url":"http://bit.ly/1ntxOTt","display_url":"bit.ly/1ntxOTt"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"459649895755157504","possibly_sensitive":false,"created_at":"2014-04-25T11:07:29.000Z","referenced_tweets":{},"id":"459649895755157504","text":"We've published our guideline on good #pharmacovigilance practices: module XVI – risk minimisation measures: http://t.co/JvQAxsRaOe","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0y6JTYTpsp","expanded_url":"http://bit.ly/1iksEkW","display_url":"bit.ly/1iksEkW"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459640738788409344","possibly_sensitive":false,"created_at":"2014-04-25T10:31:06.000Z","referenced_tweets":{},"id":"459640738788409344","text":"We've just published our guideline on good #pharmacovigilance practices: module V – risk management systems: http://t.co/0y6JTYTpsp","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/T9JN5CgOo7","expanded_url":"http://ec.europa.eu/commission_2010-2014/president/achievements/files/RoA_EN.pdf","display_url":"ec.europa.eu/commission_201…"}],"hashtags":[{"start":23,"end":26,"tag":"EU"},{"start":50,"end":57,"tag":"health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":59,"end":73,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459634944114171904","possibly_sensitive":false,"created_at":"2014-04-25T10:08:04.000Z","referenced_tweets":[{"type":"retweeted","id":"459628422260473856"}],"id":"459634944114171904","text":"RT @EU_Health: How did #EU work for better public #health? @EU_Commission achievements over the last 5 years http://t.co/T9JN5CgOo7 http://…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/8alEulOCX8","expanded_url":"http://bit.ly/registerSF2014","display_url":"bit.ly/registerSF2014"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":92,"end":99,"probability":0.9705,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459634863055077376","possibly_sensitive":false,"created_at":"2014-04-25T10:07:45.000Z","referenced_tweets":[{"type":"retweeted","id":"459630699881181184"}],"id":"459634863055077376","text":"RT @IMI_JU: Registration now open for IMI's Stakeholder Forum 2014 taking place on 21/05 in Brussels. Register at http://t.co/8alEulOCX8 #I…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/CILftmZn0F","expanded_url":"http://bit.ly/1rr4zOL","display_url":"bit.ly/1rr4zOL"}],"hashtags":{},"mentions":{},"annotations":[{"start":17,"end":36,"probability":0.6294,"type":"Other","normalized_text":"World Veterinary Day"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"459633418574524416","possibly_sensitive":false,"created_at":"2014-04-25T10:02:01.000Z","referenced_tweets":{},"id":"459633418574524416","text":"We're supporting World Veterinary Day tomorrow: http://t.co/CILftmZn0F","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/WmzsxywJC8","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459001039455518720","possibly_sensitive":false,"created_at":"2014-04-24T12:33:26.000Z","referenced_tweets":[{"type":"replied_to","id":"459042257187139584"}],"id":"459309137495871488","text":"@VanessaVanHalen The evaluation is still ongoing. For any further questions please send us a query at: http://t.co/WmzsxywJC8","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/CtV9XA9ELt","expanded_url":"http://bit.ly/1tC1pM1","display_url":"bit.ly/1tC1pM1"}],"hashtags":[{"start":32,"end":38,"tag":"H2020"},{"start":73,"end":80,"tag":"ageing"},{"start":86,"end":90,"tag":"ICT"},{"start":97,"end":105,"tag":"funding"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":131,"end":139,"username":"EIP_AHA","id":"416925949"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459303189377200128","possibly_sensitive":false,"created_at":"2014-04-24T12:09:48.000Z","referenced_tweets":[{"type":"retweeted","id":"459017646714155008"}],"id":"459303189377200128","text":"RT @EU_eHealth: 162 Million for #H2020 call Advancing active and healthy #ageing with #ICT, 100% #funding - http://t.co/CtV9XA9ELt @EIP_AHA…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":33,"end":38,"tag":"EFSA"},{"start":54,"end":68,"tag":"toxicologists"},{"start":77,"end":94,"tag":"dieteticproducts"},{"start":96,"end":106,"tag":"nutrition"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459303076344918017","possibly_sensitive":false,"created_at":"2014-04-24T12:09:21.000Z","referenced_tweets":[{"type":"retweeted","id":"459036488819568640"}],"id":"459303076344918017","text":"RT @EFSA_EU: #EFSApanel renewal: #EFSA is looking for #toxicologists for its #dieteticproducts, #nutrition and allergies panel. http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/QZR1JiYUtY","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"hashtags":[{"start":36,"end":41,"tag":"EDQM"},{"start":121,"end":132,"tag":"employment"},{"start":133,"end":139,"tag":"pheur"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459302788527173632","possibly_sensitive":false,"created_at":"2014-04-24T12:08:12.000Z","referenced_tweets":[{"type":"retweeted","id":"459248551227576320"}],"id":"459302788527173632","text":"RT @edqm_news: New position open at #EDQM: Scientific Programme Officer for the Chemical Division http://t.co/QZR1JiYUtY #employment #pheur","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":31,"end":36,"tag":"SMEs"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459301889902145536","possibly_sensitive":false,"created_at":"2014-04-24T12:04:38.000Z","referenced_tweets":[{"type":"retweeted","id":"459283204567236608"}],"id":"459301889902145536","text":"RT @IMI_JU: ‘I would encourage #SMEs to participate in IMI Calls, as their efforts would most certainly pay off’ - Taros CEO at http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":70,"end":79,"tag":"PhaseIII"},{"start":80,"end":90,"tag":"biomarker"},{"start":110,"end":125,"tag":"clinicaltrials"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459301720796180480","possibly_sensitive":false,"created_at":"2014-04-24T12:03:58.000Z","referenced_tweets":[{"type":"retweeted","id":"459292047414149120"}],"id":"459301720796180480","text":"RT @myESMO: Study considers design and analysis strategies for use in #PhaseIII #biomarker-driven, randomised #clinicaltrials http://t.co/b…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":78,"end":86,"tag":"ehealth"}],"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":118,"end":126,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459301445956009984","possibly_sensitive":false,"created_at":"2014-04-24T12:02:52.000Z","referenced_tweets":[{"type":"retweeted","id":"459301169215848448"}],"id":"459301445956009984","text":"RT @IDFEuropeBxl: Better access, deployment &amp; interoperability needed for #ehealth - Stakeholder Group report via @EPHA_EU http://t.co/lLiz…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":[{"start":19,"end":21,"probability":0.6047,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459007254252228608","possibly_sensitive":false,"created_at":"2014-04-23T16:33:52.000Z","referenced_tweets":[{"type":"retweeted","id":"459001155444813824"}],"id":"459007254252228608","text":"RT @FDA_Drug_Info: FDA warns of rare but serious neurologic problems after epidural corticosteroid injections for pain. http://t.co/X91yjOd…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/13ybtB0wpj","expanded_url":"http://bit.ly/QEZW8g","display_url":"bit.ly/QEZW8g"}],"hashtags":{},"mentions":[{"start":0,"end":9,"username":"BioRunUp","id":"102527566"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459002779160158208","possibly_sensitive":false,"created_at":"2014-04-23T16:33:02.000Z","referenced_tweets":[{"type":"replied_to","id":"459002779160158208"}],"id":"459007048542609409","text":"@BioRunUp We don't publish these dates. The groups are convened as required by the CHMP: http://t.co/13ybtB0wpj","attachments":{"media_keys":{}},"in_reply_to_user_id":"102527566"},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/pfvLdbHlWB","expanded_url":"http://bit.ly/1f6qafe","display_url":"bit.ly/1f6qafe"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459001039455518720","possibly_sensitive":false,"created_at":"2014-04-23T16:26:32.000Z","referenced_tweets":[{"type":"replied_to","id":"459001039455518720"}],"id":"459005409685434368","text":"@VanessaVanHalen This week our committee is adopting a list of questions for  an ad-hoc expert meeting. See p. 9: http://t.co/pfvLdbHlWB","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/wpDUz1KM38","expanded_url":"http://bit.ly/1ifD0lX","display_url":"bit.ly/1ifD0lX"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459000241455644674","possibly_sensitive":false,"created_at":"2014-04-23T16:12:44.000Z","referenced_tweets":[{"type":"replied_to","id":"459000241455644674"}],"id":"459001939301519360","text":"@VanessaVanHalen Information on how we avoid conflicts of interests is here: http://t.co/wpDUz1KM38","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/5R5S3Yibm6","expanded_url":"http://bit.ly/RLMW1L","display_url":"bit.ly/RLMW1L"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"459000241455644674","possibly_sensitive":false,"created_at":"2014-04-23T16:11:11.000Z","referenced_tweets":[{"type":"replied_to","id":"459000241455644674"}],"id":"459001548404981760","text":"@VanessaVanHalen 210 active days; there are clock stops to allow the company to respond to questions. See q. 31 here: http://t.co/5R5S3Yibm6","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":{},"hashtags":[{"start":23,"end":33,"tag":"scientist"},{"start":109,"end":120,"tag":"Newsletter"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458998876507500544","possibly_sensitive":false,"created_at":"2014-04-23T16:00:34.000Z","referenced_tweets":[{"type":"retweeted","id":"458998741367001089"}],"id":"458998876507500544","text":"RT @EFSA_EU: Are you a #scientist? Learn about EFSA’s Scientific Committee and Panels. Subscribe to the EFSA #Newsletter today. http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458995905346433026","possibly_sensitive":false,"created_at":"2014-04-23T15:48:46.000Z","referenced_tweets":[{"type":"retweeted","id":"458994016424452097"}],"id":"458995905346433026","text":"RT @FDAMedWatch: Epidural Corticosteroid Injection: Drug Safety Communication - Risk of Rare But Serious Neurologic Problems http://t.co/mg…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":36,"end":40,"tag":"HPV"}],"mentions":{},"annotations":[{"start":116,"end":121,"probability":0.991,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458990490940375040","possibly_sensitive":false,"created_at":"2014-04-23T15:27:15.000Z","referenced_tweets":[{"type":"retweeted","id":"458988638098190336"}],"id":"458990490940375040","text":"RT @Eurovaccine: Recent evidence on #HPV vaccines in boys and men &amp; two dose schedule may warrant policy changes in Europe http://t.co/1jCG…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/kxB9NEBKAy","expanded_url":"http://fb.me/6OolbIKsf","display_url":"fb.me/6OolbIKsf"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"medicinesmalta","id":"357784930"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458986552136577024","possibly_sensitive":false,"created_at":"2014-04-23T15:11:36.000Z","referenced_tweets":[{"type":"retweeted","id":"458986361232449536"}],"id":"458986552136577024","text":"RT @medicinesmalta: We are Recruiting a Finance and Administration Manager! http://t.co/kxB9NEBKAy","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/ZrzrQgGW2U","expanded_url":"http://blogs.bmj.com/bmj/2014/04/23/trish-groves-reader-responses-to-updated-cochrane-reviews-on-tamiflu-and-relenza/","display_url":"blogs.bmj.com/bmj/2014/04/23…"}],"hashtags":[{"start":83,"end":91,"tag":"Tamiflu"},{"start":127,"end":134,"tag":"TheBMJ"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":21,"end":32,"probability":0.9902,"type":"Person","normalized_text":"Trish Groves"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458972559669989376","possibly_sensitive":false,"created_at":"2014-04-23T14:16:00.000Z","referenced_tweets":[{"type":"retweeted","id":"458971406324473856"}],"id":"458972559669989376","text":"RT @FrancoisMaignen: Trish Groves: Reader responses to updated Cochrane reviews on #Tamiflu and Relenza http://t.co/ZrzrQgGW2U #TheBMJ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/RJ4RNAUHec","expanded_url":"http://go.usa.gov/kPxP","display_url":"go.usa.gov/kPxP"}],"hashtags":[{"start":50,"end":60,"tag":"stemcells"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":16,"end":18,"probability":0.5979,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458967310804742144","possibly_sensitive":false,"created_at":"2014-04-23T13:55:08.000Z","referenced_tweets":[{"type":"retweeted","id":"458964915626442752"}],"id":"458967310804742144","text":"RT @US_FDA: Why FDA scientists are studying adult #stemcells—and how they could change medicine: http://t.co/RJ4RNAUHec","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/hvnSuXfurR","expanded_url":"http://bit.ly/15Y2jI5","display_url":"bit.ly/15Y2jI5"}],"hashtags":[{"start":32,"end":49,"tag":"Immunizationweek"},{"start":95,"end":107,"tag":"vaccination"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458962452982804481","possibly_sensitive":false,"created_at":"2014-04-23T13:35:50.000Z","referenced_tweets":[{"type":"retweeted","id":"458961216334213121"}],"id":"458962452982804481","text":"RT @IFAHEurope: During European #Immunizationweek it’s important to remember that animals need #vaccination too: http://t.co/hvnSuXfurR #EI…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":85,"end":96,"tag":"RUuptodate"},{"start":97,"end":105,"tag":"EIW2014"},{"start":106,"end":121,"tag":"ImmunizeEurope"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":46,"end":51,"probability":0.9895,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458962084978786304","possibly_sensitive":false,"created_at":"2014-04-23T13:34:22.000Z","referenced_tweets":[{"type":"retweeted","id":"458954893634453505"}],"id":"458962084978786304","text":"RT @WHO_Europe: Infographic: Measles cases in Europe have risen by 348% from 2007-13 #RUuptodate #EIW2014 #ImmunizeEurope http://t.co/wUXOF…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/MJaYQpnHBC","expanded_url":"http://bit.ly/1l1joay","display_url":"bit.ly/1l1joay"}],"hashtags":[{"start":49,"end":58,"tag":"leukemia"},{"start":75,"end":84,"tag":"Research"},{"start":85,"end":92,"tag":"Pharma"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458961692555497472","possibly_sensitive":false,"created_at":"2014-04-23T13:32:49.000Z","referenced_tweets":[{"type":"retweeted","id":"458951407782338560"}],"id":"458961692555497472","text":"RT @EFPIA: Gene within gene drives acute myeloid #leukemia, says new study #Research #Pharma http://t.co/MJaYQpnHBC","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/6ldADixBMr","expanded_url":"http://ow.ly/w4tPB","display_url":"ow.ly/w4tPB"}],"hashtags":[{"start":52,"end":66,"tag":"gastriccancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":26,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458961498740912128","possibly_sensitive":false,"created_at":"2014-04-23T13:32:03.000Z","referenced_tweets":[{"type":"retweeted","id":"458946693355286528"}],"id":"458961498740912128","text":"RT @myESMO: @FDA_Drug_Info approves Ramucirumab for #gastriccancer or Gastroesophageal Junction Adenocarcinoma http://t.co/6ldADixBMr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/pwPkypCHzI","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/introduction","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":113,"end":120,"tag":"pharma"},{"start":121,"end":128,"tag":"health"},{"start":129,"end":138,"tag":"patients"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458961232901701632","possibly_sensitive":false,"created_at":"2014-04-23T13:30:59.000Z","referenced_tweets":[{"type":"retweeted","id":"458944072800305153"}],"id":"458961232901701632","text":"RT @egagenerics: Do you want to learn more about generic medicines? Find  more info here: http://t.co/pwPkypCHzI #pharma #health #patients …","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/0yWHoTFBYj","expanded_url":"http://bit.ly/1i8BpDo","display_url":"bit.ly/1i8BpDo"}],"hashtags":[{"start":58,"end":63,"tag":"MERS"},{"start":80,"end":87,"tag":"Greece"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":18,"end":26,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458961072691888128","possibly_sensitive":false,"created_at":"2014-04-23T13:30:21.000Z","referenced_tweets":[{"type":"retweeted","id":"458941754075787264"}],"id":"458961072691888128","text":"RT @ECDC_Flu: New @ECDC_EU update following first case of #MERS-CoV reported by #Greece. http://t.co/0yWHoTFBYj","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/BQP3vcTwtQ","expanded_url":"http://bit.ly/1l1sZhM","display_url":"bit.ly/1l1sZhM"}],"hashtags":[{"start":85,"end":95,"tag":"Herceptin"},{"start":96,"end":108,"tag":"trastuzumab"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"annotations":[{"start":108,"end":114,"probability":0.9947,"type":"Place","normalized_text":"Austria"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"458961013300531201","possibly_sensitive":false,"created_at":"2014-04-23T13:30:07.000Z","referenced_tweets":{},"id":"458961013300531201","text":"RT @agesnews: Medicine - warning: update on theft &amp; falsification of cancer drug #Herceptin #trastuzumab in Austria http://t.co/BQP3vcTwtQ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/Jo2jmDO2u4","expanded_url":"http://bit.ly/QE7qbv","display_url":"bit.ly/QE7qbv"}],"hashtags":[{"start":13,"end":25,"tag":"Infographic"},{"start":67,"end":75,"tag":"measles"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458960686874640385","possibly_sensitive":false,"created_at":"2014-04-23T13:28:49.000Z","referenced_tweets":[{"type":"retweeted","id":"458936959457439744"}],"id":"458960686874640385","text":"RT @ECDC_EU: #Infographic: Teenagers/young adults also affected by #measles: not only a childhood disease! http://t.co/Jo2jmDO2u4 http://t.…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/QZR1JiYUtY","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":68,"end":79,"tag":"laboratory"},{"start":112,"end":123,"tag":"employment"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458960601969360896","possibly_sensitive":false,"created_at":"2014-04-23T13:28:29.000Z","referenced_tweets":[{"type":"retweeted","id":"458936590874980352"}],"id":"458960601969360896","text":"RT @edqm_news: #EDQM currently looking for a Study Director to plan #laboratory projects http://t.co/QZR1JiYUtY #employment #analyticalchem…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":26,"end":36,"tag":"varicella"},{"start":37,"end":49,"tag":"vaccination"}],"mentions":[{"start":17,"end":25,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458960530464833536","possibly_sensitive":false,"created_at":"2014-04-23T13:28:12.000Z","referenced_tweets":[{"type":"retweeted","id":"458895338775281664"}],"id":"458960530464833536","text":"RT @Eurovaccine: @ECDC_EU #varicella #vaccination guidance open for public consultation. Comments welcome! Closes 23 May. http://t.co/HCpdl…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/9iu1SaYukf","expanded_url":"http://bit.ly/1forYej","display_url":"bit.ly/1forYej"}],"hashtags":[{"start":48,"end":62,"tag":"anthelminthic"},{"start":63,"end":74,"tag":"resistance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458927157549727745","possibly_sensitive":false,"created_at":"2014-04-23T11:15:35.000Z","referenced_tweets":{},"id":"458927157549727745","text":"Comments invited now on our reflection paper on #anthelminthic #resistance. Deadline is 31 July: http://t.co/9iu1SaYukf","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/RdWgJqHfGK","expanded_url":"http://bit.ly/1l0zEet","display_url":"bit.ly/1l0zEet"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458927011185307649","possibly_sensitive":false,"created_at":"2014-04-23T11:15:00.000Z","referenced_tweets":{},"id":"458927011185307649","text":"One more week to comment on our reflection paper on injection-site residues: risk assessment &amp; residue surveillance: http://t.co/RdWgJqHfGK","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/7a0xaXzXvt","expanded_url":"http://bit.ly/1jJQRFf","display_url":"bit.ly/1jJQRFf"}],"hashtags":[{"start":66,"end":79,"tag":"intramammary"},{"start":100,"end":107,"tag":"cattle"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458926897788100608","possibly_sensitive":false,"created_at":"2014-04-23T11:14:33.000Z","referenced_tweets":{},"id":"458926897788100608","text":"One more week to comment on our guideline on efficacy studies for #intramammary products for use in #cattle: http://t.co/7a0xaXzXvt","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":108,"end":120,"tag":"raredisease"},{"start":122,"end":131,"tag":"eurdchat"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458924162544074753","possibly_sensitive":false,"created_at":"2014-04-23T11:03:41.000Z","referenced_tweets":[{"type":"retweeted","id":"458923531259367424"}],"id":"458924162544074753","text":"RT @eurordis: Discussions on progressive patient access start in 2h. Let’s improve access to treatments for #raredisease! #eurdchat http://…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/u2tERPm5rN","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/04/news_detail_002078.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"fr","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458913365772230656","possibly_sensitive":false,"created_at":"2014-04-23T10:20:47.000Z","referenced_tweets":[{"type":"retweeted","id":"458912355733479424"}],"id":"458913365772230656","text":"RT @GCessak: EC/EMA-FDA bilateral cooperation: http://t.co/u2tERPm5rN","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/5220FZdncb","expanded_url":"http://ow.ly/w4dAf","display_url":"ow.ly/w4dAf"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":43,"end":50,"username":"Nature","id":"15862891"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458913240639365120","possibly_sensitive":false,"created_at":"2014-04-23T10:20:17.000Z","referenced_tweets":[{"type":"retweeted","id":"458908882652626944"}],"id":"458913240639365120","text":"RT @IMI_JU: IMI's NEWMEDS project cited in @Nature. 'Drug development: the modelling challenge': http://t.co/5220FZdncb","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/9cR815tG2u","expanded_url":"http://www.bbc.com/news/business-27107416","display_url":"bbc.com/news/business-…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":[{"start":21,"end":28,"probability":0.827,"type":"Organization","normalized_text":"Novartis"},{"start":34,"end":36,"probability":0.7869,"type":"Organization","normalized_text":"GSK"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458913019826020352","possibly_sensitive":false,"created_at":"2014-04-23T10:19:24.000Z","referenced_tweets":[{"type":"retweeted","id":"458908091774271488"}],"id":"458913019826020352","text":"RT @IlariaPassarani: Novartis and GSK to exchange assets and launch joint venture http://t.co/9cR815tG2u","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/aZ8acfnMyX","expanded_url":"http://bit.ly/1hhtumH","display_url":"bit.ly/1hhtumH"}],"hashtags":[{"start":26,"end":41,"tag":"anticoagulants"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"458912885650259968","possibly_sensitive":false,"created_at":"2014-04-23T10:18:52.000Z","referenced_tweets":{},"id":"458912885650259968","text":"RT @ansm_sante: Report on #anticoagulants: State of play in 2014 and recommendations for monitoring http://t.co/aZ8acfnMyX","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/9iu1SaYukf","expanded_url":"http://bit.ly/1forYej","display_url":"bit.ly/1forYej"}],"hashtags":[{"start":38,"end":52,"tag":"anthelminthic"},{"start":53,"end":64,"tag":"resistance"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458903356707454976","possibly_sensitive":false,"created_at":"2014-04-23T09:41:00.000Z","referenced_tweets":{},"id":"458903356707454976","text":"We've published a reflection paper on #anthelminthic #resistance for public consultation until 31 July: http://t.co/9iu1SaYukf","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/RdWgJqHfGK","expanded_url":"http://bit.ly/1l0zEet","display_url":"bit.ly/1l0zEet"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458902213298245632","possibly_sensitive":false,"created_at":"2014-04-23T09:36:28.000Z","referenced_tweets":{},"id":"458902213298245632","text":"One week left to comment on our reflection paper on injection-site residues: risk assessment &amp; residue surveillance: http://t.co/RdWgJqHfGK","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/7a0xaXzXvt","expanded_url":"http://bit.ly/1jJQRFf","display_url":"bit.ly/1jJQRFf"}],"hashtags":[{"start":66,"end":79,"tag":"intramammary"},{"start":100,"end":107,"tag":"cattle"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458901779473002496","possibly_sensitive":false,"created_at":"2014-04-23T09:34:44.000Z","referenced_tweets":{},"id":"458901779473002496","text":"One week left to comment on our guideline on efficacy studies for #intramammary products for use in #cattle: http://t.co/7a0xaXzXvt","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/QZR1JiYUtY","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"hashtags":[{"start":38,"end":43,"tag":"EDQM"},{"start":119,"end":130,"tag":"employment"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458899969517576192","possibly_sensitive":false,"created_at":"2014-04-23T09:27:33.000Z","referenced_tweets":[{"type":"retweeted","id":"458897618064928768"}],"id":"458899969517576192","text":"RT @edqm_news: 5 new vacancies at the #EDQM: 2 weeks left before closing date for applications! http://t.co/QZR1JiYUtY #employment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/X728kYtQXr","expanded_url":"http://bit.ly/1jKond5","display_url":"bit.ly/1jKond5"}],"hashtags":[{"start":123,"end":134,"tag":"lungcancer"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458899950131486720","possibly_sensitive":false,"created_at":"2014-04-23T09:27:28.000Z","referenced_tweets":[{"type":"retweeted","id":"458897423835082752"}],"id":"458899950131486720","text":"RT @EuropeanLung: EORTC and SIOG publish expert opinion on treating elderly people with lung cancer http://t.co/X728kYtQXr #lungcancer","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/uuytz0a918","expanded_url":"http://bit.ly/PsKiMi","display_url":"bit.ly/PsKiMi"}],"hashtags":[{"start":33,"end":45,"tag":"ramucirumab"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":20,"end":22,"probability":0.8833,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"458899844409856000","possibly_sensitive":false,"created_at":"2014-04-23T09:27:03.000Z","referenced_tweets":{},"id":"458899844409856000","text":"RT @Aifa_ufficiale: FDA approves #ramucirumab for the treatment of stomach cancer\nhttp://t.co/uuytz0a918","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":25,"end":34,"tag":"eurdchat"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":92,"end":105,"username":"pharmaphorum","id":"27254739"}],"annotations":[{"start":35,"end":41,"probability":0.5752,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458898032004956160","possibly_sensitive":false,"created_at":"2014-04-23T09:19:51.000Z","referenced_tweets":[{"type":"retweeted","id":"458893251437944832"}],"id":"458898032004956160","text":"RT @eurordis: Get Ready! #eurdchat Twitter chat on progressive patient access, moderated by @pharmaphorum is just four hours away http://t.…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/IuGALanRcS","expanded_url":"http://europa.eu/!ty67gb","display_url":"europa.eu/!ty67gb"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897877969149952","possibly_sensitive":false,"created_at":"2014-04-23T09:19:14.000Z","referenced_tweets":[{"type":"retweeted","id":"458891853069185024"}],"id":"458897877969149952","text":"RT @IlariaPassarani: Joint purchasing of vaccines and medicines becomes a reality in the EU http://t.co/IuGALanRcS","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":65,"end":75,"tag":"varicella"},{"start":76,"end":88,"tag":"vaccination"},{"start":122,"end":130,"tag":"EIW2014"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897782213210113","possibly_sensitive":false,"created_at":"2014-04-23T09:18:51.000Z","referenced_tweets":[{"type":"retweeted","id":"458891738418266112"}],"id":"458897782213210113","text":"RT @ECDC_EU: Wish to contribute to ECDC's public consultation on #varicella #vaccination? send us your feedback by 23 May #EIW2014 http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":20,"end":24,"tag":"vax"},{"start":83,"end":91,"tag":"measles"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":128,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897487097769984","possibly_sensitive":false,"created_at":"2014-04-23T09:17:41.000Z","referenced_tweets":[{"type":"retweeted","id":"458884506238201857"}],"id":"458897487097769984","text":"RT @WHO: By getting #vax you ensure that you, your family are protected in case of #measles outbreak at home, while travelling http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/Jo2jmDO2u4","expanded_url":"http://bit.ly/QE7qbv","display_url":"bit.ly/QE7qbv"}],"hashtags":[{"start":18,"end":30,"tag":"infographic"},{"start":37,"end":45,"tag":"measles"},{"start":81,"end":89,"tag":"EIW2014"},{"start":90,"end":103,"tag":"immunisation"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":94,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897329194803200","possibly_sensitive":false,"created_at":"2014-04-23T09:17:03.000Z","referenced_tweets":[{"type":"retweeted","id":"458879404446208000"}],"id":"458897329194803200","text":"RT @ECDC_EU: ECDC #infographic shows #measles is more contagious than you think. #EIW2014 #immunisation http://t.co/Jo2jmDO2u4 http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":87,"end":96,"tag":"patients"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897271690911744","possibly_sensitive":false,"created_at":"2014-04-23T09:16:50.000Z","referenced_tweets":[{"type":"retweeted","id":"458878465090256897"}],"id":"458897271690911744","text":"RT @EFPIA: 12/5 Webinar: \"Breakthrough designation &amp; Medicine adaptive pathways to #patients - What does it all mean?\" http://t.co/S5BLFfm1…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":72,"end":81,"tag":"eurdchat"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":95,"end":108,"username":"pharmaphorum","id":"27254739"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458897244822188032","possibly_sensitive":false,"created_at":"2014-04-23T09:16:43.000Z","referenced_tweets":[{"type":"retweeted","id":"458878303227891712"}],"id":"458897244822188032","text":"RT @eurordis: Why not patient participation in benefit/risk assessment? #eurdchat moderated by @pharmaphorum starts at 3 pm CET. http://t.c…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/bJV0JbAvZY","expanded_url":"http://bit.ly/1ebijY3","display_url":"bit.ly/1ebijY3"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458645626876862464","possibly_sensitive":false,"created_at":"2014-04-22T16:36:53.000Z","referenced_tweets":{},"id":"458645626876862464","text":"Two more weeks to apply for our #vacancy for a Data Officer in the Business Data and Support Department: http://t.co/bJV0JbAvZY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458645495347699712","possibly_sensitive":false,"created_at":"2014-04-22T16:36:21.000Z","referenced_tweets":{},"id":"458645495347699712","text":"Two more weeks to apply for our #vacancy for a Continuous Improvement Lead in the Procedure Management Department: http://t.co/hCvn8Uqhel","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458622073020383232","possibly_sensitive":false,"created_at":"2014-04-22T15:41:45.000Z","referenced_tweets":[{"type":"replied_to","id":"458622073020383232"}],"id":"458631751217475584","text":"@VanessaVanHalen There are still questions for the company as part of the evaluation, details will be published at the end of the procedure.","attachments":{"media_keys":{}},"in_reply_to_user_id":"2305187534"},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458626026042822658","possibly_sensitive":false,"created_at":"2014-04-22T15:19:00.000Z","referenced_tweets":[{"type":"retweeted","id":"458537317352083456"}],"id":"458626026042822658","text":"RT @EASDnews: Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment - http://t.co/KIfveEw…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458624995833683968","possibly_sensitive":false,"created_at":"2014-04-22T15:14:54.000Z","referenced_tweets":[{"type":"retweeted","id":"458611399263281152"}],"id":"458624995833683968","text":"RT @FDACBER: Draft Guidance - Expedited Access for Premarket Approval Medical Devices Intended for Unmet Medical Needs http://t.co/Cc4Er6kI…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/L87NJIZn7n","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458624782083555328","possibly_sensitive":false,"created_at":"2014-04-22T15:14:03.000Z","referenced_tweets":[{"type":"retweeted","id":"458619524854841344"}],"id":"458624782083555328","text":"RT @IMI_JU: Topics under consideration for 2014 future Calls for proposals under IMI 2 are now available at http://t.co/L87NJIZn7n","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/WmzsxywJC8","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"CDeRede","id":"2254792730"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458609708434481152","possibly_sensitive":false,"created_at":"2014-04-22T15:12:29.000Z","referenced_tweets":[{"type":"replied_to","id":"458609708434481152"}],"id":"458624388800471040","text":"@CDeRede Currently we do not. For a more in-depth answer, please send us a question with further details: http://t.co/WmzsxywJC8","attachments":{"media_keys":{}},"in_reply_to_user_id":"2254792730"},{"entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/WNNVGl6Ter","expanded_url":"http://bit.ly/1hkIZps","display_url":"bit.ly/1hkIZps"}],"hashtags":{},"mentions":[{"start":53,"end":60,"username":"US_FDA","id":"208120290"},{"start":65,"end":75,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"458602546169659392","possibly_sensitive":false,"created_at":"2014-04-22T13:45:42.000Z","referenced_tweets":{},"id":"458602546169659392","text":"We've published an update on our recent meeting with @US_FDA and @EU_Health: http://t.co/WNNVGl6Ter","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/bJV0JbAvZY","expanded_url":"http://bit.ly/1ebijY3","display_url":"bit.ly/1ebijY3"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"458523758467485697","possibly_sensitive":false,"created_at":"2014-04-22T08:32:37.000Z","referenced_tweets":{},"id":"458523758467485697","text":"Two weeks left to apply for our #vacancy for a Data Officer in the Business Data and Support Department: http://t.co/bJV0JbAvZY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"458523353117360128","possibly_sensitive":false,"created_at":"2014-04-22T08:31:01.000Z","referenced_tweets":{},"id":"458523353117360128","text":"Two weeks left to apply for our #vacancy for a Continuous Improvement Lead in the Procedure Management Department: http://t.co/hCvn8Uqhel","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/3yjCzAK2xe","expanded_url":"http://bit.ly/1nbNj27","display_url":"bit.ly/1nbNj27"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"458519260319715328","possibly_sensitive":false,"created_at":"2014-04-22T08:14:45.000Z","referenced_tweets":{},"id":"458519260319715328","text":"Our human medicines committee, #CHMP, is meeting this week. Highlights out on Friday afternoon: http://t.co/3yjCzAK2xe","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/zfd3rsN2ql","expanded_url":"http://bit.ly/QgZRrp","display_url":"bit.ly/QgZRrp"}],"hashtags":[{"start":36,"end":46,"tag":"Herceptin"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"conversation_id":"456821554714648576","possibly_sensitive":false,"created_at":"2014-04-17T15:48:40.000Z","referenced_tweets":{},"id":"456821554714648576","text":"@EMA_News update on stolen vials of #Herceptin http://t.co/zfd3rsN2ql","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":18,"end":23,"tag":"EASL"},{"start":64,"end":74,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456481134067466240","possibly_sensitive":false,"created_at":"2014-04-16T17:15:58.000Z","referenced_tweets":[{"type":"retweeted","id":"456477175835668480"}],"id":"456481134067466240","text":"RT @Hep_Alliance: #EASL publish new guidelines for treatment of #hepatitis C. Recommends mix and match approach to new drugs http://t.co/vi…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/f0p1xfRhum","expanded_url":"http://bit.ly/1ebijY3","display_url":"bit.ly/1ebijY3"}],"hashtags":[{"start":37,"end":45,"tag":"vacancy"},{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456463755467960321","possibly_sensitive":false,"created_at":"2014-04-16T16:06:54.000Z","referenced_tweets":{},"id":"456463755467960321","text":"Just over two weeks to apply for our #vacancy for Data Officers (Business Data and Support Department): http://t.co/f0p1xfRhum #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/6pdyS1QvtJ","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":[{"start":42,"end":50,"tag":"vacancy"},{"start":109,"end":121,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456463360209346563","possibly_sensitive":false,"created_at":"2014-04-16T16:05:20.000Z","referenced_tweets":{},"id":"456463360209346563","text":"Just over two weeks left to apply for our #vacancy for a Continuous Improvement Lead: http://t.co/6pdyS1QvtJ #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/4zjhix8nkZ","expanded_url":"http://bit.ly/1nbNj27","display_url":"bit.ly/1nbNj27"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456462704748679168","possibly_sensitive":false,"created_at":"2014-04-16T16:02:44.000Z","referenced_tweets":{},"id":"456462704748679168","text":"Our human medicines committee, #CHMP, is meeting next week (Tuesday to Friday). Highlights out on Friday afternoon: http://t.co/4zjhix8nkZ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/haWCiVnQUx","expanded_url":"http://bit.ly/1eQU5T8","display_url":"bit.ly/1eQU5T8"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456456227732877312","possibly_sensitive":false,"created_at":"2014-04-16T15:36:59.000Z","referenced_tweets":{},"id":"456456227732877312","text":"RT @ansm_sante: Scientific council of the French medicines agency: summary of minutes from 12 March 2014 meeting http://t.co/haWCiVnQUx","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":38,"end":60,"url":"http://t.co/uZwfsABDc7","expanded_url":"http://bit.ly/1gGDeGB","display_url":"bit.ly/1gGDeGB"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456450268939714560","possibly_sensitive":false,"created_at":"2014-04-16T15:13:19.000Z","referenced_tweets":{},"id":"456450268939714560","text":"RT @LV_MPA: Falsified Herceptin found http://t.co/uZwfsABDc7","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/RxsIBu659k","expanded_url":"http://bit.ly/1j0d4Nk","display_url":"bit.ly/1j0d4Nk"}],"hashtags":[{"start":16,"end":21,"tag":"INCa"},{"start":76,"end":86,"tag":"medicines"},{"start":98,"end":109,"tag":"PlanCancer"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456445063716175872","possibly_sensitive":false,"created_at":"2014-04-16T14:52:38.000Z","referenced_tweets":{},"id":"456445063716175872","text":"RT @ansm_sante: #INCa and French medicines agency strengthen cooperation on #medicines as part of #PlanCancer http://t.co/RxsIBu659k","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/fA4jHf9L4v","expanded_url":"http://bit.ly/1eyK3eD","display_url":"bit.ly/1eyK3eD"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456433383963635712","possibly_sensitive":false,"created_at":"2014-04-16T14:06:13.000Z","referenced_tweets":{},"id":"456433383963635712","text":"RT @ansm_sante: Report from French medicines agency initial-evaluation commission on benefit-risk of health products http://t.co/fA4jHf9L4v","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456416804198690816","possibly_sensitive":false,"created_at":"2014-04-16T13:00:20.000Z","referenced_tweets":[{"type":"retweeted","id":"456415645828403200"}],"id":"456416804198690816","text":"RT @FDA_MCMi: Commissioner's Fellowship Program applications open today - healthcare professionals, scientists, engineers: http://t.co/crPP…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":46,"end":55,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456413898691067904","possibly_sensitive":false,"created_at":"2014-04-16T12:48:47.000Z","referenced_tweets":[{"type":"retweeted","id":"456412580987146240"}],"id":"456413898691067904","text":"RT @PrimaryCare4um: European Medicines Agency @EMA_News alerts EU healthcare professionals after vials of falsified Herceptin identified ht…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":22,"end":26,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":97,"end":105,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456409888424730624","possibly_sensitive":false,"created_at":"2014-04-16T12:32:51.000Z","referenced_tweets":[{"type":"retweeted","id":"456409774230228992"}],"id":"456409888424730624","text":"RT @ECDC_Flu: Ongoing #flu vaccine effectiveness monitoring needed for timely improvements, says @ECDC_EU comment on recent studies http://…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/AGR8xWMPDx","expanded_url":"http://www.agenziafarmaco.gov.it/sites/default/files/comunicatistampa/pressrelease_AIFA_355_ENG.pdf","display_url":"agenziafarmaco.gov.it/sites/default/…"}],"hashtags":[{"start":20,"end":26,"tag":"Theft"},{"start":31,"end":42,"tag":"laundering"},{"start":72,"end":82,"tag":"Herceptin"},{"start":84,"end":89,"tag":"AIFA"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456409636506443776","possibly_sensitive":false,"created_at":"2014-04-16T12:31:51.000Z","referenced_tweets":[{"type":"retweeted","id":"456409524711092224"}],"id":"456409636506443776","text":"RT @Aifa_ufficiale: #Theft and #laundering abroad of vials of falsified #Herceptin. #AIFA press release [EN] http://t.co/AGR8xWMPDx","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/MllEqJRihT","expanded_url":"http://erc.europa.eu/erc-stories/targeting-cancer-nanocontainers-deliver-localised-chemotherapy","display_url":"erc.europa.eu/erc-stories/ta…"}],"hashtags":[{"start":94,"end":101,"tag":"Cancer"}],"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"},{"start":52,"end":65,"username":"ERC_Research","id":"467551928"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456408814154448896","possibly_sensitive":false,"created_at":"2014-04-16T12:28:35.000Z","referenced_tweets":[{"type":"retweeted","id":"456407965319561216"}],"id":"456408814154448896","text":"RT @EU_ScienceChief: Great Greek research funded by @ERC_Research using nanotherapy to target #Cancer http://t.co/MllEqJRihT","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/IBWGEXz42b","expanded_url":"http://bit.ly/1iZv9Lt","display_url":"bit.ly/1iZv9Lt"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"456408642989080577","possibly_sensitive":false,"created_at":"2014-04-16T12:27:54.000Z","referenced_tweets":{},"id":"456408642989080577","text":"RT @Aifa_ufficiale: Theft of medicines and money laundering abroad: first results of the AIFA project. Herceptin case http://t.co/IBWGEXz42b","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/BeeRo06E4i","expanded_url":"http://bit.ly/1eIw1rd","display_url":"bit.ly/1eIw1rd"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":69,"end":78,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456401684185751552","possibly_sensitive":false,"created_at":"2014-04-16T12:00:15.000Z","referenced_tweets":[{"type":"retweeted","id":"456401478815465475"}],"id":"456401684185751552","text":"RT @EAHPtweet: EMA alerts HCPs to falsified Herceptin vial risk. The @EMA_News alert gives more information http://t.co/BeeRo06E4i http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/644uitZQWO","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON406359","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456395901209427968","possibly_sensitive":false,"created_at":"2014-04-16T11:37:16.000Z","referenced_tweets":[{"type":"retweeted","id":"456389722383060992"}],"id":"456395901209427968","text":"RT @MHRAgovuk: Agency Business Plan for 2014-15 published http://t.co/644uitZQWO","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/kcXgRJd4jX","expanded_url":"http://bit.ly/1hISjZ6","display_url":"bit.ly/1hISjZ6"}],"hashtags":[{"start":62,"end":72,"tag":"Herceptin"}],"mentions":{},"annotations":[{"start":9,"end":10,"probability":0.6213,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"456391138711060480","possibly_sensitive":false,"created_at":"2014-04-16T11:18:21.000Z","referenced_tweets":{},"id":"456391138711060480","text":"We alert EU healthcare professionals after vials of falsified #Herceptin identified: http://t.co/kcXgRJd4jX","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/dsCm8jEiJ2","expanded_url":"http://bit.ly/1kxkfQb","display_url":"bit.ly/1kxkfQb"}],"hashtags":[{"start":41,"end":58,"tag":"medicationerrors"}],"mentions":{},"annotations":[{"start":99,"end":114,"probability":0.2645,"type":"Place","normalized_text":"EU Member States"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"456387291167346689","possibly_sensitive":false,"created_at":"2014-04-16T11:03:04.000Z","referenced_tweets":{},"id":"456387291167346689","text":"We've released an action plan to address #medicationerrors together with regulatory authorities in EU Member States: http://t.co/dsCm8jEiJ2","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/3GXhT84JKu","expanded_url":"http://bit.ly/1l0zEet","display_url":"bit.ly/1l0zEet"}],"hashtags":[{"start":42,"end":52,"tag":"injection"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456386900643696641","possibly_sensitive":false,"created_at":"2014-04-16T11:01:31.000Z","referenced_tweets":{},"id":"456386900643696641","text":"Two more weeks to comment on our paper on #injection-site residues: (risk assessment and residue surveillance): http://t.co/3GXhT84JKu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/mP8iPSJxmr","expanded_url":"http://bit.ly/1jJQRFf","display_url":"bit.ly/1jJQRFf"}],"hashtags":[{"start":70,"end":83,"tag":"intramammary"},{"start":105,"end":112,"tag":"cattle"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456386712453656577","possibly_sensitive":false,"created_at":"2014-04-16T11:00:46.000Z","referenced_tweets":{},"id":"456386712453656577","text":"Two weeks left to comment on our guideline on of efficacy studies for #intramammary medicines for use in #cattle: http://t.co/mP8iPSJxmr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/pFZAyVH87V","expanded_url":"http://bit.ly/1kxkfQb","display_url":"bit.ly/1kxkfQb"}],"hashtags":[{"start":42,"end":59,"tag":"medicationerrors"}],"mentions":{},"annotations":[{"start":74,"end":75,"probability":0.5602,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"456380716004028417","possibly_sensitive":false,"created_at":"2014-04-16T10:36:56.000Z","referenced_tweets":{},"id":"456380716004028417","text":"We've agreed on an action plan to address #medicationerrors with national EU regulatory authorities: http://t.co/pFZAyVH87V","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/VFYz1ceT84","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4889/regulatory-explainer-why-and-how-is-fda-regulating-mobile-apps.aspx#.U05W27DWC3M.twitter","display_url":"raps.org/focus-online/n…"}],"hashtags":[{"start":20,"end":31,"tag":"Regulatory"},{"start":58,"end":62,"tag":"FDA"},{"start":74,"end":85,"tag":"MobileApps"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456374222609469440","possibly_sensitive":false,"created_at":"2014-04-16T10:11:08.000Z","referenced_tweets":[{"type":"retweeted","id":"456373874343436288"}],"id":"456374222609469440","text":"RT @nakosbalamotis: #Regulatory Explainer: Why and How is #FDA Regulating #MobileApps? http://t.co/VFYz1ceT84","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":16,"end":26,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":51,"end":91,"probability":0.284,"type":"Organization","normalized_text":"British Generic Manufacturers Association"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456374043974049792","possibly_sensitive":false,"created_at":"2014-04-16T10:10:25.000Z","referenced_tweets":[{"type":"retweeted","id":"456373286868623360"}],"id":"456374043974049792","text":"RT @MHRApress: .@MHRAgovuk have teamed up with the British Generic Manufacturers Association (BGMA) to launch a quality forum http://t.co/e…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":92,"end":104,"tag":"raredisease"},{"start":121,"end":130,"tag":"eurdchat"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456364438464245761","possibly_sensitive":false,"created_at":"2014-04-16T09:32:15.000Z","referenced_tweets":[{"type":"retweeted","id":"456364207869411328"}],"id":"456364438464245761","text":"RT @eurordis: What are you doing next Wed (23 April) at 15.00 (CET)? Join our  tweetchat on #raredisease patient access! #eurdchat http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/AlmeoeQDhN","expanded_url":"http://bit.ly/1qHYWgw","display_url":"bit.ly/1qHYWgw"}],"hashtags":[{"start":118,"end":127,"tag":"Research"},{"start":128,"end":135,"tag":"Pharma"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":95,"end":102,"username":"imi_ju","id":"1473203261469790214"},{"start":103,"end":117,"username":"MichelGoldman","id":"163225697"}],"annotations":[{"start":11,"end":20,"probability":0.6938,"type":"Organization","normalized_text":"Parliament"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456364150013558784","possibly_sensitive":false,"created_at":"2014-04-16T09:31:06.000Z","referenced_tweets":[{"type":"retweeted","id":"456358791647199233"}],"id":"456364150013558784","text":"RT @EFPIA: Parliament clears €3 billion EU medicines R&amp;D initiative http://t.co/AlmeoeQDhN @IMI_JU @MichelGoldman #Research #Pharma","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/lkNJkBmvgc","expanded_url":"http://wapo.st/1hUaNRy","display_url":"wapo.st/1hUaNRy"}],"hashtags":[{"start":52,"end":63,"tag":"antibiotic"},{"start":64,"end":75,"tag":"resistance"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":25,"end":40,"username":"washingtonpost","id":"2467791"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456357712352514048","possibly_sensitive":false,"created_at":"2014-04-16T09:05:32.000Z","referenced_tweets":[{"type":"retweeted","id":"456352891159072768"}],"id":"456357712352514048","text":"RT @IMI_JU: IMI cited in @washingtonpost article on #antibiotic #resistance http://t.co/lkNJkBmvgc","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/GmPPk6OESs","expanded_url":"http://bit.ly/1gyHrZE","display_url":"bit.ly/1gyHrZE"}],"hashtags":[{"start":85,"end":95,"tag":"influenza"},{"start":96,"end":105,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"456351326998634496","possibly_sensitive":false,"created_at":"2014-04-16T08:40:09.000Z","referenced_tweets":{},"id":"456351326998634496","text":"Yesterday we published interim guidance on enhanced safety surveillance for seasonal #influenza #vaccines in the EU: http://t.co/GmPPk6OESs","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/Q9v2zNGiQF","expanded_url":"http://bit.ly/1gynZvT","display_url":"bit.ly/1gynZvT"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456351165098524672","possibly_sensitive":false,"created_at":"2014-04-16T08:39:31.000Z","referenced_tweets":{},"id":"456351165098524672","text":"We are closed from this evening until Tuesday morning for Easter: http://t.co/Q9v2zNGiQF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/3GXhT84JKu","expanded_url":"http://bit.ly/1l0zEet","display_url":"bit.ly/1l0zEet"}],"hashtags":[{"start":42,"end":52,"tag":"injection"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456350393627185152","possibly_sensitive":false,"created_at":"2014-04-16T08:36:27.000Z","referenced_tweets":{},"id":"456350393627185152","text":"Two weeks left to comment on our paper on #injection-site residues: (risk assessment and residue surveillance): http://t.co/3GXhT84JKu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/mP8iPSJxmr","expanded_url":"http://bit.ly/1jJQRFf","display_url":"bit.ly/1jJQRFf"}],"hashtags":[{"start":70,"end":83,"tag":"intramammary"},{"start":105,"end":112,"tag":"cattle"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456349959646756866","possibly_sensitive":false,"created_at":"2014-04-16T08:34:43.000Z","referenced_tweets":{},"id":"456349959646756866","text":"Two more weeks to comment on our guideline on of efficacy studies for #intramammary medicines for use in #cattle: http://t.co/mP8iPSJxmr","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/7utOBDE9TJ","expanded_url":"http://bit.ly/1eOPVeq","display_url":"bit.ly/1eOPVeq"}],"hashtags":[{"start":127,"end":131,"tag":"IMI"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456348818712559616","possibly_sensitive":false,"created_at":"2014-04-16T08:30:11.000Z","referenced_tweets":[{"type":"retweeted","id":"456335845310472192"}],"id":"456348818712559616","text":"RT @EFPIA: In case you missed it yesterday... European Parliament ITRE committee adopts IMI2 regulation http://t.co/7utOBDE9TJ #IMI @EP_Ind…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":15,"probability":0.5788,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456348741059248128","possibly_sensitive":false,"created_at":"2014-04-16T08:29:53.000Z","referenced_tweets":[{"type":"retweeted","id":"456333992279941120"}],"id":"456348741059248128","text":"RT @GCessak: EMA published interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU: http://t.co/4psMVpYe…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":38,"end":44,"tag":"ECE14"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456111505097117696","possibly_sensitive":false,"created_at":"2014-04-15T16:47:11.000Z","referenced_tweets":[{"type":"retweeted","id":"456107404535406593"}],"id":"456111505097117696","text":"RT @ESEndocrinology: Make this year's #ECE14 Conference programme work for you with a wide range of quality symposium to choose from http:/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/GmPPk6OESs","expanded_url":"http://bit.ly/1gyHrZE","display_url":"bit.ly/1gyHrZE"}],"hashtags":[{"start":78,"end":88,"tag":"influenza"},{"start":89,"end":98,"tag":"vaccines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456106743815491587","possibly_sensitive":false,"created_at":"2014-04-15T16:28:16.000Z","referenced_tweets":{},"id":"456106743815491587","text":"We've published interim guidance on enhanced safety surveillance for seasonal #influenza #vaccines in the EU: http://t.co/GmPPk6OESs","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/Q9v2zNGiQF","expanded_url":"http://bit.ly/1gynZvT","display_url":"bit.ly/1gynZvT"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456058129344892928","possibly_sensitive":false,"created_at":"2014-04-15T13:15:05.000Z","referenced_tweets":{},"id":"456058129344892928","text":"We'll be closed over Easter from 17-21 April: http://t.co/Q9v2zNGiQF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/2bUBsW0nq6","expanded_url":"http://bit.ly/IMISF2014","display_url":"bit.ly/IMISF2014"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":39,"end":46,"probability":0.9571,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456035511279575040","possibly_sensitive":false,"created_at":"2014-04-15T11:45:13.000Z","referenced_tweets":[{"type":"retweeted","id":"455992540295364608"}],"id":"456035511279575040","text":"RT @IMI_JU: Save the date! Join IMI in Brussels on Weds 21 May for the 2014 Stakeholder Forum http://t.co/2bUBsW0nq6","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/5ikkOz6gf1","expanded_url":"http://bit.ly/1hECUJr","display_url":"bit.ly/1hECUJr"}],"hashtags":[{"start":60,"end":76,"tag":"HealthProgramme"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":45,"end":55,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456034672829399040","possibly_sensitive":false,"created_at":"2014-04-15T11:41:53.000Z","referenced_tweets":[{"type":"retweeted","id":"456019010224926720"}],"id":"456034672829399040","text":"RT @EFA_Patients: Curious to know more about @EU_Health new #HealthProgramme? Have a look at our summary here: http://t.co/5ikkOz6gf1.","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/PLlzlfRBaQ","expanded_url":"http://bit.ly/1m4OSyE","display_url":"bit.ly/1m4OSyE"}],"hashtags":[{"start":51,"end":60,"tag":"Diabetes"},{"start":112,"end":122,"tag":"EU4Health"},{"start":123,"end":138,"tag":"ECVeyehealthEU"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":96,"end":109,"username":"IDFEuropeBXL","id":"848831221"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456034604479426561","possibly_sensitive":false,"created_at":"2014-04-15T11:41:37.000Z","referenced_tweets":[{"type":"retweeted","id":"456020492676501504"}],"id":"456034604479426561","text":"RT @EPHA_EU: The European Policy Action Network on #Diabetes (ExPAND): http://t.co/PLlzlfRBaQ | @IDFEuropeBxl | #EU4Health #ECVeyehealthEU","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":17,"end":39,"url":"http://t.co/1tLeUU93Ie","expanded_url":"http://bit.ly/1hEFjna","display_url":"bit.ly/1hEFjna"}],"hashtags":[{"start":52,"end":65,"tag":"mentalhealth"},{"start":67,"end":76,"tag":"CPME2014"},{"start":78,"end":88,"tag":"Manifesto"},{"start":89,"end":96,"tag":"EP2014"},{"start":98,"end":113,"tag":"clinicaltrials"},{"start":115,"end":130,"tag":"dataprotection"}],"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"456034154170568704","possibly_sensitive":false,"created_at":"2014-04-15T11:39:49.000Z","referenced_tweets":[{"type":"retweeted","id":"456024254883323904"}],"id":"456034154170568704","text":"RT @CPME_EUROPA: http://t.co/1tLeUU93Ie NEWSLETTER: #mentalhealth, #CPME2014, #Manifesto #EP2014, #clinicaltrials, #dataprotection, #transp…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/js5FP4k9WF","expanded_url":"http://bit.ly/1qyAD4O","display_url":"bit.ly/1qyAD4O"}],"hashtags":[{"start":29,"end":42,"tag":"Rivastigmine"},{"start":65,"end":73,"tag":"generic"},{"start":88,"end":98,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"456031082295857152","possibly_sensitive":false,"created_at":"2014-04-15T11:27:37.000Z","referenced_tweets":{},"id":"456031082295857152","text":"We've published the EPAR for #Rivastigmine 3M Health Care Ltd, a #generic of Exelon for #Alzheimer's disease: http://t.co/js5FP4k9WF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/VDECunOraS","expanded_url":"http://bit.ly/1qyEsqy","display_url":"bit.ly/1qyEsqy"}],"hashtags":{},"mentions":{},"annotations":[{"start":64,"end":86,"probability":0.9251,"type":"Organization","normalized_text":"Roche Registration Ltd."}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"456005606311469056","possibly_sensitive":false,"created_at":"2014-04-15T09:46:23.000Z","referenced_tweets":{},"id":"456005606311469056","text":"Yesterday we published update on infringement procedure against Roche Registration Ltd.: http://t.co/VDECunOraS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/NmEuUD6jI3","expanded_url":"http://blogs.fda.gov/fdavoice/index.php/2014/04/creating-a-new-system-to-improve-the-security-of-the-drug-supply/","display_url":"blogs.fda.gov/fdavoice/index…"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455739002142732288","possibly_sensitive":false,"created_at":"2014-04-14T16:07:00.000Z","referenced_tweets":[{"type":"retweeted","id":"455737462669996032"}],"id":"455739002142732288","text":"RT @US_FDA: FDAVoice: Creating a New System to Improve the Security of the Drug Supply  http://t.co/NmEuUD6jI3","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/gOdk8se0wT","expanded_url":"http://www.biocentury.com/dailynews/politics/2014-04-11/eu-clarifies-law-on-postmarket-trials","display_url":"biocentury.com/dailynews/poli…"},{"start":83,"end":105,"url":"http://t.co/G1YSohZK6y","expanded_url":"http://ec.europa.eu/health/docs/midday_efficacy_studies_spp_en.pdf","display_url":"ec.europa.eu/health/docs/mi…"}],"hashtags":[{"start":20,"end":23,"tag":"EU"},{"start":52,"end":59,"tag":"trials"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455732581632188416","possibly_sensitive":false,"created_at":"2014-04-14T15:41:29.000Z","referenced_tweets":[{"type":"retweeted","id":"455732413780353025"}],"id":"455732581632188416","text":"RT @nakosbalamotis: #EU clarifies law on postmarket #trials http://t.co/gOdk8se0wT http://t.co/G1YSohZK6y","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/6ILtyqs2QU","expanded_url":"http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm392205.htm#.U0wAdACCKYo.twitter","display_url":"fda.gov/Safety/MedWatc…"}],"hashtags":[{"start":31,"end":36,"tag":"Drug"},{"start":44,"end":53,"tag":"Labeling"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455732109210947584","possibly_sensitive":false,"created_at":"2014-04-14T15:39:36.000Z","referenced_tweets":[{"type":"retweeted","id":"455731366886273024"}],"id":"455732109210947584","text":"RT @nakosbalamotis: March 2014 #Drug Safety #Labeling Changes http://t.co/6ILtyqs2QU","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/VDECunOraS","expanded_url":"http://bit.ly/1qyEsqy","display_url":"bit.ly/1qyEsqy"}],"hashtags":{},"mentions":{},"annotations":[{"start":62,"end":84,"probability":0.9263,"type":"Organization","normalized_text":"Roche Registration Ltd."}]},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"455731361161433088","possibly_sensitive":false,"created_at":"2014-04-14T15:36:38.000Z","referenced_tweets":{},"id":"455731361161433088","text":"We've just published update on infringement procedure against Roche Registration Ltd.: http://t.co/VDECunOraS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/js5FP4k9WF","expanded_url":"http://bit.ly/1qyAD4O","display_url":"bit.ly/1qyAD4O"}],"hashtags":[{"start":42,"end":55,"tag":"Rivastigmine"},{"start":78,"end":86,"tag":"generic"},{"start":101,"end":111,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455729943411171328","possibly_sensitive":false,"created_at":"2014-04-14T15:31:00.000Z","referenced_tweets":{},"id":"455729943411171328","text":"We've published the assessment report for #Rivastigmine 3M Health Care Ltd, a #generic of Exelon for #Alzheimer's: http://t.co/js5FP4k9WF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/j5hdnCsAVS","expanded_url":"http://www.europeanlung.org/en/news-and-events/news/target-for-flu-virus-discovered#.U0v3yQNnTTA.twitter","display_url":"europeanlung.org/en/news-and-ev…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":47,"end":70,"probability":0.5208,"type":"Organization","normalized_text":"European Lung Foundation"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455724726178942977","possibly_sensitive":false,"created_at":"2014-04-14T15:10:16.000Z","referenced_tweets":[{"type":"retweeted","id":"455722061432758272"}],"id":"455724726178942977","text":"RT @GCessak: Target for flu virus discovered | European Lung Foundation - ELF http://t.co/j5hdnCsAVS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/F9NZ4UICr2","expanded_url":"http://bloom.bg/1eqaOlm","display_url":"bloom.bg/1eqaOlm"}],"hashtags":[{"start":11,"end":21,"tag":"Alzheimer"},{"start":91,"end":98,"tag":"Pharma"},{"start":99,"end":108,"tag":"Research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455724658742919168","possibly_sensitive":false,"created_at":"2014-04-14T15:10:00.000Z","referenced_tweets":[{"type":"retweeted","id":"455722017560752128"}],"id":"455724658742919168","text":"RT @EFPIA: #Alzheimer’s Therapy May Come From New Look at Old Drugs http://t.co/F9NZ4UICr2 #Pharma #Research","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/oZCJb0n7tq","expanded_url":"http://bit.ly/1epwQom","display_url":"bit.ly/1epwQom"}],"hashtags":[{"start":50,"end":54,"tag":"flu"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455662954630103040","possibly_sensitive":false,"created_at":"2014-04-14T11:04:48.000Z","referenced_tweets":[{"type":"retweeted","id":"455661308147671040"}],"id":"455662954630103040","text":"RT @EuropeanLung: Target for flu virus discovered #flu http://t.co/oZCJb0n7tq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/epSpfiyvEY","expanded_url":"http://who.int/features/qa/84/en/#.U0u9BZL_yXM.twitter","display_url":"who.int/features/qa/84…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455659345033068544","possibly_sensitive":false,"created_at":"2014-04-14T10:50:28.000Z","referenced_tweets":[{"type":"retweeted","id":"455658906954366977"}],"id":"455659345033068544","text":"RT @GCessak: WHO | What are some of the myths – and facts – about vaccination? http://t.co/epSpfiyvEY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/4zS0ydG5ZY","expanded_url":"http://bit.ly/1hM4S0Q","display_url":"bit.ly/1hM4S0Q"}],"hashtags":[{"start":33,"end":41,"tag":"vaccine"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":106,"end":110,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455638433705508864","possibly_sensitive":false,"created_at":"2014-04-14T09:27:22.000Z","referenced_tweets":[{"type":"retweeted","id":"455637624934256640"}],"id":"455638433705508864","text":"RT @WHO_Europe_VPI: Giving &gt;1 #vaccine at a time has no adverse effect on a child’s immune system. See @WHO Q&amp;A: http://t.co/4zS0ydG5ZY #im…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/SC11y4Lame","expanded_url":"http://bit.ly/1nbILpU","display_url":"bit.ly/1nbILpU"}],"hashtags":[{"start":75,"end":92,"tag":"reninangiotensin"},{"start":94,"end":98,"tag":"RAS"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455632916203450368","possibly_sensitive":false,"created_at":"2014-04-14T09:05:27.000Z","referenced_tweets":{},"id":"455632916203450368","text":"Last week PRAC recommended against combined use of medicines affecting the #reninangiotensin (#RAS) system: http://t.co/SC11y4Lame","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/f7svrAjMZk","expanded_url":"http://bit.ly/1kA7vKY","display_url":"bit.ly/1kA7vKY"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"455630842925432832","possibly_sensitive":false,"created_at":"2014-04-14T08:57:12.000Z","referenced_tweets":{},"id":"455630842925432832","text":"Last Friday we published the PRAC meeting highlights: http://t.co/f7svrAjMZk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/y5YqsuWObS","expanded_url":"http://bit.ly/1p2cOVI","display_url":"bit.ly/1p2cOVI"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"DiabMedJournal","id":"1663290626"},{"start":16,"end":32,"username":"alldiabetesnews","id":"528251665"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454652227970662400","possibly_sensitive":false,"created_at":"2014-04-14T08:54:33.000Z","referenced_tweets":[{"type":"replied_to","id":"454652227970662400"}],"id":"455630174865088513","text":"@DiabMedJournal @alldiabetesnews Our latest list of human medicines under evaluation is here: http://t.co/y5YqsuWObS","attachments":{"media_keys":{}},"in_reply_to_user_id":"1663290626"},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/GgspXVQPyx","expanded_url":"http://bit.ly/1i8IseP","display_url":"bit.ly/1i8IseP"}],"hashtags":[{"start":54,"end":64,"tag":"medicines"},{"start":69,"end":79,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"455628380063670272","possibly_sensitive":false,"created_at":"2014-04-14T08:47:25.000Z","referenced_tweets":{},"id":"455628380063670272","text":"We're holding a workshop on clinical investigation of #medicines for #Alzheimer’s disease in November. Register now: http://t.co/GgspXVQPyx","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/6SiDouuyJz","expanded_url":"http://bit.ly/1hGpffT","display_url":"bit.ly/1hGpffT"}],"hashtags":[{"start":76,"end":87,"tag":"veterinary"},{"start":88,"end":98,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455627664905469952","possibly_sensitive":false,"created_at":"2014-04-14T08:44:35.000Z","referenced_tweets":{},"id":"455627664905469952","text":"On Friday we published the highlights from the meeting of our committee for #veterinary #medicines (CVMP): http://t.co/6SiDouuyJz","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/x2ekpJ1rJJ","expanded_url":"http://bit.ly/1iLfP3Y","display_url":"bit.ly/1iLfP3Y"}],"hashtags":[{"start":42,"end":51,"tag":"Research"},{"start":128,"end":135,"tag":"Pharma"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":120,"end":127,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"455625696434737152","possibly_sensitive":false,"created_at":"2014-04-14T08:36:45.000Z","referenced_tweets":[{"type":"retweeted","id":"455609687418089472"}],"id":"455625696434737152","text":"RT @EFPIA: NEW EFPIA BLOG - Collaborative #Research Gets a Boost with Project Data Sphere Launch http://t.co/x2ekpJ1rJJ @IMI_JU #Pharma #Da…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/GgspXVQPyx","expanded_url":"http://bit.ly/1i8IseP","display_url":"bit.ly/1i8IseP"}],"hashtags":[{"start":55,"end":65,"tag":"medicines"},{"start":79,"end":89,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454651861250084864","possibly_sensitive":false,"created_at":"2014-04-11T16:07:05.000Z","referenced_tweets":{},"id":"454651861250084864","text":"Register for our workshop on clinical investigation of #medicines for treating #Alzheimer’s disease in November: http://t.co/GgspXVQPyx","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/6SiDouuyJz","expanded_url":"http://bit.ly/1hGpffT","display_url":"bit.ly/1hGpffT"}],"hashtags":[{"start":77,"end":88,"tag":"veterinary"},{"start":89,"end":99,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454633258631041024","possibly_sensitive":false,"created_at":"2014-04-11T14:53:10.000Z","referenced_tweets":{},"id":"454633258631041024","text":"We've published the highlights from this week's meeting of our committee for #veterinary #medicines (CVMP): http://t.co/6SiDouuyJz","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/gWxY7BfiLa","expanded_url":"http://bit.ly/1sLQAGH","display_url":"bit.ly/1sLQAGH"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":20,"end":28,"username":"ECDC_EU","id":"204752573"},{"start":29,"end":40,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454631696345100288","possibly_sensitive":false,"created_at":"2014-04-11T14:46:57.000Z","referenced_tweets":[{"type":"retweeted","id":"454617894991958016"}],"id":"454631696345100288","text":"RT @ECDC_Flu: Joint @ECDC_EU @WHO_Europe report on consultation on pandemic and all hazard preparedness http://t.co/gWxY7BfiLa","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/eV1d3d18Kq","expanded_url":"http://bit.ly/QdaxXJ","display_url":"bit.ly/QdaxXJ"}],"hashtags":[{"start":14,"end":18,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454631512806522880","possibly_sensitive":false,"created_at":"2014-04-11T14:46:13.000Z","referenced_tweets":[{"type":"retweeted","id":"454625049626939392"}],"id":"454631512806522880","text":"RT @ECDC_Flu: #flu activity declining but viruses still detected in most reporting countries. Weekly report: http://t.co/eV1d3d18Kq http://…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":94,"end":101,"tag":"health"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454631230202740736","possibly_sensitive":false,"created_at":"2014-04-11T14:45:06.000Z","referenced_tweets":[{"type":"retweeted","id":"454626477926256642"}],"id":"454631230202740736","text":"RT @EU_Commission: We're launching a consultation for ideas on how mobile tech could  improve #health services - find out more:http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/948qVdjxH0","expanded_url":"http://www.gabionline.net/Biosimilars/Research/Quality-by-design-for-biosimilars","display_url":"gabionline.net/Biosimilars/Re…"}],"hashtags":[{"start":20,"end":28,"tag":"Quality"},{"start":43,"end":55,"tag":"biosimilars"}],"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454619831082692608","possibly_sensitive":false,"created_at":"2014-04-11T13:59:48.000Z","referenced_tweets":[{"type":"retweeted","id":"454614752057376769"}],"id":"454619831082692608","text":"RT @nakosbalamotis: #Quality by design for #biosimilars http://t.co/948qVdjxH0","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/lsUowxDA83","expanded_url":"http://bit.ly/1qnEKAz","display_url":"bit.ly/1qnEKAz"},{"start":114,"end":136,"url":"http://t.co/WmzsxywJC8","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"andrebroekmans","id":"260396247"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454585003872382976","possibly_sensitive":false,"created_at":"2014-04-11T13:42:35.000Z","referenced_tweets":[{"type":"replied_to","id":"454585003872382976"}],"id":"454615498865778688","text":"@andrebroekmans Thanks for your tweet. Fore more info on the PRAC see: http://t.co/lsUowxDA83 or send us a query: http://t.co/WmzsxywJC8","attachments":{"media_keys":{}},"in_reply_to_user_id":"260396247"},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/SC11y4Lame","expanded_url":"http://bit.ly/1nbILpU","display_url":"bit.ly/1nbILpU"}],"hashtags":[{"start":64,"end":81,"tag":"reninangiotensin"},{"start":83,"end":87,"tag":"RAS"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"454583590744260608","possibly_sensitive":false,"created_at":"2014-04-11T11:35:48.000Z","referenced_tweets":{},"id":"454583590744260608","text":"PRAC recommends against combined use of medicines affecting the #reninangiotensin (#RAS) system: http://t.co/SC11y4Lame","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/f7svrAjMZk","expanded_url":"http://bit.ly/1kA7vKY","display_url":"bit.ly/1kA7vKY"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454583131593785344","possibly_sensitive":false,"created_at":"2014-04-11T11:33:58.000Z","referenced_tweets":{},"id":"454583131593785344","text":"We've just published the PRAC meeting highlights: http://t.co/f7svrAjMZk","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/oIbJF2Q9Fy","expanded_url":"http://bit.ly/1sKQsHq","display_url":"bit.ly/1sKQsHq"}],"hashtags":[{"start":69,"end":79,"tag":"medicines"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454552988586377216","possibly_sensitive":false,"created_at":"2014-04-11T09:34:12.000Z","referenced_tweets":{},"id":"454552988586377216","text":"Specifications are now published for additional efficacy studies for #medicines following authorisation: http://t.co/oIbJF2Q9Fy","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/D72w66RZiF","expanded_url":"http://bit.ly/Q9fbpD","display_url":"bit.ly/Q9fbpD"}],"hashtags":[{"start":29,"end":37,"tag":"Adempas"},{"start":39,"end":49,"tag":"riociguat"},{"start":58,"end":67,"tag":"medicine"},{"start":72,"end":82,"tag":"pulmonary"},{"start":83,"end":96,"tag":"hypertension"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454535827465699328","possibly_sensitive":false,"created_at":"2014-04-11T08:26:00.000Z","referenced_tweets":{},"id":"454535827465699328","text":"We've published the EPAR for #Adempas (#riociguat), a new #medicine for #pulmonary #hypertension: http://t.co/D72w66RZiF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/54yMVaSOHj","expanded_url":"http://bit.ly/Q9znb2","display_url":"bit.ly/Q9znb2"}],"hashtags":[{"start":36,"end":44,"tag":"Eperzan"},{"start":46,"end":58,"tag":"albiglutide"},{"start":67,"end":76,"tag":"medicine"},{"start":88,"end":97,"tag":"diabetes"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454535678668595200","possibly_sensitive":false,"created_at":"2014-04-11T08:25:25.000Z","referenced_tweets":{},"id":"454535678668595200","text":"We've published the EPAR report for #Eperzan (#albiglutide), a new #medicine for type-2 #diabetes: http://t.co/54yMVaSOHj","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454534565508694016","possibly_sensitive":false,"created_at":"2014-04-11T08:20:59.000Z","referenced_tweets":[{"type":"retweeted","id":"454518000675086337"}],"id":"454534565508694016","text":"RT @innovationunion: #ResearchHeadlines - New stem cell-based treatment for rheumatoid arthritis: EU-funded researchers have developed... h…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/54yMVaSOHj","expanded_url":"http://bit.ly/Q9znb2","display_url":"bit.ly/Q9znb2"}],"hashtags":[{"start":42,"end":50,"tag":"Eperzan"},{"start":52,"end":64,"tag":"albiglutide"},{"start":73,"end":82,"tag":"medicine"},{"start":94,"end":103,"tag":"diabetes"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"454278896478089216","possibly_sensitive":false,"created_at":"2014-04-10T15:25:03.000Z","referenced_tweets":{},"id":"454278896478089216","text":"We've published the assessment report for #Eperzan (#albiglutide), a new #medicine for type-2 #diabetes: http://t.co/54yMVaSOHj","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/WeQDU0F7Qg","expanded_url":"http://bit.ly/1mZmUEK","display_url":"bit.ly/1mZmUEK"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454276397130076160","possibly_sensitive":false,"created_at":"2014-04-10T15:15:07.000Z","referenced_tweets":[{"type":"retweeted","id":"454269196939976704"}],"id":"454276397130076160","text":"RT @EFPIA: New agents may revitalize antibiotics to fight superbugs http://t.co/WeQDU0F7Qg","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/D72w66RZiF","expanded_url":"http://bit.ly/Q9fbpD","display_url":"bit.ly/Q9fbpD"}],"hashtags":[{"start":42,"end":50,"tag":"Adempas"},{"start":52,"end":62,"tag":"riociguat"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":95,"tag":"pulmonary"},{"start":96,"end":109,"tag":"hypertension"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454254849644048386","possibly_sensitive":false,"created_at":"2014-04-10T13:49:30.000Z","referenced_tweets":{},"id":"454254849644048386","text":"We've published the assessment report for #Adempas (#riociguat), a new #medicine for #pulmonary #hypertension: http://t.co/D72w66RZiF","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/DCuGh20xzc","expanded_url":"http://ht.ly/vvFgz","display_url":"ht.ly/vvFgz"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":14,"end":16,"probability":0.9534,"type":"Organization","normalized_text":"FDA"},{"start":65,"end":95,"probability":0.7552,"type":"Organization","normalized_text":"MCMi Regulatory Science Program"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454242124012486656","possibly_sensitive":false,"created_at":"2014-04-10T12:58:56.000Z","referenced_tweets":[{"type":"retweeted","id":"454236189902770176"}],"id":"454242124012486656","text":"RT @FDA_MCMi: FDA supports a robust research portfolio under the MCMi Regulatory Science Program: http://t.co/DCuGh20xzc (MCMi FY13 report …","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":68,"end":74,"tag":"GDUFA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454241926800474112","possibly_sensitive":false,"created_at":"2014-04-10T12:58:09.000Z","referenced_tweets":[{"type":"retweeted","id":"454232942785859584"}],"id":"454241926800474112","text":"RT @FDA_Drug_Info: Scientific research opportunities funded through #GDUFA Regulatory Science Research Program. FY 2014: http://t.co/cnuR50…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454241518057193472","possibly_sensitive":false,"created_at":"2014-04-10T12:56:32.000Z","referenced_tweets":[{"type":"retweeted","id":"454232012833169408"}],"id":"454241518057193472","text":"RT @FDACBER: #FDA develops alternative assay that could speed availability of influenza vaccines in the event of a future pandemic http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":67,"end":75,"tag":"Tamiflu"},{"start":98,"end":113,"tag":"clinicaltrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":41,"end":56,"username":"cochranecollab","id":"20429156"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454224067462443011","possibly_sensitive":false,"created_at":"2014-04-10T11:47:11.000Z","referenced_tweets":[{"type":"retweeted","id":"454221754358304768"}],"id":"454224067462443011","text":"RT @HAIEurope: On our blog, thoughts re: @cochranecollab review of #Tamiflu. Proves need for full #clinicaltrials data transparency. http:/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/DnDcJlA8CU","expanded_url":"http://bit.ly/PTVB0O","display_url":"bit.ly/PTVB0O"}],"hashtags":[{"start":81,"end":86,"tag":"PSUR"}],"mentions":{},"annotations":[{"start":105,"end":110,"probability":0.9972,"type":"Place","normalized_text":"London"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454214359842312192","possibly_sensitive":false,"created_at":"2014-04-10T11:08:36.000Z","referenced_tweets":{},"id":"454214359842312192","text":"On 29 April, we're holding an information day on periodic safety update reports (#PSUR) at our office in London: http://t.co/DnDcJlA8CU","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":14,"end":22,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454206781036986368","possibly_sensitive":false,"created_at":"2014-04-10T10:38:30.000Z","referenced_tweets":[{"type":"retweeted","id":"454206704960667648"}],"id":"454206781036986368","text":"RT @EU_ECHA: \"@EU_ECHA is recruiting a senior scientific officer - ecotoxicology/environmental fate. Apply by Monday 14 April! http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/ByRg0i2ypr","expanded_url":"http://bit.ly/1qkpxjD","display_url":"bit.ly/1qkpxjD"}],"hashtags":[{"start":46,"end":54,"tag":"Tamiflu"}],"mentions":[{"start":0,"end":11,"username":"CallanLuke","id":"478009487"},{"start":99,"end":115,"username":"IlariaPassarani","id":"1106659014"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454195021458456576","possibly_sensitive":false,"created_at":"2014-04-10T09:51:46.000Z","referenced_tweets":{},"id":"454195021458456576","text":"@CallanLuke Full details of our assessment of #Tamiflu are published here: http://t.co/ByRg0i2ypr  @IlariaPassarani","attachments":{"media_keys":{}},"in_reply_to_user_id":"478009487"},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/rZyux2lAPe","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2014%2F04%2Fnews_detail_002063.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":21,"end":31,"tag":"alltrials"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"annotations":[{"start":32,"end":34,"probability":0.4622,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454187908686438400","possibly_sensitive":false,"created_at":"2014-04-10T09:23:30.000Z","referenced_tweets":[{"type":"retweeted","id":"454187631904313345"}],"id":"454187908686438400","text":"RT @IlariaPassarani: #alltrials EMA announces final steps for its clinical-trial data policy http://t.co/rZyux2lAPe","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/SQigoZu0lR","expanded_url":"http://gu.com/p/3zat8/tw","display_url":"gu.com/p/3zat8/tw"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"},{"start":112,"end":121,"username":"guardian","id":"87818409"}],"annotations":[{"start":30,"end":41,"probability":0.3531,"type":"Organization","normalized_text":"Tamiflu saga"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454187877011034112","possibly_sensitive":false,"created_at":"2014-04-10T09:23:22.000Z","referenced_tweets":[{"type":"retweeted","id":"454186804774576129"}],"id":"454187877011034112","text":"RT @IlariaPassarani: What the Tamiflu saga tells us about drug trials and big pharma http://t.co/SQigoZu0lR via @guardian","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/DnDcJlA8CU","expanded_url":"http://bit.ly/PTVB0O","display_url":"bit.ly/PTVB0O"}],"hashtags":[{"start":68,"end":73,"tag":"PSUR"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"454182146178314240","possibly_sensitive":false,"created_at":"2014-04-10T09:00:36.000Z","referenced_tweets":{},"id":"454182146178314240","text":"We're hosting an information day on periodic safety update reports (#PSUR) on 29 April: http://t.co/DnDcJlA8CU","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"hashtags":[{"start":77,"end":91,"tag":"sterilisation"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454170096270065665","possibly_sensitive":false,"created_at":"2014-04-10T08:12:43.000Z","referenced_tweets":{},"id":"454170096270065665","text":"Comment now on our concept paper on establishing a guideline on selection of #sterilisation processes: http://t.co/2nmTQZDdbE","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/8GcAtInG9W","expanded_url":"http://www.bbc.com/news/health-26954482","display_url":"bbc.com/news/health-26…"}],"hashtags":[{"start":22,"end":37,"tag":"clinicaltrials"},{"start":77,"end":85,"tag":"Tamiflu"}],"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"annotations":[{"start":107,"end":114,"probability":0.8711,"type":"Organization","normalized_text":"BBC News"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454169886521303040","possibly_sensitive":false,"created_at":"2014-04-10T08:11:53.000Z","referenced_tweets":[{"type":"retweeted","id":"454169664038633472"}],"id":"454169886521303040","text":"RT @beuctweet: Hiding #clinicaltrials data can cost millions to governments. #Tamiflu is just one example. BBC News http://t.co/8GcAtInG9W …","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Jkqbkn7E2z","expanded_url":"http://ow.ly/vnpdY","display_url":"ow.ly/vnpdY"}],"hashtags":[{"start":60,"end":72,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":24,"end":29,"probability":0.9255,"type":"Place","normalized_text":"Berlin"},{"start":89,"end":94,"probability":0.9975,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454168945478893570","possibly_sensitive":false,"created_at":"2014-04-10T08:08:09.000Z","referenced_tweets":[{"type":"retweeted","id":"454168535968022528"}],"id":"454168945478893570","text":"RT @eurordis: ECRD 2014 Berlin has the largest gathering of #raredisease stakeholders in Europe! Join us 8-10 May http://t.co/Jkqbkn7E2z","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/3kUHkSqNba","expanded_url":"http://fb.me/2MFvGdPMX","display_url":"fb.me/2MFvGdPMX"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":14,"end":16,"probability":0.5574,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"454166281496059904","possibly_sensitive":false,"created_at":"2014-04-10T07:57:34.000Z","referenced_tweets":[{"type":"retweeted","id":"454164731633610752"}],"id":"454166281496059904","text":"RT @cancereu: EMA announces final steps for its clinical-trial data policy... http://t.co/3kUHkSqNba","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2nmTQZDdbE","expanded_url":"http://bit.ly/1erfQbU","display_url":"bit.ly/1erfQbU"}],"hashtags":[{"start":73,"end":87,"tag":"sterilisation"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"453937360213118976","possibly_sensitive":false,"created_at":"2014-04-09T16:47:55.000Z","referenced_tweets":{},"id":"453937360213118976","text":"We've issued a concept paper on establishing a guideline on selection of #sterilisation processes for drug products: http://t.co/2nmTQZDdbE","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/BvuKxQcwkj","expanded_url":"http://ht.ly/vBafj","display_url":"ht.ly/vBafj"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":75,"end":115,"probability":0.3007,"type":"Other","normalized_text":"FDA Office of Orphan Products Development"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453899668528050176","possibly_sensitive":false,"created_at":"2014-04-09T14:18:08.000Z","referenced_tweets":[{"type":"retweeted","id":"453877614227492864"}],"id":"453899668528050176","text":"RT @FDA_MCMi: More on developing products for rare diseases &amp; conditions - FDA Office of Orphan Products Development: http://t.co/BvuKxQcwkj","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/VZF473hhx5","expanded_url":"http://bit.ly/1hry96N","display_url":"bit.ly/1hry96N"}],"hashtags":{},"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453857222385491968","possibly_sensitive":false,"created_at":"2014-04-09T11:29:28.000Z","referenced_tweets":[{"type":"retweeted","id":"453837249424404480"}],"id":"453857222385491968","text":"RT @EuropeanLung: Could a blood test be used to detect lung cancer? http://t.co/VZF473hhx5","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":128,"end":134,"tag":"ECE14"}],"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453856818792792064","possibly_sensitive":false,"created_at":"2014-04-09T11:27:52.000Z","referenced_tweets":[{"type":"retweeted","id":"453842393138081792"}],"id":"453856818792792064","text":"RT @ESEndocrinology: Join the congress a day early join one of the hot topic pre-congress courses taking place in the run up to #ECE14! htt…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/BnSbRJPrgZ","expanded_url":"http://goo.gl/0X27js","display_url":"goo.gl/0X27js"}],"hashtags":[{"start":30,"end":40,"tag":"Hepatitis"},{"start":87,"end":92,"tag":"HepC"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":192,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453856512243671040","possibly_sensitive":false,"created_at":"2014-04-09T11:26:39.000Z","referenced_tweets":[{"type":"retweeted","id":"453854259898249216"}],"id":"453856512243671040","text":"RT @WHO: WHO issues its first #Hepatitis C treatment guidelines http://t.co/BnSbRJPrgZ #HepC","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":35,"end":38,"tag":"EU"},{"start":87,"end":94,"tag":"Health"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":25,"end":34,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453856478244667392","possibly_sensitive":false,"created_at":"2014-04-09T11:26:31.000Z","referenced_tweets":[{"type":"retweeted","id":"453854497018621953"}],"id":"453856478244667392","text":"RT @innovationunion: via @myCORDIS #EU-funded project develops roadmap for cooperative #Health research: Ill health and disease do not... h…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/80tj1TrCjl","expanded_url":"http://bit.ly/1g24Ndb","display_url":"bit.ly/1g24Ndb"}],"hashtags":[{"start":29,"end":36,"tag":"Latuda"},{"start":38,"end":49,"tag":"lurasidone"},{"start":58,"end":67,"tag":"medicine"},{"start":72,"end":86,"tag":"schizophrenia"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"453855994335207424","possibly_sensitive":false,"created_at":"2014-04-09T11:24:35.000Z","referenced_tweets":{},"id":"453855994335207424","text":"We've published the EPAR for #Latuda (#lurasidone), a new #medicine for #schizophrenia in adults: http://t.co/80tj1TrCjl","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/79slADLw5A","expanded_url":"http://bit.ly/PZuAss","display_url":"bit.ly/PZuAss"}],"hashtags":[{"start":88,"end":95,"tag":"ctdata"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"453827195006648320","possibly_sensitive":false,"created_at":"2014-04-09T09:30:09.000Z","referenced_tweets":{},"id":"453827195006648320","text":"We're taking the final steps for our clinical-trial data policy: http://t.co/79slADLw5A #ctdata","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/79slADLw5A","expanded_url":"http://bit.ly/PZuAss","display_url":"bit.ly/PZuAss"}],"hashtags":[{"start":91,"end":98,"tag":"ctdata"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"453570629745516544","possibly_sensitive":false,"created_at":"2014-04-08T16:30:39.000Z","referenced_tweets":{},"id":"453570629745516544","text":"We've announced the final steps for our clinical-trial data policy: http://t.co/79slADLw5A #ctdata","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/80tj1TrCjl","expanded_url":"http://bit.ly/1g24Ndb","display_url":"bit.ly/1g24Ndb"}],"hashtags":[{"start":47,"end":54,"tag":"Latuda"},{"start":56,"end":67,"tag":"lurasidone"},{"start":76,"end":85,"tag":"medicine"},{"start":90,"end":104,"tag":"schizophrenia"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453539154941714432","possibly_sensitive":false,"created_at":"2014-04-08T14:25:35.000Z","referenced_tweets":{},"id":"453539154941714432","text":"We've just published the assessment report for #Latuda (#lurasidone), a new #medicine for #schizophrenia in adults: http://t.co/80tj1TrCjl","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/JDb5rMWXUc","expanded_url":"http://bit.ly/1kGfNg7","display_url":"bit.ly/1kGfNg7"}],"hashtags":[{"start":23,"end":40,"tag":"UniversityofBonn"},{"start":65,"end":77,"tag":"antibiotics"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453527517178380289","possibly_sensitive":false,"created_at":"2014-04-08T13:39:20.000Z","referenced_tweets":[{"type":"retweeted","id":"453522036221296640"}],"id":"453527517178380289","text":"RT @IFAHEurope: VIDEO: #UniversityofBonn highlights need for new #antibiotics and calls for investment in R&amp;D - http://t.co/JDb5rMWXUc @Uni…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":46,"end":56,"tag":"hepatitis"},{"start":83,"end":88,"tag":"EASL"},{"start":89,"end":97,"tag":"ILC2014"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453526657597710336","possibly_sensitive":false,"created_at":"2014-04-08T13:35:55.000Z","referenced_tweets":[{"type":"retweeted","id":"453519118084636672"}],"id":"453526657597710336","text":"RT @Hep_Alliance: WHO to release first global #hepatitis c treatment guidelines at #EASL #ILC2014 this Thurs 10th April http://t.co/epcCxKg…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/RMcWRQkF8K","expanded_url":"http://nyti.ms/PYs9q4","display_url":"nyti.ms/PYs9q4"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453526479457251328","possibly_sensitive":false,"created_at":"2014-04-08T13:35:13.000Z","referenced_tweets":[{"type":"retweeted","id":"453517630088151040"}],"id":"453526479457251328","text":"RT @EFPIA: Sidestepping the Biopsy With New Tools to Spot Cancer http://t.co/RMcWRQkF8K","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/0I1vooz62j","expanded_url":"http://bit.ly/1mu5OMb","display_url":"bit.ly/1mu5OMb"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":74,"tag":"Rosa"},{"start":81,"end":86,"tag":"rose"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453490739583143936","possibly_sensitive":false,"created_at":"2014-04-08T11:13:12.000Z","referenced_tweets":{},"id":"453490739583143936","text":"One more week to comment on our draft Community #herbal monograph on #Rosa flos (#rose flower): http://t.co/0I1vooz62j","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2m6Xqvj6X4","expanded_url":"http://bit.ly/1jTbbY1","display_url":"bit.ly/1jTbbY1"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":80,"tag":"Sisymbrium"},{"start":106,"end":114,"tag":"mustard"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453490673770315777","possibly_sensitive":false,"created_at":"2014-04-08T11:12:56.000Z","referenced_tweets":{},"id":"453490673770315777","text":"One more week to comment on our draft Community #herbal monograph on #Sisymbrium officinale, herba (hedge #mustard): http://t.co/2m6Xqvj6X4","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/al7AUdZpY7","expanded_url":"https://www.youtube.com/watch?v=8ICd_1ixBVM&list","display_url":"youtube.com/watch?v=8ICd_1…"},{"start":108,"end":130,"url":"http://t.co/B9NfBLEPbv","expanded_url":"https://twitter.com/MHRAgovuk/status/453483573522071552/photo/1","display_url":"pic.twitter.com/B9NfBLEPbv"}],"hashtags":[{"start":50,"end":62,"tag":"EarlyAccess"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":21,"end":33,"probability":0.9207,"type":"Person","normalized_text":"Dr Ian Hudson"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453485184634335233","possibly_sensitive":false,"created_at":"2014-04-08T10:51:08.000Z","referenced_tweets":[{"type":"retweeted","id":"453483573522071552"}],"id":"453485184634335233","text":"RT @MHRAgovuk: Watch Dr Ian Hudson talk about the #EarlyAccess to Medicines Scheme: https://t.co/al7AUdZpY7 http://t.co/B9NfBLEPbv","attachments":{"media_keys":["3_453483573530460161"]}},{"entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/48xGFnCgEX","expanded_url":"http://bit.ly/1lNfWCn","display_url":"bit.ly/1lNfWCn"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":56,"end":68,"username":"PharmaTimes","id":"52354784"},{"start":92,"end":101,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":11,"end":12,"probability":0.5091,"type":"Organization","normalized_text":"EU"},{"start":18,"end":26,"probability":0.9601,"type":"Place","normalized_text":"Australia"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453482019067269121","possibly_sensitive":false,"created_at":"2014-04-08T10:38:33.000Z","referenced_tweets":[{"type":"retweeted","id":"453481885269000192"}],"id":"453482019067269121","text":"RT @EFPIA: EU and Australia link up on orphan drugs via @PharmaTimes http://t.co/48xGFnCgEX @EMA_News","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/LXVQY8uhpw","expanded_url":"http://bit.ly/1hyZsWU","display_url":"bit.ly/1hyZsWU"}],"hashtags":[{"start":29,"end":37,"tag":"ESCAIDE"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":60,"end":68,"probability":0.9956,"type":"Place","normalized_text":"Stockholm"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453471828393328640","possibly_sensitive":false,"created_at":"2014-04-08T09:58:03.000Z","referenced_tweets":[{"type":"retweeted","id":"453471786311909376"}],"id":"453471828393328640","text":"RT @ECDC_EU: Save the date : #ESCAIDE 2014 to take place in Stockholm, from 5 to 7 November 2014 http://t.co/LXVQY8uhpw! Visit http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/qQJ8OmkjYl","expanded_url":"http://bit.ly/HnanoTech","display_url":"bit.ly/HnanoTech"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453468294084050944","possibly_sensitive":false,"created_at":"2014-04-08T09:44:01.000Z","referenced_tweets":[{"type":"retweeted","id":"453467872795590656"}],"id":"453468294084050944","text":"RT @innovationunion: Nanocarriers could deliver drugs locally to tumours to reduce side effects of  treatment http://t.co/qQJ8OmkjYl #Horiz…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2m6Xqvj6X4","expanded_url":"http://bit.ly/1jTbbY1","display_url":"bit.ly/1jTbbY1"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":80,"tag":"Sisymbrium"},{"start":106,"end":114,"tag":"mustard"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453455382783229952","possibly_sensitive":false,"created_at":"2014-04-08T08:52:42.000Z","referenced_tweets":{},"id":"453455382783229952","text":"One week left to comment on our draft Community #herbal monograph on #Sisymbrium officinale, herba (hedge #mustard): http://t.co/2m6Xqvj6X4","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/0I1vooz62j","expanded_url":"http://bit.ly/1mu5OMb","display_url":"bit.ly/1mu5OMb"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":74,"tag":"Rosa"},{"start":81,"end":86,"tag":"rose"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453454924912021504","possibly_sensitive":false,"created_at":"2014-04-08T08:50:53.000Z","referenced_tweets":{},"id":"453454924912021504","text":"One week left to comment on our draft Community #herbal monograph on #Rosa flos (#rose flower): http://t.co/0I1vooz62j","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":39,"end":53,"tag":"EUHealthPrize"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453452397931921408","possibly_sensitive":false,"created_at":"2014-04-08T08:40:51.000Z","referenced_tweets":[{"type":"retweeted","id":"453446174041964544"}],"id":"453452397931921408","text":"RT @EU_Health: Tonight we are awarding #EUHealthPrize &amp; we will be live tweeting the winners. Meet our national finalists  http://t.co/Q64Q…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Vx5P8kyBJ4","expanded_url":"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=COM:2014:215:FIN&qid=1396882418494&from=EN","display_url":"eur-lex.europa.eu/legal-content/…"}],"hashtags":[{"start":96,"end":99,"tag":"EU"},{"start":100,"end":114,"tag":"healthsystems"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453211434647056386","possibly_sensitive":false,"created_at":"2014-04-07T16:43:20.000Z","referenced_tweets":[{"type":"retweeted","id":"453184681484488704"}],"id":"453211434647056386","text":"RT @EURLex: Commission stresses need for greater effectiveness, accessibility and resilience of #EU #healthsystems http://t.co/Vx5P8kyBJ4 ……","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/gJ09lzUGNP","expanded_url":"https://www.youtube.com/watch?v=ZEHAG3D2NJg","display_url":"youtube.com/watch?v=ZEHAG3…"}],"hashtags":[{"start":67,"end":78,"tag":"YellowCard"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":95,"end":105,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453210854864220160","possibly_sensitive":false,"created_at":"2014-04-07T16:41:02.000Z","referenced_tweets":[{"type":"retweeted","id":"453210360296644608"}],"id":"453210854864220160","text":"RT @MHRAgovuk: Parents, give medicine and vaccine side effects the #YellowCard by reporting to @mhragovuk https://t.co/gJ09lzUGNP http://t.…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/0IWO9etLS2","expanded_url":"http://bit.ly/1hkwNe2","display_url":"bit.ly/1hkwNe2"}],"hashtags":[{"start":126,"end":138,"tag":"raredisease"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"453210787352678400","possibly_sensitive":false,"created_at":"2014-04-07T16:40:46.000Z","referenced_tweets":{},"id":"453210787352678400","text":"We've reinforced collaboration with the Australian medicine regulator in the area of orphan medicines: http://t.co/0IWO9etLS2 #raredisease","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":18,"end":33,"tag":"WorldHealthDay"},{"start":34,"end":38,"tag":"DYK"},{"start":45,"end":55,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453168218509946880","possibly_sensitive":false,"created_at":"2014-04-07T13:51:37.000Z","referenced_tweets":[{"type":"retweeted","id":"453123732664774656"}],"id":"453168218509946880","text":"RT @Hep_Alliance: #WorldHealthDay #DYK viral #hepatitis kills 1.5million people a year, as many as HIV/AIDS. Get involved in the fight http…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/jofajhd45y","expanded_url":"http://ow.ly/vvlkd","display_url":"ow.ly/vvlkd"}],"hashtags":[{"start":108,"end":116,"tag":"WHD2014"},{"start":117,"end":137,"tag":"GenderEqualityIndex"}],"mentions":[{"start":3,"end":14,"username":"eurogender","id":"146793059"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453167623073988608","possibly_sensitive":false,"created_at":"2014-04-07T13:49:15.000Z","referenced_tweets":[{"type":"retweeted","id":"453133306981134336"}],"id":"453167623073988608","text":"RT @eurogender: There're small gender gaps in unmet medical &amp; dental needs in EU http://t.co/jofajhd45y #WHD2014 #GenderEqualityIndex http:…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/QuZ9gs14Lj","expanded_url":"http://bit.ly/1mTKb8c","display_url":"bit.ly/1mTKb8c"},{"start":99,"end":121,"url":"http://t.co/MLlB9XVc5I","expanded_url":"https://twitter.com/WHO_Europe/status/453134335676149760/photo/1","display_url":"pic.twitter.com/MLlB9XVc5I"}],"hashtags":[{"start":65,"end":75,"tag":"Just1Bite"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"453166794669555712","possibly_sensitive":false,"created_at":"2014-04-07T13:45:57.000Z","referenced_tweets":[{"type":"retweeted","id":"453134335676149760"}],"id":"453166794669555712","text":"RT @WHO_Europe: Infographic: check out how to get protected from #Just1Bite http://t.co/QuZ9gs14Lj http://t.co/MLlB9XVc5I","attachments":{"media_keys":["3_453134335684538368"]}},{"entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/0IWO9etLS2","expanded_url":"http://bit.ly/1hkwNe2","display_url":"bit.ly/1hkwNe2"}],"hashtags":[{"start":128,"end":140,"tag":"RareDisease"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"453107387374002176","possibly_sensitive":false,"created_at":"2014-04-07T09:49:54.000Z","referenced_tweets":{},"id":"453107387374002176","text":"We've strengthened collaboration in the area of orphan medicines with the Australian medicine regulator: http://t.co/0IWO9etLS2 #RareDisease","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/RPOwKW4lvv","expanded_url":"http://bit.ly/1hnXgkM","display_url":"bit.ly/1hnXgkM"}],"hashtags":[{"start":17,"end":32,"tag":"WorldHealthDay"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"453097126411915264","possibly_sensitive":false,"created_at":"2014-04-07T09:09:07.000Z","referenced_tweets":{},"id":"453097126411915264","text":"We're supporting #WorldHealthDay today. This year's focus is on diseases transmitted by vectors: http://t.co/RPOwKW4lvv","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9271,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452155456308641792","possibly_sensitive":false,"created_at":"2014-04-04T18:47:16.000Z","referenced_tweets":[{"type":"retweeted","id":"452122605102071809"}],"id":"452155456308641792","text":"RT @US_FDA: FDA’s Commissioner’s Fellowship Program is accepting applications April 16-May 26, 2014. Read details and apply http://t.co/und…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/RPOwKW4lvv","expanded_url":"http://bit.ly/1hnXgkM","display_url":"bit.ly/1hnXgkM"}],"hashtags":[{"start":17,"end":32,"tag":"WorldHealthDay"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"452095643298037760","possibly_sensitive":false,"created_at":"2014-04-04T14:49:35.000Z","referenced_tweets":{},"id":"452095643298037760","text":"We're supporting #WorldHealthDay 2014: focus on diseases transmitted by vectors: http://t.co/RPOwKW4lvv","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/8Asyldcryl","expanded_url":"http://bit.ly/1gVjxLz","display_url":"bit.ly/1gVjxLz"}],"hashtags":[{"start":14,"end":18,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":45,"end":50,"probability":0.9927,"type":"Place","normalized_text":"Europe"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452093476457689088","possibly_sensitive":false,"created_at":"2014-04-04T14:40:58.000Z","referenced_tweets":[{"type":"retweeted","id":"452084714073907202"}],"id":"452093476457689088","text":"RT @ECDC_Flu: #flu activity declining across Europe, with substantial decrease in positive flu samples: http://t.co/8Asyldcryl http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/RmVSkeDMhH","expanded_url":"http://www.neurope.eu/article/world-health-day-2014-eu-funded-research-fight-vector-borne-diseases","display_url":"neurope.eu/article/world-…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":28,"probability":0.6476,"type":"Other","normalized_text":"World Health Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452082728222351360","possibly_sensitive":false,"created_at":"2014-04-04T13:58:16.000Z","referenced_tweets":[{"type":"retweeted","id":"452082620181270529"}],"id":"452082728222351360","text":"RT @GCessak: World Health Day 2014: EU-funded research to fight vector-borne diseases http://t.co/RmVSkeDMhH","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/RFiapPH8UM","expanded_url":"http://bit.ly/1lupkbr","display_url":"bit.ly/1lupkbr"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":16,"end":31,"probability":0.6476,"type":"Other","normalized_text":"World Health Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452076883795271680","possibly_sensitive":false,"created_at":"2014-04-04T13:35:02.000Z","referenced_tweets":[{"type":"retweeted","id":"452075446507560961"}],"id":"452076883795271680","text":"RT @Berlaymont: World Health Day 2014: EU-funded research to fight vector-borne diseases http://t.co/RFiapPH8UM","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/dMw6Bf8fNy","expanded_url":"http://bit.ly/1gsOr9l","display_url":"bit.ly/1gsOr9l"},{"start":122,"end":144,"url":"http://t.co/urFD94nUxM","expanded_url":"http://bit.ly/QKBz9T","display_url":"bit.ly/QKBz9T"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452063124460666880","possibly_sensitive":false,"created_at":"2014-04-04T12:40:22.000Z","referenced_tweets":{},"id":"452063124460666880","text":"Our pharmacovigilance &amp; veterinary committees meet next week. Highlights published on Friday: http://t.co/dMw6Bf8fNy  http://t.co/urFD94nUxM","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/1JjM6jtZVK","expanded_url":"http://bit.ly/1fEHHJm","display_url":"bit.ly/1fEHHJm"}],"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"mentions":[{"start":0,"end":7,"username":"abbvie","id":"531892451"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452063009473835008","possibly_sensitive":false,"created_at":"2014-04-04T12:39:55.000Z","referenced_tweets":{},"id":"452063009473835008","text":"@AbbVie has withdrawn its two court cases against us concerning access to clinical-trial data: http://t.co/1JjM6jtZVK  #ctdata","attachments":{"media_keys":{}},"in_reply_to_user_id":"531892451"},{"entities":{"urls":{},"hashtags":[{"start":124,"end":130,"tag":"150BP"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":39,"end":51,"probability":0.9484,"type":"Person","normalized_text":"Lesley Graham"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452062219036282880","possibly_sensitive":false,"created_at":"2014-04-04T12:36:46.000Z","referenced_tweets":[{"type":"retweeted","id":"452059299871985664"}],"id":"452062219036282880","text":"RT @MHRAgovuk: MHRA Senior Inspector’s Lesley Graham to explain how independent QC labs differ from manufacturing site labs #150BP http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":[{"start":18,"end":36,"probability":0.4093,"type":"Other","normalized_text":"World Hepatitis Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452062094301872128","possibly_sensitive":false,"created_at":"2014-04-04T12:36:16.000Z","referenced_tweets":[{"type":"retweeted","id":"452056286277169152"}],"id":"452062094301872128","text":"RT @Hep_Alliance: World Hepatitis Day 2014 info now available from our website incl. messages, posters, and how to take part! http://t.co/p…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":34,"end":49,"tag":"WorldHealthDay"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":108,"end":112,"username":"WHO","id":"14499829"},{"start":113,"end":124,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452061731012218880","possibly_sensitive":false,"created_at":"2014-04-04T12:34:50.000Z","referenced_tweets":[{"type":"retweeted","id":"452051174318157824"}],"id":"452061731012218880","text":"RT @EFPIA: Next Monday 7 April is #WorldHealthDay ! This year's focus: Vector-borne diseases. Find out more @WHO @WHO_Europe http://t.co/OM…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/4RPUczrtvu","expanded_url":"https://www.linkedin.com/groups/MHRA-British-Pharmacopoeia-Quality-Medicines-7487648","display_url":"linkedin.com/groups/MHRA-Br…"}],"hashtags":[{"start":85,"end":91,"tag":"150BP"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452060768092319744","possibly_sensitive":false,"created_at":"2014-04-04T12:31:00.000Z","referenced_tweets":[{"type":"retweeted","id":"452040091268313088"}],"id":"452060768092319744","text":"RT @MHRAgovuk: Join the discussion about our Quality of Medicines event on 9th April #150BP https://t.co/4RPUczrtvu","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/6bGZ0rEn7i","expanded_url":"http://bit.ly/1hbuD0f","display_url":"bit.ly/1hbuD0f"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"452057606920880128","possibly_sensitive":false,"created_at":"2014-04-04T12:18:27.000Z","referenced_tweets":[{"type":"retweeted","id":"452031716254044160"}],"id":"452057606920880128","text":"RT @EFPIA: It's Friday... That means... NEW EFPIA NEWSLETTER!!! Take a read - and have a great Friday! http://t.co/6bGZ0rEn7i","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/dMw6Bf8fNy","expanded_url":"http://bit.ly/1gsOr9l","display_url":"bit.ly/1gsOr9l"},{"start":122,"end":144,"url":"http://t.co/urFD94nUxM","expanded_url":"http://bit.ly/QKBz9T","display_url":"bit.ly/QKBz9T"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"452002707126386688","possibly_sensitive":false,"created_at":"2014-04-04T08:40:17.000Z","referenced_tweets":{},"id":"452002707126386688","text":"Next week our pharmacovigilance &amp; veterinary committees are meeting. Highlights out on Friday: http://t.co/dMw6Bf8fNy http://t.co/urFD94nUxM","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/1JjM6jtZVK","expanded_url":"http://bit.ly/1fEHHJm","display_url":"bit.ly/1fEHHJm"}],"hashtags":[{"start":131,"end":138,"tag":"ctdata"}],"mentions":[{"start":16,"end":23,"username":"abbvie","id":"531892451"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"452001449413992448","possibly_sensitive":false,"created_at":"2014-04-04T08:35:17.000Z","referenced_tweets":{},"id":"452001449413992448","text":"We confirm that @AbbVie has withdrawn its court cases against us concerning access to clinical-trial data: http://t.co/1JjM6jtZVK  #ctdata","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/TB2xBASS4g","expanded_url":"http://bit.ly/1dVb6QV","display_url":"bit.ly/1dVb6QV"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":24,"end":39,"probability":0.708,"type":"Other","normalized_text":"World Health Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451999174830338048","possibly_sensitive":false,"created_at":"2014-04-04T08:26:15.000Z","referenced_tweets":[{"type":"retweeted","id":"451995235925905408"}],"id":"451999174830338048","text":"RT @ECDC_EU: 7 April is World Health Day. Check out our special page on  vector-borne carriers to mark WHD. http://t.co/TB2xBASS4g #Just1bi…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/YMeuYSpJfe","expanded_url":"http://bit.ly/1h80MWh","display_url":"bit.ly/1h80MWh"}],"hashtags":[{"start":50,"end":65,"tag":"ClinicalTrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":85,"end":97,"username":"Europarl_EN","id":"36329597"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451752712145993729","possibly_sensitive":false,"created_at":"2014-04-03T16:06:54.000Z","referenced_tweets":[{"type":"retweeted","id":"451744385336881152"}],"id":"451752712145993729","text":"RT @HAIEurope: We welcome the adoption of the new #ClinicalTrials Regulation by the \n@Europarl_EN. Our statement: http://t.co/YMeuYSpJfe #d…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/Q7yLblLHrY","expanded_url":"http://1.usa.gov/1hhiX6b","display_url":"1.usa.gov/1hhiX6b"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451752667145318400","possibly_sensitive":false,"created_at":"2014-04-03T16:06:43.000Z","referenced_tweets":[{"type":"retweeted","id":"451743782011432961"}],"id":"451752667145318400","text":"RT @FDACBER: #FDA study findings could facilitate development of safe artificial blood http://t.co/Q7yLblLHrY","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/aLafBRNDjG","expanded_url":"http://bit.ly/1jFbW4q","display_url":"bit.ly/1jFbW4q"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":99,"end":114,"username":"mnt_healthnews","id":"2422354153"}],"annotations":[{"start":61,"end":63,"probability":0.6179,"type":"Other","normalized_text":"HIV"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451752179062554624","possibly_sensitive":false,"created_at":"2014-04-03T16:04:47.000Z","referenced_tweets":[{"type":"retweeted","id":"451737807518982145"}],"id":"451752179062554624","text":"RT @EFPIA: Could transplant drugs replace antiretrovirals in HIV treatment? http://t.co/aLafBRNDjG @mnt_healthnews","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451751352734351360","possibly_sensitive":false,"created_at":"2014-04-03T16:01:30.000Z","referenced_tweets":[{"type":"retweeted","id":"451736406659178496"}],"id":"451751352734351360","text":"RT @EFPIA: EFPIA Calls for Collaboration in the Implementation of Clinical Trials Regulation Following Vote in the EP http://t.co/4s9P9MmpH…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8744,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451751250221334528","possibly_sensitive":false,"created_at":"2014-04-03T16:01:05.000Z","referenced_tweets":[{"type":"retweeted","id":"451734699728457728"}],"id":"451751250221334528","text":"RT @US_FDA: FDA approves Evzio, new mechanism for emergency use that rapidly reverses overdose of prescription or illicit opioids http://t.…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":[{"start":111,"end":116,"probability":0.5422,"type":"Place","normalized_text":"London"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451750498681778176","possibly_sensitive":false,"created_at":"2014-04-03T15:58:06.000Z","referenced_tweets":[{"type":"retweeted","id":"451720937340428289"}],"id":"451750498681778176","text":"RT @NICEcomms: We are also looking for a Communications Executive to join NICE's dynamic, creative Comms team (London office) https://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/xOM8C46BFy","expanded_url":"http://www.jobs.nhs.uk/xi/vacancy/6230ef08d35922dc1cc3775a7ad6774a/?vac_ref=913345238","display_url":"jobs.nhs.uk/xi/vacancy/623…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":[{"start":100,"end":109,"probability":0.9613,"type":"Place","normalized_text":"Manchester"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451750344444612608","possibly_sensitive":false,"created_at":"2014-04-03T15:57:29.000Z","referenced_tweets":[{"type":"retweeted","id":"451719622921035776"}],"id":"451750344444612608","text":"RT @NICEcomms: We are looking for a senior scientific adviser on join our scientific advice team in Manchester: http://t.co/xOM8C46BFy …","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":87,"end":94,"probability":0.7758,"type":"Organization","normalized_text":"LinkedIn"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451750079230402560","possibly_sensitive":false,"created_at":"2014-04-03T15:56:26.000Z","referenced_tweets":[{"type":"retweeted","id":"451719184557551617"}],"id":"451750079230402560","text":"RT @MHRAgovuk: Are you attending our Quality of Medicines event on 9th April? Join our LinkedIn group to discuss talking points http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":17,"end":21,"tag":"EMA"},{"start":64,"end":71,"tag":"ctdata"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451697909961355264","possibly_sensitive":false,"created_at":"2014-04-03T12:29:08.000Z","referenced_tweets":[{"type":"retweeted","id":"451697639063822336"}],"id":"451697909961355264","text":"RT @EUombudsman: #EMA previously declared its intention to make #ctdata publicly available. The Ombudsman strongly supports this aim http:/…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":89,"end":95,"tag":"150BP"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451697789802905600","possibly_sensitive":false,"created_at":"2014-04-03T12:28:39.000Z","referenced_tweets":[{"type":"retweeted","id":"451696872936439808"}],"id":"451697789802905600","text":"RT @MHRAgovuk: Discuss manufacturing controls and pharmacopoeial practices on 9 April at #150BP the Quality of Medicines event http://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/20sdusNqeU","expanded_url":"http://www.pharmafile.com/news/184220/eu-votes-trial-transparency#.Uz0-h4vNV6p.twitter","display_url":"pharmafile.com/news/184220/eu…"}],"hashtags":[{"start":70,"end":80,"tag":"alltrials"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":15,"end":16,"probability":0.453,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451675490248450048","possibly_sensitive":false,"created_at":"2014-04-03T11:00:03.000Z","referenced_tweets":[{"type":"retweeted","id":"451674850067628032"}],"id":"451675490248450048","text":"RT @EAHPtweet: EU votes for trial transparency http://t.co/20sdusNqeU #alltrials","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/Tb102EY8Nq","expanded_url":"http://bit.ly/1qyF3cP","display_url":"bit.ly/1qyF3cP"}],"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":57,"end":65,"tag":"experts"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451674996654358529","possibly_sensitive":false,"created_at":"2014-04-03T10:58:05.000Z","referenced_tweets":[{"type":"retweeted","id":"451674436278976512"}],"id":"451674996654358529","text":"RT @EFSA_EU: #EFSApanel renewal: EFSA is looking for top #experts. Apply online as of 9 April http://t.co/Tb102EY8Nq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/k4mnZtpBdf","expanded_url":"http://goo.gl/CYDbSU","display_url":"goo.gl/CYDbSU"}],"hashtags":[{"start":30,"end":48,"tag":"WorldHepatitisDay"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451668143187165185","possibly_sensitive":false,"created_at":"2014-04-03T10:30:51.000Z","referenced_tweets":[{"type":"retweeted","id":"451666896589684736"}],"id":"451668143187165185","text":"RT @Hep_Alliance: Excited for #WorldHepatitisDay 2014? 1 of many amazing campaigns from 2013 http://t.co/k4mnZtpBdf Find out more here http…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/4s9P9MmpH3","expanded_url":"http://bit.ly/1mColpG","display_url":"bit.ly/1mColpG"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451665195476451328","possibly_sensitive":false,"created_at":"2014-04-03T10:19:08.000Z","referenced_tweets":[{"type":"retweeted","id":"451648285359755265"}],"id":"451665195476451328","text":"RT @EFPIA: EFPIA Calls for Collaboration in the Implementation of Clinical Trials Regulation Following Vote in the EP http://t.co/4s9P9MmpH3","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451646582866591744","possibly_sensitive":false,"created_at":"2014-04-03T09:05:11.000Z","referenced_tweets":[{"type":"retweeted","id":"451646485932015616"}],"id":"451646582866591744","text":"RT @Berlaymont: Pharmaceutical companies will have to post results of all their European clinical trials in a public database.\nhttp://t.co/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/zpJdFnWZaS","expanded_url":"http://www.europarl.europa.eu/news/en/news-room/content/20140331IPR41186/","display_url":"europarl.europa.eu/news/en/news-r…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451646118670393344","possibly_sensitive":false,"created_at":"2014-04-03T09:03:20.000Z","referenced_tweets":[{"type":"retweeted","id":"451646043281559552"}],"id":"451646118670393344","text":"RT @GCessak: Clinical trials: clearer rules, better protection for patients (Press release - European Parliament) http://t.co/zpJdFnWZaS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/ffMr03AV87","expanded_url":"http://buzz.mw/bpaca_f","display_url":"buzz.mw/bpaca_f"}],"hashtags":[{"start":71,"end":84,"tag":"transparency"},{"start":125,"end":132,"tag":"ctdata"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451645470335860736","possibly_sensitive":false,"created_at":"2014-04-03T09:00:45.000Z","referenced_tweets":[{"type":"retweeted","id":"451642764607107072"}],"id":"451645470335860736","text":"RT @EUombudsman: [Press release] Clinical trials vote is a triumph for #transparency in EU healthcare http://t.co/ffMr03AV87 #ctdata #alltr…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/CEW16kIrbn","expanded_url":"http://bit.ly/1j3boV4","display_url":"bit.ly/1j3boV4"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":16,"end":19,"probability":0.6119,"type":"Organization","normalized_text":"Borg"},{"start":42,"end":51,"probability":0.3585,"type":"Place","normalized_text":"Parliament"},{"start":60,"end":85,"probability":0.596,"type":"Other","normalized_text":"Clinical Trials Regulation"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451645011831308288","possibly_sensitive":false,"created_at":"2014-04-03T08:58:56.000Z","referenced_tweets":[{"type":"retweeted","id":"451639416168009728"}],"id":"451645011831308288","text":"RT @Berlaymont: Borg welcomes the vote in Parliament on the Clinical Trials Regulation http://t.co/CEW16kIrbn","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/8ZDZ8P1RML","expanded_url":"http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&reference=A7-2013-0208&language=EN","display_url":"europarl.europa.eu/sides/getDoc.d…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451390183288889345","possibly_sensitive":false,"created_at":"2014-04-02T16:06:20.000Z","referenced_tweets":[{"type":"retweeted","id":"451382791180414976"}],"id":"451390183288889345","text":"RT @GCessak: Vote in EP on Clinical trials on medicinal products for human use: http://t.co/8ZDZ8P1RML","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":66,"end":80,"tag":"ClinicalTrial"},{"start":111,"end":119,"tag":"DIA2014"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451389970125967360","possibly_sensitive":false,"created_at":"2014-04-02T16:05:30.000Z","referenced_tweets":[{"type":"retweeted","id":"451381385417068544"}],"id":"451389970125967360","text":"RT @DrugInfoAssn: Enabling Participants' Access to the Electronic #ClinicalTrial Data: The Blue Button Project #DIA2014 http://t.co/tmkTPSe…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":12,"end":19,"tag":"Autism"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451367669376516096","possibly_sensitive":false,"created_at":"2014-04-02T14:36:53.000Z","referenced_tweets":[{"type":"retweeted","id":"451367464539291648"}],"id":"451367669376516096","text":"RT @IMI_JU: #Autism affects 1 in 100 &amp; there are no drugs designed specifically to treat it. IMI is working to change this http://t.co/JiqE…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/HcNGGWmqZB","expanded_url":"http://bit.ly/1hmyqrS","display_url":"bit.ly/1hmyqrS"}],"hashtags":[{"start":31,"end":46,"tag":"ClinicalTrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451367630419808256","possibly_sensitive":false,"created_at":"2014-04-02T14:36:43.000Z","referenced_tweets":[{"type":"retweeted","id":"451367543903879168"}],"id":"451367630419808256","text":"RT @HAIEurope: Our position on #ClinicalTrials transparency: http://t.co/HcNGGWmqZB","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/mBSy03hgBJ","expanded_url":"http://bit.ly/1iZI2GW","display_url":"bit.ly/1iZI2GW"}],"hashtags":[{"start":60,"end":71,"tag":"Scientists"},{"start":72,"end":80,"tag":"Vacancy"},{"start":84,"end":89,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451367266157076480","possibly_sensitive":false,"created_at":"2014-04-02T14:35:16.000Z","referenced_tweets":[{"type":"retweeted","id":"451367207847489536"}],"id":"451367266157076480","text":"RT @EFSA_EU: We are looking for Senior Scientific Officers. #Scientists #Vacancy at #EFSA - Apply before 6 May http://t.co/mBSy03hgBJ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/k6BtixjNDJ","expanded_url":"http://bit.ly/1kssdrO","display_url":"bit.ly/1kssdrO"}],"hashtags":[{"start":60,"end":75,"tag":"ClinicalTrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":30,"end":42,"probability":0.5896,"type":"Organization","normalized_text":"EU Parliament"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451366812102713345","possibly_sensitive":false,"created_at":"2014-04-02T14:33:28.000Z","referenced_tweets":[{"type":"retweeted","id":"451366493771800576"}],"id":"451366812102713345","text":"RT @HAIEurope: Coming up: The EU Parliament plenary vote on #ClinicalTrials Regulation. Watch here: http://t.co/k6BtixjNDJ","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/2wk84cBHIc","expanded_url":"http://blogs.biomedcentral.com/bmcblog/2014/04/02/final-countdown-for-the-eu-clinical-trials-regulation/","display_url":"blogs.biomedcentral.com/bmcblog/2014/0…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":39,"end":67,"probability":0.6329,"type":"Other","normalized_text":"EU Clinical Trials Regulation"},{"start":71,"end":84,"probability":0.7346,"type":"Organization","normalized_text":"BioMed Central"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451365104878358528","possibly_sensitive":false,"created_at":"2014-04-02T14:26:41.000Z","referenced_tweets":[{"type":"retweeted","id":"451364983238971392"}],"id":"451365104878358528","text":"RT @EAHPtweet: Final countdown for the EU Clinical Trials Regulation - BioMed Central blog http://t.co/2wk84cBHIc","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451357817698807808","possibly_sensitive":false,"created_at":"2014-04-02T13:57:44.000Z","referenced_tweets":[{"type":"retweeted","id":"451357278323900419"}],"id":"451357817698807808","text":"RT @FDACBER: #FDA approves Oralair, the first sublingual allergen extract for the treatment of certain grass pollen allergies   http://t.co…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/dtZoaIaKxw","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":106,"end":118,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451357454585323520","possibly_sensitive":false,"created_at":"2014-04-02T13:56:17.000Z","referenced_tweets":{},"id":"451357454585323520","text":"We're looking to recruit a Head for our Administration Division. Apply by 14 May: http://t.co/dtZoaIaKxw  #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/bJV0JbAvZY","expanded_url":"http://bit.ly/1ebijY3","display_url":"bit.ly/1ebijY3"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451357346846212096","possibly_sensitive":false,"created_at":"2014-04-02T13:55:51.000Z","referenced_tweets":{},"id":"451357346846212096","text":"We're looking to recruit one to two Data Officers to support the Data Management Team. Apply by 2 May: http://t.co/bJV0JbAvZY  #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"451357013235466240","possibly_sensitive":false,"created_at":"2014-04-02T13:54:32.000Z","referenced_tweets":{},"id":"451357013235466240","text":"We're recruiting a Continuous Improvement Lead in our Procedure Management Department. Apply by 2 May: http://t.co/hCvn8Uqhel  #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":19,"end":34,"probability":0.5719,"type":"Other","normalized_text":"World Health Day"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451353274474856448","possibly_sensitive":false,"created_at":"2014-04-02T13:39:41.000Z","referenced_tweets":[{"type":"retweeted","id":"451338574018138113"}],"id":"451353274474856448","text":"RT @WHO_Europe: On World Health Day 7 April 2014, WHO calls on everyone to protect themselves from vector-borne diseases http://t.co/B2ORGG…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/iNQIc1KMr3","expanded_url":"http://buff.ly/1j5sW1t","display_url":"buff.ly/1j5sW1t"}],"hashtags":[{"start":74,"end":80,"tag":"150BP"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"annotations":[{"start":23,"end":33,"probability":0.9772,"type":"Person","normalized_text":"Sabine Kopp"},{"start":47,"end":66,"probability":0.5892,"type":"Organization","normalized_text":"Quality of Medicines"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451353099186470912","possibly_sensitive":false,"created_at":"2014-04-02T13:38:59.000Z","referenced_tweets":[{"type":"retweeted","id":"451334508038864897"}],"id":"451353099186470912","text":"RT @MHRAgovuk: .@WHO’s Sabine Kopp to speak at Quality of Medicines event #150BP on 9 April http://t.co/iNQIc1KMr3","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/YaIwcOJN41","expanded_url":"http://gu.com/p/3z35z/tw","display_url":"gu.com/p/3z35z/tw"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451352735284486145","possibly_sensitive":false,"created_at":"2014-04-02T13:37:32.000Z","referenced_tweets":[{"type":"retweeted","id":"451324426173177857"}],"id":"451352735284486145","text":"RT @EU_eHealth: \"Thousands of lives put at risk by clinical trials system that is 'not fit for purpose'\": http://t.co/YaIwcOJN41 via @guard…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":44,"end":59,"tag":"medicaldevices"},{"start":66,"end":81,"tag":"clinicaltrials"},{"start":114,"end":122,"tag":"plenary"}],"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"annotations":[{"start":81,"end":93,"probability":0.6864,"type":"Organization","normalized_text":"EU Parliament"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451351836206059521","possibly_sensitive":false,"created_at":"2014-04-02T13:33:58.000Z","referenced_tweets":[{"type":"retweeted","id":"451311028874522624"}],"id":"451351836206059521","text":"RT @beuctweet: Health shake-up in sight for #medicaldevices &amp; #clinicaltrials as EU Parliament votes today in #plenary. BEUC stance: http:/…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451284064738484224","possibly_sensitive":false,"created_at":"2014-04-02T10:40:01.000Z","referenced_tweets":[{"type":"replied_to","id":"451284064738484224"}],"id":"451308062130073600","text":"Apologies, the deadline to apply for this job is 2 May, not 14 May. We've corrected it on our website: http://t.co/hCvn8Uqhel","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"entities":{"urls":{},"hashtags":[{"start":92,"end":99,"tag":"autism"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451303396688297984","possibly_sensitive":false,"created_at":"2014-04-02T10:21:29.000Z","referenced_tweets":[{"type":"retweeted","id":"451301076319604736"}],"id":"451303396688297984","text":"RT @IMI_JU: Key finding from our EU-AIMS project: some of the brain changes associated with #autism could be reversed http://t.co/i9MAJNN2r…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/bJV0JbAvZY","expanded_url":"http://bit.ly/1ebijY3","display_url":"bit.ly/1ebijY3"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"451284928710590464","possibly_sensitive":false,"created_at":"2014-04-02T09:08:06.000Z","referenced_tweets":{},"id":"451284928710590464","text":"We're looking to recruit up to 2 Data Officers to support the Data Management Team. Apply by 2 May: http://t.co/bJV0JbAvZY #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"451284064738484224","possibly_sensitive":false,"created_at":"2014-04-02T09:04:40.000Z","referenced_tweets":{},"id":"451284064738484224","text":"We're looking for a Continuous Improvement Lead (Procedure Management Department). Apply by 14 May: http://t.co/hCvn8Uqhel #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/dtZoaIaKxw","expanded_url":"http://bit.ly/1fMvCi1","display_url":"bit.ly/1fMvCi1"}],"hashtags":[{"start":83,"end":95,"tag":"recruitment"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451283133925982208","possibly_sensitive":false,"created_at":"2014-04-02T09:00:58.000Z","referenced_tweets":{},"id":"451283133925982208","text":"We're recruiting a Head of Administration. Apply by 14 May: http://t.co/dtZoaIaKxw #recruitment","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/XVHSKjl90S","expanded_url":"http://bit.ly/1jwnVRI","display_url":"bit.ly/1jwnVRI"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"451279170614878208","possibly_sensitive":false,"created_at":"2014-04-02T08:45:13.000Z","referenced_tweets":{},"id":"451279170614878208","text":"Companies: our fees have increased by 1.5% to account for annual inflation: http://t.co/XVHSKjl90S","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/kCQe4lSvfM","expanded_url":"http://bit.ly/1hfonOZ","display_url":"bit.ly/1hfonOZ"}],"hashtags":[{"start":0,"end":5,"tag":"SMEs"},{"start":96,"end":107,"tag":"innovation"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451278905371295744","possibly_sensitive":false,"created_at":"2014-04-02T08:44:10.000Z","referenced_tweets":{},"id":"451278905371295744","text":"#SMEs now receive new fee incentives for post-authorisation activities: http://t.co/kCQe4lSvfM  #innovation","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/1z3lTW55KB","expanded_url":"http://ow.ly/vk9qn","display_url":"ow.ly/vk9qn"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451277751832821761","possibly_sensitive":false,"created_at":"2014-04-02T08:39:35.000Z","referenced_tweets":[{"type":"retweeted","id":"451275459871789056"}],"id":"451277751832821761","text":"RT @ESEndocrinology: In the news: Novel study into breast cancer origins paves way for personalized treatment http://t.co/1z3lTW55KB","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/JiqEHrff6e","expanded_url":"http://bit.ly/1lBrh8z","display_url":"bit.ly/1lBrh8z"}],"hashtags":[{"start":75,"end":82,"tag":"autism"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451276906378588160","possibly_sensitive":false,"created_at":"2014-04-02T08:36:13.000Z","referenced_tweets":[{"type":"retweeted","id":"451265312911273984"}],"id":"451276906378588160","text":"RT @IMI_JU: IMI’s EU-AIMS project is paving the way for new treatments for #autism – find out how in this short film http://t.co/JiqEHrff6e…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/0I1vooz62j","expanded_url":"http://bit.ly/1mu5OMb","display_url":"bit.ly/1mu5OMb"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451034898493890560","possibly_sensitive":false,"created_at":"2014-04-01T16:34:34.000Z","referenced_tweets":{},"id":"451034898493890560","text":"Two weeks left to comment on the draft Community herbal monograph for rose flower: http://t.co/0I1vooz62j","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/2m6Xqvj6X4","expanded_url":"http://bit.ly/1jTbbY1","display_url":"bit.ly/1jTbbY1"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451034346095661057","possibly_sensitive":false,"created_at":"2014-04-01T16:32:22.000Z","referenced_tweets":{},"id":"451034346095661057","text":"Two more weeks to comment on draft herbal monograph on Sisymbrium officinale (L.) Scop., herba (hedge mustard): http://t.co/2m6Xqvj6X4","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/dnf7BNjhIf","expanded_url":"http://bit.ly/1hYlfrW","display_url":"bit.ly/1hYlfrW"}],"hashtags":[{"start":4,"end":8,"tag":"SME"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451034246086664195","possibly_sensitive":false,"created_at":"2014-04-01T16:31:58.000Z","referenced_tweets":{},"id":"451034246086664195","text":"Our #SME workshop on quality of medicines takes place this Friday. Register in advance to follow the live broadcast: http://t.co/dnf7BNjhIf","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/bE0isHAHVh","expanded_url":"http://ow.ly/vidwq","display_url":"ow.ly/vidwq"}],"hashtags":[{"start":26,"end":33,"tag":"ELCC14"},{"start":95,"end":107,"tag":"OncologyPRO"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451033919585280000","possibly_sensitive":false,"created_at":"2014-04-01T16:30:40.000Z","referenced_tweets":[{"type":"retweeted","id":"451017796735234048"}],"id":"451033919585280000","text":"RT @myESMO: Webcasts from #ELCC14 lung cancer conference are now online. ESMO members, view on #OncologyPRO here http://t.co/bE0isHAHVh","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/sB937jBBV2","expanded_url":"http://bit.ly/IMIjobs","display_url":"bit.ly/IMIjobs"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451033768263184384","possibly_sensitive":false,"created_at":"2014-04-01T16:30:04.000Z","referenced_tweets":[{"type":"retweeted","id":"451024912917209088"}],"id":"451033768263184384","text":"RT @IMI_JU: Want to work at IMI? We’re looking for a Scientific Project Officer http://t.co/sB937jBBV2  Deadline for applications: 4 May #j…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/qdmspj3ppz","expanded_url":"http://bit.ly/1flEkXJ","display_url":"bit.ly/1flEkXJ"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"redacre","id":"380500399"}],"annotations":[{"start":43,"end":44,"probability":0.5217,"type":"Organization","normalized_text":"EU"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"451022866054930432","possibly_sensitive":false,"created_at":"2014-04-01T16:27:56.000Z","referenced_tweets":[{"type":"replied_to","id":"451023111929208832"}],"id":"451033228363976704","text":"@redacre The annual adjustment is based on EU inflation the previous year. Full details on our website: http://t.co/qdmspj3ppz","attachments":{"media_keys":{}},"in_reply_to_user_id":"380500399"},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/kCQe4lSvfM","expanded_url":"http://bit.ly/1hfonOZ","display_url":"bit.ly/1hfonOZ"}],"hashtags":[{"start":40,"end":45,"tag":"SMEs"},{"start":104,"end":115,"tag":"innovation"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"451032146183217153","possibly_sensitive":false,"created_at":"2014-04-01T16:23:38.000Z","referenced_tweets":{},"id":"451032146183217153","text":"We've introduced new fee incentives for #SMEs for post-authorisation activities: http://t.co/kCQe4lSvfM #innovation","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/XVHSKjl90S","expanded_url":"http://bit.ly/1jwnVRI","display_url":"bit.ly/1jwnVRI"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"451022866054930432","possibly_sensitive":false,"created_at":"2014-04-01T15:46:45.000Z","referenced_tweets":{},"id":"451022866054930432","text":"Our increased fees for companies come into effect today to account for annual inflation: http://t.co/XVHSKjl90S","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":101,"end":122,"tag":"AntibioticResistance"}],"mentions":[{"start":31,"end":41,"username":"FIDIN_DGM","id":"281540837"}],"annotations":[{"start":78,"end":86,"probability":0.8451,"type":"Place","normalized_text":"Amsterdam"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450990865520271360","possibly_sensitive":false,"created_at":"2014-04-01T13:39:36.000Z","referenced_tweets":[{"type":"retweeted","id":"450968653547446272"}],"id":"450990865520271360","text":"RT @IFAHEurope: Save the date! @FIDIN_DGM Jubilee Conference, 1 October 2014, Amsterdam: Wrap up the #AntibioticResistance - http://t.co/75…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/QlHwOzY8r9","expanded_url":"http://buff.ly/1cZaoBM","display_url":"buff.ly/1cZaoBM"}],"hashtags":[{"start":82,"end":88,"tag":"150BP"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":15,"end":28,"probability":0.9745,"type":"Person","normalized_text":"Susanne Keitel"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450990386945994752","possibly_sensitive":false,"created_at":"2014-04-01T13:37:41.000Z","referenced_tweets":[{"type":"retweeted","id":"450972136036126720"}],"id":"450990386945994752","text":"RT @MHRAgovuk: Susanne Keitel to talk about updates from the European Directorate #150BP on 9 April http://t.co/QlHwOzY8r9","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/xvIYD25CtN","expanded_url":"http://bit.ly/1hYZJ6l","display_url":"bit.ly/1hYZJ6l"}],"hashtags":[{"start":20,"end":35,"tag":"Medicaldevices"},{"start":64,"end":68,"tag":"MEP"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":69,"end":83,"username":"DRothBehrendt","id":"20757050"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450989495488622592","possibly_sensitive":false,"created_at":"2014-04-01T13:34:09.000Z","referenced_tweets":[{"type":"retweeted","id":"450984311735713792"}],"id":"450989495488622592","text":"RT @EP_Environment: #Medicaldevices: press conference with lead #MEP @DRothBehrendt tmw Wed, 15h, PHS 0A50. Webstr http://t.co/xvIYD25CtN v…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/dnf7BNjhIf","expanded_url":"http://bit.ly/1hYlfrW","display_url":"bit.ly/1hYlfrW"}],"hashtags":[{"start":17,"end":21,"tag":"SME"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450941740493864960","possibly_sensitive":false,"created_at":"2014-04-01T10:24:23.000Z","referenced_tweets":{},"id":"450941740493864960","text":"We're holding an #SME workshop on quality of medicines this Friday. Register to follow the live broadcast: http://t.co/dnf7BNjhIf","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/2m6Xqvj6X4","expanded_url":"http://bit.ly/1jTbbY1","display_url":"bit.ly/1jTbbY1"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450939788523495424","possibly_sensitive":false,"created_at":"2014-04-01T10:16:38.000Z","referenced_tweets":{},"id":"450939788523495424","text":"Two weeks left to comment on draft herbal monograph on Sisymbrium officinale (L.) Scop., herba (hedge mustard): http://t.co/2m6Xqvj6X4","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/khoNlLymBI","expanded_url":"http://www.haematologica.org/content/current","display_url":"haematologica.org/content/current"},{"start":98,"end":120,"url":"http://t.co/fgJVmWbrRd","expanded_url":"http://fb.me/6IWBdj4m4","display_url":"fb.me/6IWBdj4m4"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"EHA_Hematology","id":"279001852"}],"annotations":[{"start":39,"end":51,"probability":0.3739,"type":"Organization","normalized_text":"Haematologica"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450912218595749888","possibly_sensitive":false,"created_at":"2014-04-01T08:27:05.000Z","referenced_tweets":[{"type":"retweeted","id":"450908103773806592"}],"id":"450912218595749888","text":"RT @EHA_Hematology: The April issue of Haematologica is available online:\n\nhttp://t.co/khoNlLymBI http://t.co/fgJVmWbrRd","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/0I1vooz62j","expanded_url":"http://bit.ly/1mu5OMb","display_url":"bit.ly/1mu5OMb"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450912005206315008","possibly_sensitive":false,"created_at":"2014-04-01T08:26:14.000Z","referenced_tweets":{},"id":"450912005206315008","text":"Two more weeks to comment on the draft Community herbal monograph for Rose flower: http://t.co/0I1vooz62j","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/VEw58uCXpZ","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON399321","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450707806380113920","possibly_sensitive":false,"created_at":"2014-03-31T18:54:49.000Z","referenced_tweets":[{"type":"retweeted","id":"450671827086749696"}],"id":"450707806380113920","text":"RT @MHRAgovuk: Medicines and Healthcare Products Regulatory Agency publishes 2013 perceptions audit report http://t.co/VEw58uCXpZ","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":[{"start":59,"end":65,"probability":0.681,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"450670271578767361","possibly_sensitive":false,"created_at":"2014-03-31T16:25:40.000Z","referenced_tweets":{},"id":"450670271578767361","text":"Many thanks to all of you who completed our survey on this Twitter feed! We're analysing the results now...","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/33l7dn3TFW","expanded_url":"http://ecranproject.eu/node/10","display_url":"ecranproject.eu/node/10"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450658198991949824","possibly_sensitive":false,"created_at":"2014-03-31T15:37:42.000Z","referenced_tweets":[{"type":"retweeted","id":"450657184209469440"}],"id":"450658198991949824","text":"RT @nice_intl: Watch the story of the first clinical trial: http://t.co/33l7dn3TFW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":52,"end":58,"probability":0.7391,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450617905013878784","possibly_sensitive":false,"created_at":"2014-03-31T12:57:35.000Z","referenced_tweets":{},"id":"450617905013878784","text":"Just 3 hours left to tell us what you think of this Twitter feed. Fill in our quick survey now: http://t.co/q987RFusP6","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/4Xa1uHHejG","expanded_url":"http://bit.ly/1gg7jrU","display_url":"bit.ly/1gg7jrU"}],"hashtags":[{"start":59,"end":69,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450611171352391680","possibly_sensitive":false,"created_at":"2014-03-31T12:30:49.000Z","referenced_tweets":[{"type":"retweeted","id":"450611047120904192"}],"id":"450611171352391680","text":"RT @euparkinsons: Nearly 40 new medicines in development 4 #Parkinson’s disease: http://t.co/4Xa1uHHejG","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":15,"end":31,"probability":0.9909,"type":"Person","normalized_text":"Samantha Atkinson"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450610341186383873","possibly_sensitive":false,"created_at":"2014-03-31T12:27:31.000Z","referenced_tweets":[{"type":"retweeted","id":"450609742562742273"}],"id":"450610341186383873","text":"RT @MHRAgovuk: Samantha Atkinson to speak about 150 years of @BPpublisher #150BP at Quality of Medicines event on 9 April http://t.co/ErVt0…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/9K675z56FS","expanded_url":"http://bit.ly/1gHamyd","display_url":"bit.ly/1gHamyd"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":51,"end":55,"probability":0.9062,"type":"Place","normalized_text":"Italy"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"450610147979567104","possibly_sensitive":false,"created_at":"2014-03-31T12:26:45.000Z","referenced_tweets":{},"id":"450610147979567104","text":"RT @Aifa_ufficiale: Harmonisation and flexibility: Italy's work in the Coordination Group for Mutual Recognition &amp;... http://t.co/9K675z56FS","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Oc5MKC0noW","expanded_url":"http://goo.gl/lCm5nR","display_url":"goo.gl/lCm5nR"}],"hashtags":[{"start":44,"end":48,"tag":"HCV"},{"start":73,"end":81,"tag":"ILC2014"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":18,"end":22,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450595903792238592","possibly_sensitive":false,"created_at":"2014-03-31T11:30:09.000Z","referenced_tweets":[{"type":"retweeted","id":"450594332996038656"}],"id":"450595903792238592","text":"RT @Hep_Alliance: @WHO to launch first ever #HCV treatment guidelines at #ILC2014 http://t.co/Oc5MKC0noW","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/3YN1exEdRI","expanded_url":"http://www.egagenerics.com/index.php/generic-medicines/facts-and-figures","display_url":"egagenerics.com/index.php/gene…"}],"hashtags":[{"start":81,"end":90,"tag":"patients"},{"start":91,"end":106,"tag":"sustainability"},{"start":107,"end":114,"tag":"health"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450584674382147584","possibly_sensitive":false,"created_at":"2014-03-31T10:45:32.000Z","referenced_tweets":[{"type":"retweeted","id":"450582354500005888"}],"id":"450584674382147584","text":"RT @egagenerics: Facts &amp; Figures on Generic Medicines http://t.co/3YN1exEdRI #patients #sustainability #health","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/MVfrxBYleG","expanded_url":"https://erecruit.who.int/public/hrd-cl-vac-view.asp?o_c=1000&jobinfo_uid_c=29003&vaclng=en","display_url":"erecruit.who.int/public/hrd-cl-…"}],"hashtags":[{"start":74,"end":77,"tag":"TB"},{"start":97,"end":104,"tag":"TBChat"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450571046564159488","possibly_sensitive":false,"created_at":"2014-03-31T09:51:23.000Z","referenced_tweets":[{"type":"retweeted","id":"450570413806874624"}],"id":"450571046564159488","text":"RT @WHO_Europe_TB: WHO e-Recruit - Technical Officer (GDF-Drug Management/#TB) (EURO/14/FT160) | #TBChat https://t.co/MVfrxBYleG","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/Tb102EY8Nq","expanded_url":"http://bit.ly/1qyF3cP","display_url":"bit.ly/1qyF3cP"}],"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":57,"end":65,"tag":"experts"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450569567400886272","possibly_sensitive":false,"created_at":"2014-03-31T09:45:30.000Z","referenced_tweets":[{"type":"retweeted","id":"450569448744058880"}],"id":"450569567400886272","text":"RT @EFSA_EU: #EFSApanel renewal: EFSA is looking for top #experts. Apply online as of 9 April http://t.co/Tb102EY8Nq","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":43,"end":49,"probability":0.7339,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450567401273561088","possibly_sensitive":false,"created_at":"2014-03-31T09:36:54.000Z","referenced_tweets":{},"id":"450567401273561088","text":"Last chance to complete our survey on this Twitter feed: http://t.co/q987RFusP6","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ih6nfK77Fw","expanded_url":"http://bit.ly/1gGNRti","display_url":"bit.ly/1gGNRti"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"450564348097077248","possibly_sensitive":false,"created_at":"2014-03-31T09:24:46.000Z","referenced_tweets":{},"id":"450564348097077248","text":"RT @GCessak: I encourage you to familiarise yourself with the issues in our handbook on adverse reactions to drugs at:http://t.co/ih6nfK77Fw","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/he2UXzdRGo","expanded_url":"http://bit.ly/1gGNfEe","display_url":"bit.ly/1gGNfEe"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"450562909102669824","possibly_sensitive":false,"created_at":"2014-03-31T09:19:03.000Z","referenced_tweets":{},"id":"450562909102669824","text":"RT @URPLWMiPB: Handbook on reporting adverse reactioms from the Polish medicines agency http://t.co/he2UXzdRGo","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":58,"end":69,"tag":"antibiotic"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450562287003521024","possibly_sensitive":false,"created_at":"2014-03-31T09:16:34.000Z","referenced_tweets":[{"type":"retweeted","id":"450535993444421632"}],"id":"450562287003521024","text":"RT @IMI_JU: Deadline 17:00 CEST today! Got an interesting #antibiotic hit/lead against Gram-negs? Contact IMI project ENABLE http://t.co/Zi…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":38,"end":47,"tag":"Diabetes"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450562114370162688","possibly_sensitive":false,"created_at":"2014-03-31T09:15:53.000Z","referenced_tweets":[{"type":"retweeted","id":"450533571141177344"}],"id":"450562114370162688","text":"RT @EFPIA: NEW BLOG from EFPIA's DG \" #Diabetes Toolkit Highlights Collaborative Efforts Taking Aim at Chronic Conditions\" - http://t.co/XL…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":25,"tag":"EU4Health"},{"start":54,"end":70,"tag":"chronicdiseases"},{"start":85,"end":88,"tag":"EU"},{"start":101,"end":104,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"450561987404386304","possibly_sensitive":false,"created_at":"2014-03-31T09:15:23.000Z","referenced_tweets":[{"type":"retweeted","id":"450533031741112321"}],"id":"450561987404386304","text":"RT @EU_Health: #EU4Health How to reduce the burden of #chronicdiseases &amp; what is #EU action? 1st #EU summit on the topic 3-4/04/14 http://t…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/KFfwjugdGi","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449595187543945216","possibly_sensitive":false,"created_at":"2014-03-28T17:13:40.000Z","referenced_tweets":{},"id":"449595187543945216","text":"Still time to comment on our draft guideline on core SmPC for plasma-derived fibrin sealant / haemostatic products: http://t.co/KFfwjugdGi","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":97,"end":101,"tag":"HIV"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594908165541888","possibly_sensitive":false,"created_at":"2014-03-28T17:12:33.000Z","referenced_tweets":{},"id":"449594908165541888","text":"Last opportunity to comment on our draft guideline on clinical development of medicines to treat #HIV infection: http://t.co/9jX4i4VlnA","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"hashtags":[{"start":102,"end":115,"tag":"hypertension"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594603948490752","possibly_sensitive":false,"created_at":"2014-03-28T17:11:21.000Z","referenced_tweets":{},"id":"449594603948490752","text":"Still time to comment on a paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":20,"end":26,"probability":0.7553,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594472507383809","possibly_sensitive":false,"created_at":"2014-03-28T17:10:49.000Z","referenced_tweets":{},"id":"449594472507383809","text":"Help us enhance our Twitter feed by completing a quick survey: http://t.co/q987RFusP6","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":16,"end":25,"tag":"diabetes"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594343931002880","possibly_sensitive":false,"created_at":"2014-03-28T17:10:19.000Z","referenced_tweets":[{"type":"retweeted","id":"449487631475572737"}],"id":"449594343931002880","text":"RT @IMI_JU: IMI #diabetes project SUMMIT has developed a life-saving device that could help prevent heart attacks and strokes http://t.co/3…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/2QqmPUqFn0","expanded_url":"http://cordis.europa.eu/result/story/rcn/12448_en.html","display_url":"cordis.europa.eu/result/story/r…"}],"hashtags":[{"start":71,"end":74,"tag":"EU"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":99,"end":115,"username":"puzzledbypolicy","id":"234843896"},{"start":117,"end":129,"username":"OURSPACE_EU","id":"213315680"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594153731903488","possibly_sensitive":false,"created_at":"2014-03-28T17:09:33.000Z","referenced_tweets":[{"type":"retweeted","id":"449505089292886016"}],"id":"449594153731903488","text":"RT @myCORDIS: E-Participation: the Future of Citizen Engagement in the #EU http://t.co/2QqmPUqFn0 \n@puzzledbypolicy \n@OURSPACE_EU","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/6rP6TIVxVp","expanded_url":"http://ow.ly/v71O7","display_url":"ow.ly/v71O7"}],"hashtags":[{"start":136,"end":143,"tag":"ELCC14"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449594037545492481","possibly_sensitive":false,"created_at":"2014-03-28T17:09:06.000Z","referenced_tweets":[{"type":"retweeted","id":"449510629867790336"}],"id":"449594037545492481","text":"RT @myESMO: ESMOChannel: Lung adenocarcinoma w/ RET fusion: early experience w/ diagnosis &amp; targeted therapy http://t.co/6rP6TIVxVp #ELCC14","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":30,"end":43,"tag":"Transparency"},{"start":57,"end":65,"tag":"EMWABud"}],"mentions":[{"start":3,"end":17,"username":"Official_EMWA","id":"215785753"},{"start":88,"end":97,"username":"EMA_News","id":"116716199"},{"start":102,"end":113,"username":"Boehringer","id":"17437735"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449593055763771393","possibly_sensitive":false,"created_at":"2014-03-28T17:05:12.000Z","referenced_tweets":[{"type":"retweeted","id":"449517348475920384"}],"id":"449593055763771393","text":"RT @Official_EMWA: Clin Trial #Transparency Symposium at #EMWABud 15 May w/ speakers of @EMA_News and @Boehringer Transparency Initiat http…","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":97,"end":101,"tag":"FP7"},{"start":106,"end":118,"tag":"Horizon2020"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449592883738574848","possibly_sensitive":false,"created_at":"2014-03-28T17:04:31.000Z","referenced_tweets":[{"type":"retweeted","id":"449592460214554624"}],"id":"449592883738574848","text":"RT @eubookshop: SME participation made easier and faster in biotechnologies and bioeconomy under #FP7 and #Horizon2020 http://t.co/IJOMevUW…","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":24,"end":30,"probability":0.7213,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449476308624744448","possibly_sensitive":false,"created_at":"2014-03-28T09:21:17.000Z","referenced_tweets":{},"id":"449476308624744448","text":"Give us feedback on our Twitter feed by filling in a quick survey: http://t.co/q987RFusP6","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"hashtags":[{"start":103,"end":116,"tag":"hypertension"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449476127753789440","possibly_sensitive":false,"created_at":"2014-03-28T09:20:34.000Z","referenced_tweets":{},"id":"449476127753789440","text":"Last chance to comment on a paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":92,"end":96,"tag":"HIV"}],"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449475988020539392","possibly_sensitive":false,"created_at":"2014-03-28T09:20:01.000Z","referenced_tweets":{},"id":"449475988020539392","text":"Last chance to comment on our draft guideline on clinical development of medicines to treat #HIV infection: http://t.co/9jX4i4VlnA","attachments":{"media_keys":{}}},{"entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/KFfwjugdGi","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"hashtags":{},"mentions":{},"annotations":{}},"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449474672334487554","possibly_sensitive":false,"created_at":"2014-03-28T09:14:47.000Z","referenced_tweets":{},"id":"449474672334487554","text":"Last chance to comment on our draft guideline on core SmPC for plasma-derived fibrin sealant / haemostatic products: http://t.co/KFfwjugdGi","attachments":{"media_keys":{}}},{"entities":{"urls":{},"hashtags":[{"start":34,"end":44,"tag":"EUfunding"},{"start":46,"end":57,"tag":"EUpartners"},{"start":70,"end":76,"tag":"grant"},{"start":80,"end":86,"tag":"H2020"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":113,"end":119,"username":"H2020","id":"39855385"}],"annotations":{}},"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"449171729278328832","possibly_sensitive":false,"created_at":"2014-03-27T13:11:00.000Z","referenced_tweets":[{"type":"retweeted","id":"449167524287234049"}],"id":"449171729278328832","text":"RT @EU_eHealth: How to look for a #EUfunding/ #EUpartners or manage a #grant in #H2020 Here all you have to know @H2020 http://t.co/t0PO68j…","attachments":{"media_keys":{}}}]
